CpGmarker,CoefficientTraining,CoefficientTrainingShrunk,varByCpG,minByCpG,maxByCpG,medianByCpG,medianByCpGYoung,medianByCpGOld,Gene_ID,GenomeBuild,Chr,MapInfo,SourceVersion,TSS_Coordinate,Gene_Strand,Symbol,Synonym,Accession,GID,Annotation,Product,Marginal Age Relationship,chr.coord_hg19,H3K27ac,H3K4me3,H3K36me3,H3K27me3,H3K9ac,H3K4me1,H3K9me3,RNF2,EZH2,RNA,Replication_timing,LaminB1,Gene_body,CGI,Shore,Shelf,ChrHMM_state,ChrHMM_state_reann
cg00075967,0.12933661,0.108096063,0.026,0.016,0.97,0.75,0.72,0.75,64220,36,15,72282407,36.1,72282245,-,STRA6,PP14296; FLJ12541;,NM_022369.2,GI:21314699,synonyms: PP14296; FLJ12541,stimulated by retinoic acid gene 6 homolog,positive,chr15:74495354,-0.628321205430349,-0.750848267193375,0.0388056037369547,0.419245285738915,-0.83063632507108,-0.420019928435952,0.657487505494997,0.317193790478332,0.422428017122834,-0.439261680600165,77.4845659251225,1.48161921077772,Yes,No,No,No,16,Weak enhancer
cg00091693,-0.002008493,NA,0.0067,0.15,0.9,0.7,0.7,0.69,54474,36,17,36295128,36.1,36295005,-,KRT20,K20; CK20; KRT21; MGC35423;,NM_019010.1,GI:27894336,cytokeratin 20; keratin; type I cytoskeletal 20; go_component: intermediate filament; go_function: structural constituent of cytoskeleton; go_process: biological process unknown,keratin 20,negative,chr17:39041602,-0.893797923355669,-0.619564221995792,-0.444040241410558,0.585821813396829,-0.76125510616465,-0.778987279448586,0.432387561906358,0.400693007507631,-0.225044325926353,-0.428393973721974,73.7494720687295,0.585621351183812,No,No,No,No,24,Repressed polycomb
cg00168942,-0.111945219,NA,0.022,0.0012,0.94,0.59,0.62,0.56,219770,36,10,35934436,36.1,35934344,+,CX40.1,FLJ90023; RP11-425A6.2;,NM_153368.1,GI:23503308,go_component: connexon complex; go_component: integral to membrane; go_function: connexon channel activity; go_process: cell communication,connexin40.1,negative,chr10:35894430,-0.77723363379672,-0.941338175808236,-0.316913746174471,0.589727919273152,-0.913608888537585,-0.844330736661377,0.199265377224352,0.670981230998269,-0.133439992048483,-0.439261680600165,61.7861455218156,1.6457472572699,Yes,No,No,Yes,23,Bivalent promoter
cg00374717,0.005017857,NA,0.012,0.0031,1,0.89,0.87,0.9,22901,36,17,63814740,36.1,63815191,+,ARSG,KIAA1001;,NM_014960.2,GI:45430056,go_function: hydrolase activity; go_function: calcium ion binding; go_function: sulfuric ester hydrolase activity; go_process: metabolism,Arylsulfatase G,positive,chr17:66303145,-0.796236004457278,-0.865501475581162,0.459434614821253,-0.698229371698663,-0.876268259730056,-0.864932725357694,-0.485062036655263,0.382323484034946,0.680753068205069,0.460354853175859,63.9686317443848,0.0957613044631871,Yes,No,No,No,25,Quiescent/low
cg00431549,-0.136199957,-0.350739715,0.032,0,0.98,0.26,0.31,0.22,4256,36,12,14930292,36.1,14930095,-,MGP,NTI; GIG36; MGLAP;,NM_000900.2,GI:49574513,###############################################################################################################################################################################################################################################################,matrix Gla protein,negative,chr12:15039025,-0.830089302567064,-0.856111258665764,-0.124582675473568,0.366291831334956,-0.787185352423093,-0.111063492253448,-0.349588759155019,-0.139204259563662,-0.605600210517759,-0.415948311400376,38.5430488586426,0.683297536910631,Yes,No,No,No,17,Weak enhancer
cg00436603,0.000265206,NA,0.018,0.023,0.99,0.72,0.75,0.7,1571,36,10,135190730,36.1,135190857,+,CYP2E1,CPE1; CYP2E; P450-J; P450C2E;,NM_000773.3,GI:75709190,###############################################################################################################################################################################################################################################################,cytochrome P450; family 2; subfamily E; polypeptide 1,negative,chr10:135340740,-0.955109129185801,-0.514384579835832,-0.335202748501637,2.47660312541679,-0.858507768117452,-0.912171887908218,0.760180264703942,-0.691922959105812,-0.445666956784869,-0.361702905218027,54.4927177429199,2.28935234702805,Yes,No,Yes,No,24,Repressed polycomb
cg00864867,1.59976405,1.863968574,0.00087,0,0.58,0.049,0.045,0.053,5074,36,12,78609399,36.1,78608921,-,PAWR,PAR4; Par-4;,NM_002583.2,GI:55769532,###############################################################################################################################################################################################################################################################,PRKC; apoptosis; WT1; regulator,positive,chr12:80085268,-0.553408766255008,-0.295514900368553,0.384454285714091,1.27118002643155,-0.409967933975871,0.365563636668613,0.4224817484058,-1.21415691084953,1.19132754755599,-0.383492963955522,74.5351715087891,-0.681678740781561,No,No,Yes,No,2,Promoter
cg00945507,0.056852418,NA,0.016,0,0.96,0.24,0.23,0.25,23480,36,7,54795171,36.1,54794433,-,SEC61G,SSS1;,NM_014302.3,GI:60279263,###############################################################################################################################################################################################################################################################,Sec61 gamma subunit,positive,chr7:54827677,-0.423171079895735,-0.501955727994655,-0.50226121311686,-0.40758262635834,-0.726206379362379,0.464607042619322,0.839273219264551,-0.0166809353365348,-0.496891775321149,-0.296839671767893,74.355054403481,-0.0379527104591543,No,No,Yes,No,2,Promoter
cg01027739,0.102862854,NA,0.011,0,0.99,0.071,0.067,0.074,57171,36,9,130882559,36.1,130883227,+,DOLPP1,LSFR2;,NM_020438.3,GI:48976059,###############################################################################################################################################################################################################################################################,dolichyl pyrophosphate phosphatase 1,positive,chr9:131842738,-0.443111203459176,-0.00234492563704325,-0.114057092565173,-0.693529987866515,-0.217505538420904,0.345633694907342,-0.319743439899919,-0.471515406214702,-0.304830761647866,-0.419642557742483,83.5766372680664,2.8678497532453,No,No,Yes,No,2,Promoter
cg01027805,-0.167672796,-0.301922411,0.00033,0.012,0.23,0.069,0.068,0.069,51222,36,14,20636703,36.1,20636639,-,ZNF219,ZFP219;,NM_016423.1,GI:7705974,###############################################################################################################################################################################################################################################################,zinc finger protein 219,negative,chr14:21566863,-0.17356935089023,-0.193359243137678,-0.742070477898586,-0.484390406446446,0.0834954048695358,-0.284855618137041,-0.771855243888517,-0.429655880574013,1.46856717524788,-0.428742201405788,60.0784187316895,1.32151583407628,Yes,No,Yes,No,1,Active TSS
cg01234063,-0.040535924,NA,0.0029,0,0.72,0.058,0.065,0.053,6484,36,11,125731217,36.1,125731306,+,ST3GAL4,STZ; SAT3; CGS23; SIAT4; NANTA3; SIAT4C; FLJ11867; ST3GalIV; ST3Gal IV;,NM_006278.1,GI:5454057,###############################################################################################################################################################################################################################################################,ST3 beta-galactoside alpha-2;3-sialyltransferase 4,negative,chr11:126226007,-0.266087354707587,0.596179880344273,0.25831801913334,-0.260822901554417,0.13390712931008,-0.0869791885414285,0.251882244044092,-0.0278608236226962,-0.53483437036916,-0.365341287134287,65.7971115112305,0.493517133428408,Yes,Yes,No,No,3,Promoter
cg01262913,-0.033581152,NA,0.02,0,0.94,0.094,0.096,0.093,257203,36,21,37502356,36.1,37502674,+,DSCR9,,NM_148675.2,GI:45433549,go_component: cellular component unknown; go_function: molecular function unknown; go_process: biological process unknown,hypothetical protein LOC257203,negative,chr21:38580486,-0.403020450793667,-0.787682859850061,-0.283491704727264,-0.191818733489657,-0.58437491795355,0.0503949429428377,-0.670063451760467,0.419932473495294,-0.461899806856825,-0.428562946327597,66.1082905034472,1.31437034961258,No,No,No,No,2,Promoter
cg01353448,0.238560451,0.235852029,0.021,0.0018,0.94,0.53,0.47,0.57,10842,36,7,31693437,36.1,31693372,+,C7orf16,GSBS;,NM_006658.2,GI:31542288,###############################################################################################################################################################################################################################################################,G-substrate,positive,chr7:31726912,-0.73286025886978,-0.665813579669522,0.441550447420691,0.0880237438121374,-0.892428674151487,-0.746629455617397,-0.00872826841803019,-0.775159419260266,-0.352240378948546,-0.333308351183731,35.396541595459,1.38851432179474,Yes,No,No,No,25,Quiescent/low
cg01407797,-0.379166543,-0.141060864,0.0084,0,0.93,0.078,0.092,0.07,150275,36,22,27498514,36.1,27498707,+,FLJ33814,dJ366L4.1;,NM_173510.1,GI:27735132,synonym: dJ366L4.1,hypothetical protein LOC150275,negative,chr22:29168514,-0.296052867920115,-0.457709790606149,-0.461703302988988,-0.626459943752807,-0.702969791678999,-0.303160229100958,-0.51197317916758,-0.155765351038027,0.277864757535794,-0.147976624778755,78.2843815905792,0.413607734328216,No,No,Yes,No,2,Promoter
cg01459453,-0.345952077,-0.592415753,0.012,0.13,0.97,0.77,0.81,0.72,6403,36,1,167865836,36.1,167866031,-,SELP,CD62; GRMP; PSEL; CD62P; GMP140; PADGEM; FLJ45155;,NM_003005.2,GI:6031196,###############################################################################################################################################################################################################################################################,selectin P precursor,negative,chr1:169599212,-0.642108983581033,-0.742068543025367,0.150005369032625,-0.549741765914068,-0.918462431292781,-0.325798356991868,-0.856422622123129,-0.488066373338377,-0.474989456161077,0.347832281492932,33.6176834106445,0.0479749908074924,Yes,No,No,No,25,Quiescent/low
cg01485645,-0.025753328,NA,0.0014,0.039,0.51,0.13,0.12,0.13,4302,36,17,34115725,36.1,34115401,+,MLLT6,AF17; FLJ23480;,NM_005937.2,GI:57222567,###############################################################################################################################################################################################################################################################,myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog; Drosophila); translocated to; 6,negative,chr17:36862199,0.372407370312764,0.460911302464818,-0.544164670506959,-0.412958555095688,0.423023726036267,0.0845418457650617,-0.3607329052607,-0.0293638834386091,-0.288589202823705,-0.16270864854573,81.1899032592773,2.18714890371942,Yes,No,Yes,No,3,Promoter
cg01511567,-0.686111875,-1.864349749,0.0079,0.022,0.77,0.14,0.17,0.12,6749,36,11,56860207,36.1,56859927,-,SSRP1,FACT; T160;,NM_003146.2,GI:28416943,###############################################################################################################################################################################################################################################################,structure specific recognition protein 1,negative,chr11:57103631,0.539054887822635,-0.469853158960971,-0.4112163372735,-0.528707868247229,0.0468083008972101,-0.326799516632828,-0.399335779948961,0.490430600204283,-0.411030087344512,-0.429456221072508,67.9407896198834,1.17808438120621,No,No,Yes,No,3,Promoter
cg01560871,-0.036910708,NA,0.0099,0,0.97,0.81,0.84,0.75,219793,36,10,72215430,36.1,72215163,-,C10orf27,spatial; FLJ32820;,NM_152710.1,GI:22749412,synonyms: spatial; FLJ32820,chromosome 10 open reading frame 27,negative,chr10:72545424,-0.592455337134388,-0.0514336465914061,-0.318689205248137,-0.0488265574297978,-0.62738319520523,-0.33114283203479,-0.249748051840214,-0.832634140173163,-0.701484252414219,-0.419642557742483,52.0936126994373,0.0732019886055431,No,No,No,No,17,Weak enhancer
cg01570885,-0.031258306,-0.092113005,0.0076,0.004,0.95,0.45,0.47,0.44,26240,36,6,3794271,36.1,3794631,+,FAM50B,X5L; D6S2654E;,NM_012135.1,GI:6912325,go_component: nucleus,family with sequence similarity 50; member B,negative,chr6:3849272,-0.508466308592484,-0.391603285874677,0.681913828658837,-0.648124433335055,-0.693685920323785,-0.797435637590142,0.526842656706604,-0.486945090653321,-0.472346311145596,-0.439261680600165,81.5661087036133,0.481857557539413,No,Yes,No,No,1,Active TSS
cg01584473,0.088628396,NA,0.0058,0.0042,0.96,0.82,0.83,0.82,140453,36,7,100450087,36.1,100450084,+,MUC17,MUC3;,NM_001004430.1,GI:52138722,small intestinal mucin MUC3; membrane mucin MUC17; secreted mucin MUC17; go_component: cellular component unknown; go_function: extracellular matrix constituent; lubricant activity; go_process: biological process unknown,mucin 17,positive,chr7:100663367,-0.776605070312444,-0.789977111956801,0.503776895627003,-0.0994602389933839,-0.836372671323089,-0.804582269541128,-0.313484221655572,-0.68894693579183,-0.600730031085389,-0.439261680600165,79.0654133822853,0.759379294454601,Yes,No,No,No,25,Quiescent/low
cg01644850,0.159948713,NA,0.002,0,0.65,0.041,0.036,0.044,90233,36,19,62885043,36.1,62885217,+,ZNF551,MGC52307;,NM_138347.2,GI:34147525,KOX 23 protein (56 AA); go_component: nucleus; go_function: DNA binding; go_function: zinc ion binding; go_function: metal ion binding; go_process: transcription; go_process: regulation of transcription; DNA-dependent,zinc finger protein 551,positive,chr19:58193231,-0.512470327403744,0.424665727042318,-0.324941043984904,-0.683077151877845,-0.0459828985858388,-0.333741643603967,1.32700987942605,0.644158104031875,-0.528950180368421,0.217594647017622,46.5752487182617,0.480647077920004,No,No,Yes,No,1,Active TSS
cg01656216,0.042805528,NA,0.023,0.0033,1,0.71,0.68,0.72,220929,36,10,31313716,36.1,31313361,-,ZNF438,FLJ32761; MGC126671; bA330O11.1; RP11-330O11.1;,NM_182755.1,GI:33300650,ZNF438 transcript variant 2; go_component: nucleus; go_function: zinc ion binding; go_function: metal ion binding; go_function: nucleic acid binding,ZNF438 transcript variant 3,positive,chr10:31273710,-0.908559245064269,-1.06809570726967,-0.359289706848752,-0.73401248277192,-0.850760322912947,-0.741881231832604,-0.565844019909237,-0.244827986816704,-0.171245794573197,-0.365791765200831,79.7825775146484,-0.843723513992968,Yes,No,No,No,19,DNase
cg01820374,-0.271122363,-0.211852245,0.039,0.074,0.95,0.48,0.56,0.34,3902,36,12,6752344,36.1,6751931,+,LAG3,CD223;,NM_002286.4,GI:15718681,go_component: integral to plasma membrane; go_function: antigen binding,lymphocyte-activation protein 3 precursor,negative,chr12:6882083,-0.850200497536875,-0.589697716737632,-0.521356957643318,0.433176617371457,-0.564335616291348,-0.196252488267691,-0.685311531964461,-0.773018437380688,0.926672739808191,-0.393226120933337,83.8590545654297,1.86440014493856,Yes,No,Yes,No,23,Bivalent promoter
cg01873645,-0.604056375,NA,0.00017,0,0.77,0.036,0.036,0.037,138241,36,9,73716469,36.1,73716243,+,C9orf85,MGC61599; RP11-346E17.2;,NM_182505.3,GI:38327628,isoform a is encoded by transcript variant 1,hypothetical protein LOC138241 isoform a,positive,chr9:74526649,0.350171601393858,0.481797846191999,-0.321366986488299,-0.611101808232784,0.726761947850742,0.420673391791824,-0.415401602530274,0.485303187516564,-0.499244275532255,-0.118714980219009,34.8394388403381,1.61014871798474,Yes,Yes,No,No,3,Promoter
cg01968178,1.169245865,0.289320053,0.005,0.012,0.99,0.065,0.051,0.082,65055,36,2,86418549,36.1,86418288,-,REEP1,C2orf23; FLJ13110;,NM_022912.1,GI:12597656,go_component: membrane; go_component: integral to membrane,receptor expression enhancing protein 1,positive,chr2:86565038,-0.902744644928867,-0.391798304312722,-0.48847656997438,1.69971428939349,-0.611427049661945,-0.168924768988785,0.476730497444128,-0.891820409854833,0.542104353478504,-0.439261680600165,50.021800994873,1.14574129462843,Yes,Yes,No,No,23,Bivalent promoter
cg02047577,-0.658400181,NA,6e-05,0,0.15,0.0098,0.011,0.0093,54963,36,20,62058146,36.1,62058212,-,UCKL1,URKL1;,NM_017859.2,GI:57863311,uridine kinase-like 1; go_function: ATP binding; go_function: kinase activity; go_function: nucleotide binding; go_function: transferase activity; go_function: uridine kinase activity; go_process: biosynthesis,uridine-cytidine kinase 1-like 1,negative,chr20:62587702,-0.0909331777441757,0.281161948924106,-0.0841918500955331,-0.705066673139054,1.61975700880618,0.283023373825268,-0.359724988532721,0.535590851294556,-0.420320908938923,0.258612053568785,79.5386810302734,1.44452621369278,Yes,Yes,No,No,3,Promoter
cg02071305,-0.048429497,NA,0.0082,0.002,0.97,0.22,0.26,0.2,57617,36,15,38973265,36.1,38973920,+,VPS18,KIAA1475;,NM_020857.2,GI:42544225,go_component: membrane; go_function: zinc ion binding; go_function: metal ion binding; go_process: protein transport,vacuolar protein sorting 18,negative,chr15:41185973,-0.400642729413486,-0.655528170381113,-0.374744541490042,-0.390446785797265,-0.539190941098157,0.432990533754916,0.138706163138522,-0.449070795005796,-0.501530216362054,-0.400166480002088,84.6526565551758,1.931752032537,No,No,Yes,No,2,Promoter
cg02085507,0.006127551,NA,0.031,0,0.96,0.49,0.47,0.5,9322,36,19,6690192,36.1,6690707,+,TRIP10,STP; CIP4; HSTP; STOT;,NM_004240.2,GI:42516568,thyroid receptor interacting protein 10; salt tolerator; CDC42-interacting protein 4; go_component: cytoplasm; go_function: protein binding; go_process: signal transduction; go_process: actin cytoskeleton organization and biogenesis,thyroid hormone receptor interactor 10,positive,chr19:6739192,-0.307762602763096,-0.122119332586056,-0.0748109714573648,-0.713671351958758,0.0892109496997994,1.88347856634067,-0.145121992064217,0.148122152264266,-0.368824865129404,-0.380953390499307,40.5048027038574,1.81822466670116,Yes,No,Yes,No,2,Promoter
cg02154074,0.044757003,NA,0.0013,0,0.41,0.056,0.046,0.071,27429,36,2,74609742,36.1,74610040,+,HTRA2,OMI; PRSS25;,NM_013247.4,GI:73747817,###############################################################################################################################################################################################################################################################,HtrA serine peptidase 2 isoform 1 preproprotein,positive,chr2:74756234,-0.118668472555669,-0.130628476579279,0.0600791331960971,-0.660889364040596,0.292452628020076,1.15842891803847,-0.527478986723567,0.141491704103773,-0.132441025507118,2.87737951828064,82.1988372802734,1.91340150400733,Yes,Yes,No,No,3,Promoter
cg02217159,-0.086512604,-0.067976604,0.008,0.0085,0.96,0.09,0.093,0.091,202559,36,6,63054656,36.1,63054091,-,KHDRBS2,SLM1; SLM-1; MGC26664; bA535F17.1;,NM_152688.1,GI:22749380,Sam68-like mammalian protein 1; go_function: protein binding; go_function: nucleic acid binding,KH domain-containing; RNA-binding; signal transduction-associated protein 2,positive,chr6:62996697,-0.733442127722637,-0.426340827900525,0.0347939853867673,0.748698023595798,-0.768815941008311,-0.368093503968582,0.618783542161717,-1.06381317140755,0.471013166416255,-0.439261680600165,5.53523116932248,-0.0944086030191303,No,No,Yes,No,22,Poised promoter
cg02275294,-0.337498333,-0.740069387,0.0015,0,0.4,0.064,0.076,0.06,6646,36,1,177529085,36.1,177529640,+,SOAT1,ACAT; SOAT; STAT; ACACT; ACAT1; RP11-215I23.2;,NM_003101.4,GI:49533616,###############################################################################################################################################################################################################################################################,sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1,negative,chr1:179262462,-0.204378894103724,-0.217583697997406,-0.218410448273023,-0.552216280153505,-0.142488045079135,0.584464338222359,0.0445670650296767,0.0294470672098642,-0.15512905196213,-0.410955988830152,67.6920099995677,0.954931723906351,No,No,Yes,No,2,Promoter
cg02331561,0.126928853,0.354782962,0.0058,0,0.92,0.024,0.02,0.028,21,36,16,2331082,36.1,2330595,-,ABCA3,ABC3; ABC-C; LBM180; MGC72201; EST111653;,NM_001089.1,GI:4501848,###############################################################################################################################################################################################################################################################,ATP-binding cassette; sub-family A member 3,positive,chr16:2391081,-0.623730867698558,-0.182820328110063,-0.0323061560808292,0.0738816692474541,-0.535734105640401,-0.468387113561495,1.29783674362099,8.4715002020002,-0.508668952659275,-0.439261680600165,80.4430236816406,1.32642172941333,No,Yes,No,No,23,Bivalent promoter
cg02332492,0.062771342,0.134285197,0.0086,0.3,0.97,0.85,0.85,0.84,733,36,9,138960499,36.1,138959534,+,C8G,C8C;,NM_000606.1,GI:4557392,###############################################################################################################################################################################################################################################################,complement component 8; gamma polypeptide,positive,chr9:139840678,-0.721305945012291,-0.57413881203594,-0.0908617718391927,-0.391981755112511,-0.544589774375244,0.0315319796377112,-0.159454447427076,-0.462362648463038,-0.60080403803449,-0.439261680600165,82.6618825669895,0.13121580242435,Yes,No,Yes,No,25,Quiescent/low
cg02335441,-0.17128537,NA,0.00095,0,0.4,0.04,0.046,0.038,28990,36,3,132228638,36.1,132228336,-,ASTE1,HT001; MGC129980;,NM_014065.2,GI:33469986,HT001 protein,hypothetical protein LOC28990,negative,chr3:130745948,0.0282773752065371,-0.244667918062974,-0.115068740273538,-0.622516237141329,-0.180025492214481,0.00977584109496193,-0.716200355297133,0.737776412985809,-0.503079378114173,-0.326399029748056,20.1578731536865,0.872461858414282,Yes,No,Yes,No,2,Promoter
cg02364642,-0.024270255,NA,0.0064,0,0.72,0.19,0.18,0.2,115557,36,12,56292025,36.1,56291485,+,GEFT,p63RhoGEF;,NM_133483.1,GI:19311007,isoform 2 is encoded by transcript variant 2; go_function: guanyl-nucleotide exchange factor activity,RAC/CDC42 exchange factor isoform 2,positive,chr12:58005758,-0.822176635505125,-0.939437075384627,-0.473835002186121,1.05583278628931,-0.940787403523333,-0.447635726258233,-0.428865437356586,-0.486041232325712,0.982173897980776,-0.439261680600165,79.6056747436523,1.52839164627289,Yes,No,Yes,No,2,Promoter
cg02388150,0.425971257,0.009137213,0.0094,0,0.92,0.18,0.16,0.21,6422,36,8,41284856,36.1,NA,-,SFRP1,FRP; FRP1; FrzA; FRP-1; SARP2;,NT_007995.14,,secreted apoptosis-related protein 2; go_process: cell differentiation; go_process: Wnt receptor signaling pathway,secreted frizzled-related protein 1,positive,chr8:41165699,-0.807127093010668,-1.02772196631326,-0.192808313219388,1.28689065514345,-0.845324544721847,-0.790783838106288,-0.0576952285906721,-0.269764646774242,-0.258032978155768,-0.429456221072508,73.1711484951866,0.681349952956216,Yes,No,Yes,No,23,Bivalent promoter
cg02479575,1.875446187,2.039720589,0.00042,0,0.35,0.029,0.023,0.037,284424,36,19,4720653,36.1,4720152,+,C19orf30,PGSF1; PGSF1a; PGSF1b;,NM_174947.2,GI:29126235,pituitary gland specific factor 1a,hypothetical protein LOC284424,positive,chr19:4769653,-0.807644593445284,-0.733472160386497,-0.306370783521536,-0.486083400995357,-0.967951465584373,-0.823981926246825,0.204469213108536,1.07297711619394,-0.268818126153131,-0.419642557742483,82.9238549896012,3.31348485219989,No,No,No,No,19,DNase
cg02489552,0.073741383,0.00110968,0.042,0.0031,0.96,0.43,0.33,0.52,126402,36,19,14982531,36.1,14982556,+,FLJ40365,,NM_173482.1,GI:27735062,,hypothetical protein LOC126402,positive,chr19:15121531,-0.835780871764088,-0.661307110757792,0.55323751990919,2.67141235710852,-0.971214939978803,-0.756689262697169,1.12819788822907,-0.895834195041827,-0.718067315478671,-0.439261680600165,65.6490447503373,0.889347088727303,Yes,No,Yes,No,24,Repressed polycomb
cg02580606,0.349274493,0.185193882,0.0094,0.046,0.98,0.86,0.85,0.86,3884,36,17,36780252,36.1,36779573,-,KRTHA3B,HA3II; Ha-3II; KRTHA3A; hHa3-II;,NM_002279.3,GI:15022816,keratin; hair; acidic;3B; hard keratin; type I; 3II; go_component: intermediate filament; go_function: structural molecule activity,type I hair keratin 3B,positive,chr17:39526726,-0.802688993524494,-1.03966226941278,-0.185487932419412,0.196983109005812,-0.84780233368671,-0.793574022464744,0.400090744555807,-0.534457993413331,-0.618180453309147,-0.439261680600165,72.7075576782227,0.695229014311389,No,No,No,No,25,Quiescent/low
cg02654291,0.140583491,NA,0.019,0.011,0.9,0.39,0.36,0.41,84267,36,9,85761834,36.1,85761721,-,C9orf64,MGC10999; RP11-575L7.5;,NM_032307.2,GI:31543143,synonyms: MGC10999; RP11-575L7.5,hypothetical protein LOC84267,positive,chr9:86572014,0.454569474924994,-0.0922689568740613,-0.0432855846020299,-0.631283142363019,-0.0696244177713985,0.75544724126492,-0.510447138772476,0.947013460411226,-0.522608760801307,-0.439261680600165,53.9561767578125,0.883008763888471,No,Yes,No,No,2,Promoter
cg02827112,0.050646083,NA,0.00079,0,0.62,0.059,0.054,0.065,56916,36,4,95348426,36.1,95348217,+,SMARCAD1,ETL1; KIAA1122; DKFZp762K2015;,NM_020159.1,GI:14149729,###############################################################################################################################################################################################################################################################,SWI/SNF-related; matrix-associated actin-dependent regulator of chromatin; subfamily a; containing DEAD/H box 1,positive,chr4:95129403,0.513292595122689,0.290482459450552,0.221494376145069,-0.457760445079847,-0.196685428570851,-0.271437386436158,0.10433482579253,0.251899059184082,-0.347307603785398,0.108723478355304,58.3887925469073,3.21716368307245,Yes,No,Yes,No,3,Promoter
cg02972551,0.47394601,NA,0.0033,0.0016,0.94,0.056,0.057,0.055,55818,36,2,86521579,36.1,86521954,+,JMJD1A,TSGA; JMJD1; KIAA0742; DKFZp686A24246; DKFZp686P07111;,NM_018433.3,GI:46358420,testis-specific protein A; zinc finger protein,jumonji domain containing 1A,positive,chr2:86668068,0.523458225725231,-0.332444212973018,-0.550237964860726,-0.720820781926976,-0.572946064520697,-0.677579644931574,0.92952482348901,7.22201137863105,0.762288366975374,-0.405030560815705,41.9049682617188,-1.00543780591086,Yes,Yes,No,No,2,Promoter
cg03019000,-0.459777041,-0.546028961,0.0094,0.027,0.95,0.76,0.77,0.74,51368,36,3,51679391,36.1,51680330,+,TEX264,SIG11; ZSIG11; FLJ13935;,NM_015926.3,GI:34147580,putative secreted protein ZSIG11; testis expressed gene 264,testis expressed sequence 264,negative,chr3:51704351,-0.489297811664017,-0.797263493581443,-0.0594812390476441,-0.628740010192669,-0.554148723004046,0.218856563604026,-0.186391021280628,-0.495885034100962,-0.471593948275216,-0.361165589343126,65.1100110746084,1.11932771332018,Yes,No,Yes,No,17,Weak enhancer
cg03103192,0.023536343,NA,0.021,0.026,0.94,0.5,0.48,0.52,132671,36,4,52612028,36.1,52612350,+,SPATA18,FLJ32906;,NM_145263.1,GI:21687118,synonym: FLJ32906,spermatogenesis associated 18 homolog,positive,chr4:52917271,-0.804246618891701,-0.496571108018256,-0.472571466682665,0.952524654958031,-0.755721749043932,-0.55698793397411,-0.25947547977495,-0.763399704124289,0.365983603833489,-0.419642557742483,33.274169921875,0.323723328316242,No,No,Yes,No,23,Bivalent promoter
cg03167275,-0.551041258,NA,0.0011,0.0015,0.61,0.082,0.072,0.089,1525,36,21,17807964,36.1,17807201,+,CXADR,CAR; HCAR;,NM_001338.3,GI:45827793,###############################################################################################################################################################################################################################################################,coxsackie virus and adenovirus receptor precursor,positive,chr21:18886093,-0.422793368190928,-0.488043261883739,-0.26347035551596,1.28494067676455,-0.493212995362859,-0.143110846197782,-0.255155043330818,1.67158648446825,1.58827545608733,-0.417447040714595,48.2187461853027,1.15446881443187,Yes,Yes,No,No,3,Promoter
cg03270204,0.013544725,NA,0.043,0.024,0.98,0.84,0.82,0.85,780,36,6,30959617,36.1,30959840,+,DDR1,CAK; DDR; NEP; PTK3; RTK6; TRKE; CD167; EDDR1; MCK10; NTRK4; PTK3A;,NM_001954.3,GI:38327631,###############################################################################################################################################################################################################################################################,discoidin domain receptor family; member 1 isoform b,positive,chr6:30851638,-0.597156116894869,-0.602558219637035,-0.147639684653023,0.257878075383866,-0.364932341902585,0.222884655229917,-0.230657286340908,-0.210884324788065,-0.0476045838641517,-0.407505280747167,81.9911617745188,1.31508890837806,Yes,No,Yes,No,2,Promoter
cg03286783,-0.854784621,-0.559727496,0.0041,0,0.98,0.06,0.06,0.059,113201,36,15,42368265,36.1,42368221,+,CASC4,H63; MGC74708;,NM_138423.2,GI:29826288,isoform a is encoded by transcript variant 1; gene associated with HER-2/neu overexpression,cancer susceptibility candidate 4 isoform a,negative,chr15:44580973,0.500025865305371,0.496148403829202,-0.011226753405504,-0.577057530034704,0.43311845746916,-0.213667425760618,-0.1816594992837,0.130270439477771,-0.15905151557514,1.30000329931014,79.9413909912109,1.44199754680584,Yes,Yes,No,No,3,Promoter
cg03330058,-0.064471129,NA,0.021,0.022,0.97,0.32,0.4,0.29,80325,36,3,128875093,36.1,128874471,+,ABTB1,BPOZ; EF1ABP; PP2259; MGC20585;,NM_032548.2,GI:25777622,isoform 1 is encoded by transcript variant 1; elongation factor 1A binding protein; go_function: protein binding; go_function: translation elongation factor activity,ankyrin repeat and BTB (POZ) domain containing 1 isoform 1,negative,chr3:127392403,1.14742145786574,0.7821364425062,0.0298634845533671,-0.55913607358408,0.850000752863807,1.45385795832677,-0.285895399874561,0.230707628805469,-0.197240917155256,-0.00435778837826871,74.8651339752121,1.7039488676363,Yes,Yes,No,No,2,Promoter
cg03565323,-0.207653221,NA,0.0031,0.014,0.59,0.11,0.11,0.12,57336,36,17,16413591,36.1,16413189,-,ZNF287,,NM_020653.1,GI:10190687,go_component: nucleus; go_function: zinc ion binding; go_function: metal ion binding; go_function: transcription factor activity; go_process: transcription; go_process: regulation of transcription; DNA-dependent,zinc finger protein 287,positive,chr17:16472866,-0.622307885749668,-0.502451049387459,-0.461311457376265,-0.425726144791453,-0.849533184228921,-0.244455072205994,-0.423463327160922,-0.814021389555876,-0.157757990338986,-0.429456221072508,71.8232116699219,1.28286569944632,No,No,Yes,No,17,Weak enhancer
cg03578041,-0.032630972,NA,0.0089,0,0.89,0.27,0.28,0.27,55323,36,15,68934361,36.1,68933552,-,LARP6,FLJ11196;,NM_197958.1,GI:37537705,###############################################################################################################################################################################################################################################################,acheron isoform 2,negative,chr15:71147307,-0.891946716534679,-0.458735400258054,-0.235257083168502,1.1508384854457,-0.933995661609254,-0.660408957706561,-0.157475680540229,-0.258224351785416,-0.160650746092108,-0.439261680600165,85.350604126281,0.305480452121368,Yes,No,Yes,No,24,Repressed polycomb
cg03588357,-0.858843002,NA,0.0011,0.01,0.97,0.057,0.052,0.061,8111,36,14,90789926,36.1,90789977,-,GPR68,OGR1; MGC111379;,NM_003485.3,GI:74316010,###############################################################################################################################################################################################################################################################,G protein-coupled receptor 68,positive,chr14:91720173,0.524689707153741,0.159643251189427,-0.501438317764832,-0.0674445584949458,0.472009128689339,1.64870293916027,-0.442085683300558,0.0756813896161368,-0.115998575879317,-0.330705814615586,45.4345855712891,1.88815901231405,Yes,Yes,No,No,2,Promoter
cg03682823,-0.112677232,NA,0.0042,0.021,0.95,0.46,0.47,0.46,8910,36,7,94124889,36.1,94123414,-,SGCE,ESG; DYT11;,NM_003919.1,GI:10835046,###############################################################################################################################################################################################################################################################,sarcoglycan; epsilon,negative,chr7:94286953,-0.813703700568798,-0.238857853750755,-0.171430432322942,-0.268438305481114,-0.686044322494316,-0.495382863644733,0.721810613148793,-0.305858206919397,0.523438456463188,-0.429456221072508,66.1882019042969,0.359594732748171,Yes,No,Yes,No,2,Promoter
cg03760483,0.014946399,NA,0.025,0,0.95,0.43,0.39,0.46,239,36,17,6840021,36.1,6840128,+,ALOX12,LOG12;,NM_000697.1,GI:4502050,12(S)-lipoxygenase; platelet-type 12-lipoxygenase/arachidonate 12-lipoxygenase; go_component: cytosol; go_component: sarcolemma; go_function: iron ion binding; go_function: metal ion binding; go_function: lipoxygenase activity; go_function: oxidoreductase activity; go_function: hepoxilin-epoxide hydrolase activity; go_function: potassium channel inhibitor activity; go_function: arachidonate 12-lipoxygenase activity; go_function: arachidonate 12-lipoxygenase activity; go_process: cell motility; go_process: anti-apoptosis; go_process: anti-apoptosis; go_process: electron transport; go_process: superoxide release; go_process: fatty acid oxidation; go_process: leukotriene biosynthesis; go_process: arachidonic acid metabolism; go_process: regulation of membrane potential; go_process: negative regulation of cell volume; go_process: positive regulation of cell growth; go_process: positive regulation of cell adhesion; go_process: positive regulation of cell proliferation; go_process: positive regulation of cell proliferation; go_process: oxygen and reactive oxygen species metabolism,arachidonate 12-lipoxygenase,positive,chr17:6899297,-0.664073379493629,-0.688664658666503,3.05129865762477,-0.393211640110702,-0.752972459520646,-0.624200861420782,0.151361947201302,-1.2184467063799,0.557340183876449,-0.125523331090248,63.3056983947754,1.14508706061005,No,Yes,No,No,23,Bivalent promoter
cg03891319,-0.026893522,NA,0.0017,0.0073,0.49,0.061,0.079,0.057,95,36,3,51991878,36.1,51992603,+,ACY1,ACY1D; ACYLASE;,NM_000666.1,GI:4501900,###############################################################################################################################################################################################################################################################,aminoacylase 1,negative,chr3:52016838,-0.0342325497645224,0.219879235489944,-0.408137070172499,-0.653535680075548,0.438011360792421,1.06333794617944,-0.312010888339337,0.503411745760912,-0.378840120282679,-0.40010251416111,84.6597747802734,1.63323270553906,Yes,No,Yes,No,3,Promoter
cg03947362,-0.301555266,NA,0.00017,0,0.17,0.041,0.043,0.04,129450,36,2,200528399,36.1,200528468,-,FLJ37953,MGC70509;,NM_152382.1,GI:22748818,synonym: MGC70509,hypothetical protein LOC129450,negative,chr2:200820154,0.803440251432991,1.94856086165121,0.386984662742475,-0.663573345254359,1.33010080320241,0.471672886870952,-0.14148730136289,0.383608651014295,-0.295811376012163,0.0472692465100539,63.6093215942383,2.66240919244379,Yes,Yes,No,No,3,Promoter
cg04005032,-0.144763726,NA,0.00025,0,0.19,0.045,0.044,0.045,114884,36,3,31997771,36.1,31998242,-,OSBPL10,ORP10; OSBP9; FLJ20363;,NM_017784.3,GI:23111057,oxysterol-binding protein-related protein 10; OSBP-related protein 10; go_process: lipid transport; go_process: steroid metabolism,oxysterol-binding protein-like protein 10,negative,chr3:32022767,-0.052936602418907,1.42985086327702,-0.0370368296889054,2.47522655492975,-0.133723618367415,0.409328050972754,-0.00302595826064757,-0.733395076027685,0.222958893504442,0.0439084445700963,44.7399978637695,1.5616041079811,Yes,Yes,No,No,1,Active TSS
cg04084157,1.034144196,0.763330927,0.003,0.01,0.44,0.11,0.086,0.14,7425,36,7,100595769,36.1,100595572,-,VGF,,NM_003378.2,GI:17136077,neuro-endocrine specific protein VGF; go_component: cellular component unknown; go_function: growth factor activity; go_process: biological process unknown,VGF nerve growth factor inducible precursor,positive,chr7:100809049,-0.873067128904107,-0.427900858644311,-0.421291912623552,1.00475503833283,-0.945630462308965,0.133664771109057,0.195297207924723,0.609290489259769,0.143875278750845,-0.439261680600165,82.0953750610352,0.729999134725227,No,Yes,No,No,23,Bivalent promoter
cg04094160,-0.201195165,NA,0.00027,0,0.82,0.046,0.048,0.043,9925,36,9,37455712,36.1,37455396,-,ZBTB5,,NM_014872.1,GI:7662073,go_component: nucleus; go_function: DNA binding; go_function: protein binding; go_function: zinc ion binding; go_function: metal ion binding; go_process: transcription; go_process: regulation of transcription; DNA-dependent,zinc finger and BTB domain containing 5,negative,chr9:37465712,-0.669601076465177,-0.729231486505102,-0.546959064255409,-0.7426147298224,-0.278182939414779,-0.707907371522644,-0.431305227945398,-0.0810304037806125,0.502022759082628,-0.356518495766061,71.8728179931641,-2.38963818009614,No,Yes,No,No,1,Active TSS
cg04121983,0.054920672,NA,0.0015,0,0.46,0.072,0.071,0.073,57513,36,17,71022680,36.1,71023222,-,CASKIN2,ANKS5B; FLJ21609; KIAA1139;,NM_020753.2,GI:45433546,go_component: cytoplasm; go_function: molecular function unknown; go_process: biological process unknown,cask-interacting protein 2,negative,chr17:73511085,-0.752108901095732,-0.676928197574405,-0.508751931283152,0.985750254244721,-0.746596601801939,-0.214455370421911,-0.379583416101181,-0.49709214940852,1.85492907653942,-0.439261680600165,79.6541213989258,1.1347171165781,Yes,Yes,No,No,3,Promoter
cg04126866,0.079374551,NA,0.013,0.09,0.98,0.83,0.82,0.84,387695,36,10,85922743,36.1,85923547,+,C10orf99,UNQ1833; FLJ21763;,NM_207373.1,GI:46409375,RLLV1833; Em:AC022389.2,hypothetical protein LOC387695,positive,chr10:85932763,-0.721747537520558,-0.850469539178077,0.0418501908973804,-0.328057796226538,-0.916455946167635,-0.496255127393452,-0.146513396877731,-0.580298400137894,-0.577850055341888,-0.429456221072508,55.1083145141602,0.923769478137213,No,No,No,No,18,Weak enhancer
cg04268405,-0.416694314,-0.23291363,0.033,0,0.99,0.9,0.9,0.91,9469,36,10,73393227,36.1,73394126,+,CHST3,C6ST; C6ST1;,NM_004273.2,GI:19923280,###############################################################################################################################################################################################################################################################,carbohydrate (chondroitin 6) sulfotransferase 3,negative,chr10:73723221,-0.901138525960015,-0.4804680560877,0.539978416588246,2.44547800742211,-0.867301549972241,-0.627155472081181,1.18109928281385,0.329421964821341,0.339142148634749,-0.439261680600165,75.9247589111328,0.351712769089778,No,No,Yes,No,23,Bivalent promoter
cg04431054,-0.05992505,NA,0.013,0,0.96,0.17,0.22,0.14,133619,36,5,126880923,36.1,126881247,+,LOC133619,,NM_130809.2,GI:31377624,,hypothetical protein LOC133619,negative,chr5:126853024,-0.365440912683177,-0.285154666860148,-0.117111177789053,-0.498913812700518,-0.317633062327548,0.625188795185396,-0.22656098063899,0.93604176282239,-0.186642255151821,-0.439261680600165,46.7197723388672,2.37503768845229,No,No,Yes,No,2,Promoter
cg04452713,-0.001478366,NA,0.0091,0.014,0.93,0.14,0.15,0.15,667,36,6,56815646,36.1,56816422,-,DST,BPA; BP240; BPAG1; MACF2; CATX-15; KIAA0465; KIAA1470;,NM_020388.2,GI:20357503,isoform 1eB precursor is encoded by transcript variant 1eB; bullous pemphigoid antigen 1; 230/240kDa; hemidesmosomal plaque protein; go_component: cytoplasm; go_component: cytoskeleton; go_component: cytoplasm; go_component: cytoplasm; go_component: hemidesmosome; go_component: hemidesmosome; go_component: extracellular space; go_component: basement membrane; go_component: intercellular junction; go_component: cytoplasmic membrane-bound vesicle; go_function: actin binding; go_function: protein binding; go_function: calcium ion binding; go_function: integrin binding; go_function: actin filament binding; go_function: protein C-terminus binding; go_function: structural constituent of cytoskeleton; go_function: structural constituent of cytoskeleton; go_process: cell adhesion; go_process: cell cycle arrest; go_process: integrin-mediated signaling pathway; go_process: cytoskeleton organization and biogenesis; go_process: actin cytoskeleton organization and biogenesis; go_process: intermediate filament cytoskeleton organization and biogenesis; go_process: intermediate filament cytoskeleton organization and biogenesis; go_process: intermediate filament cytoskeleton organization and biogenesis,dystonin isoform 1eB precursor,negative,chr6:56707687,-0.574011571061114,-0.328292739726261,0.193051471718491,1.95030139235768,-0.657359722726125,0.953539346572207,0.582901582004705,1.31289001762847,0.790505880474795,-0.369709569267075,75.248542671489,2.3372719880916,Yes,No,Yes,No,3,Promoter
cg04474832,-0.444042106,-0.275148589,0.011,0.025,0.88,0.25,0.3,0.22,25864,36,3,51983527,36.1,51984124,+,ABHD14A,DORZ1; DKFZP564O243;,NM_015407.3,GI:34147328,go_function: hydrolase activity; go_process: aromatic compound metabolism,abhydrolase domain containing 14A,negative,chr3:52008487,-0.568320853503778,-0.211071763258344,-0.427702352450218,-0.642812779038473,-0.253486465101557,0.726424889164996,-0.0165865836580406,-0.114161482956625,-0.350775053792936,-0.356195386213725,84.3882556258889,2.34125130032412,Yes,No,Yes,No,2,Promoter
cg04528819,0.771798107,1.447966286,0.0027,0.019,0.56,0.11,0.077,0.14,136259,36,7,130068855,36.1,130069400,-,KLF14,BTEB5;,NM_138693.1,GI:20162553,BTE-binding protein 5; go_component: nucleus; go_function: DNA binding; go_function: zinc ion binding; go_function: metal ion binding; go_process: transcription; go_process: regulation of transcription; DNA-dependent,Kruppel-like factor 14,positive,chr7:130418315,-0.742084366014638,-0.00513677785980563,1.18225726854062,4.02216231876062,-0.718027958418037,0.35325251144056,13.2081073906571,0.0977932867453919,1.0001197251362,-0.439261680600165,81.4757347011804,1.85243238977881,Yes,Yes,No,No,23,Bivalent promoter
cg04836038,0.440056203,NA,0.0025,0.018,0.77,0.091,0.078,0.1,23348,36,13,98537383,36.1,98536661,-,DOCK9,ZIZ1; KIAA1058; KIAA1085; zizimin1; RP11-155N3.2; DKFZp686N04132;,NM_015296.1,GI:24308028,go_component: cellular component unknown; go_function: GTP binding; go_function: GTPase binding; go_function: guanyl-nucleotide exchange factor activity; go_process: biological process unknown,dedicator of cytokinesis 9,positive,chr13:99739382,3.05034819014505,1.95623210232574,0.466656944835323,0.872086581661713,1.5754195440407,1.32738870065854,-0.083284505681693,0.645690966491751,3.70850977824504,1.21535379474987,51.0787765236567,3.1241922645785,No,Yes,No,No,2,Promoter
cg04999691,-0.001756899,NA,0.026,0.05,0.94,0.68,0.7,0.67,113763,36,7,149657983,36.1,149657871,+,C7orf29,,NM_138434.2,GI:49574496,,hypothetical protein LOC113763,negative,chr7:150027050,-0.643878399644413,-0.65058414897948,6.73550337584145,-0.466487460498837,-0.812790460138528,-0.883799433732211,-0.268967434762808,-0.847717884816026,-0.718067315478671,0.435614563967891,36.0716247558594,0.64929174746314,Yes,No,No,No,7,Transcribed
cg05250458,0.087295559,NA,0.0072,0.002,0.99,0.24,0.23,0.26,7730,36,19,9334565,36.1,9334696,+,ZNF177,,NM_003451.1,GI:4508008,###############################################################################################################################################################################################################################################################,zinc finger protein 177,positive,chr19:9473565,-0.746756275187167,-0.988390346680192,0.551206316783036,1.05793932547485,-0.784492033257047,-0.711895831265719,7.31821263257079,0.346053759721775,-0.173008000241995,-0.439261680600165,35.9448697002154,1.39450546446015,Yes,No,Yes,No,22,Poised promoter
cg05294243,0.11851793,NA,0.0056,0,0.7,0.23,0.22,0.25,26085,36,19,56260918,36.1,56260179,-,KLK13,KLKL4; KLK-L4; DKFZP586J1923;,NM_015596.1,GI:11496280,###############################################################################################################################################################################################################################################################,kallikrein 13 precursor,positive,chr19:51569106,-0.775066446907792,-0.83916406590229,0.331795407079018,1.44195114998956,-0.831512240449048,-0.40451116438489,0.546294195431972,0.297296394208769,-0.297152412343262,-0.439261680600165,31.0250968933105,2.22823698567203,No,No,Yes,No,23,Bivalent promoter
cg05365729,0.052940133,NA,0.0093,0.034,0.71,0.32,0.33,0.31,4017,36,8,23318018,36.1,23317667,-,LOXL2,LOR2; WS9-14;,NM_002318.2,GI:67782347,###############################################################################################################################################################################################################################################################,lysyl oxidase-like 2 precursor,positive,chr8:23262073,-0.920957256151123,-0.833621689680268,0.111737998662199,2.00695259344806,-0.92040059999611,0.264252303280153,0.286980193674913,-0.165241940357452,0.605673591738428,-0.40989114295842,80.5533142089844,1.97520121459096,Yes,No,Yes,No,23,Bivalent promoter
cg05442902,-0.578208568,-0.618797077,0.0059,0.0097,0.97,0.23,0.26,0.22,9127,36,22,19699010,36.1,19699449,+,P2RXL1,P2X6; P2XM; P2RX6;,NM_005446.2,GI:38327545,###############################################################################################################################################################################################################################################################,purinergic receptor P2X-like 1; orphan receptor,negative,chr22:21369010,-0.437851434626641,-0.288732976751627,0.10505269446162,-0.286402315207272,-0.237083139437758,1.90884214246811,-0.294609445791085,0.411171028463708,-0.322319018671827,-0.439261680600165,77.9031448364258,2.84938736136074,Yes,No,Yes,No,2,Promoter
cg05590257,-0.031153885,NA,0.014,0,1,0.095,0.12,0.075,201164,36,17,17050295,36.1,17050357,-,LOC201164,,NM_178836.2,GI:31343395,go_function: hydrolase activity; go_process: metabolism; go_process: lipid catabolism,hypothetical protein LOC201164,negative,chr17:17109570,0.00908784874390321,0.338452939835609,-0.176903631529914,-0.408519556787332,0.139811769409069,0.284374077181181,0.780444013513365,0.772822398407123,-0.508277840078188,-0.155331457229031,81.4117203139307,1.5184455682859,Yes,Yes,Yes,No,2,Promoter
cg05675373,0.346355946,0.187092941,0.0056,0,0.72,0.09,0.053,0.12,3749,36,1,110555780,36.1,110555500,+,KCNC4,KV3.4; KSHIIIC; HKSHIIIC; MGC126818;,NM_004978.2,GI:24497461,###############################################################################################################################################################################################################################################################,Shaw-related voltage-gated potassium channel protein 4 isoform a,positive,chr1:110754257,0.0484537476085092,0.164019233976666,-0.182565372763148,0.664666772438765,-0.251439075801607,0.45554824237123,0.223487843108976,0.0320874780708474,1.91471008805301,-0.274035306214024,67.9964981079102,1.65162143358956,Yes,Yes,No,No,23,Bivalent promoter
cg05755779,0.060215102,NA,0.0058,0.058,0.99,0.85,0.83,0.86,10584,36,8,120148806,36.1,120148627,+,COLEC10,CLL1; MGC118794; MGC118795;,NM_006438.2,GI:18105033,###############################################################################################################################################################################################################################################################,collectin sub-family member 10,positive,chr8:120079625,-0.735585305373884,-0.99538424689645,0.144874366029649,0.109627891356431,-0.912694005604362,-0.986290153899602,0.14798709595065,-0.900902785377109,-0.302353866663241,-0.439261680600165,76.6713427117935,-0.844801622163739,Yes,No,No,No,25,Quiescent/low
cg05847778,-0.058704445,NA,1e-04,0,0.13,0.033,0.033,0.032,129880,36,2,170044413,36.1,170044252,+,BBS5,,NM_152384.2,GI:54145494,,Bardet-Biedl syndrome 5,negative,chr2:170336167,0.136488330647033,1.44970156801421,-0.308811247463726,-0.372294475537304,0.516418612550725,0.400330456499591,0.769435773385752,1.43303494457421,-0.146182194656575,-0.353167221910099,54.6589164733887,2.90157026938287,Yes,Yes,No,No,1,Active TSS
cg05903609,-0.158648055,NA,0.0026,0.024,0.53,0.1,0.1,0.1,10594,36,17,1534638,36.1,1534850,-,PRPF8,PRP8; RP13; HPRP8; PRPC8;,NM_006445.2,GI:17999536,###############################################################################################################################################################################################################################################################,U5 snRNP-specific protein,negative,chr17:1587888,2.12371371708315,1.65084180655261,0.298872896336506,-0.484784693500466,1.94517076903717,0.421783081950277,0.329629691767117,-0.168819578961753,0.089527924262047,1.29140676689208,84.7420654296875,2.93580284494184,Yes,Yes,No,No,3,Promoter
cg05921699,0.018064958,NA,0.019,0.0044,0.97,0.82,0.8,0.83,973,36,19,47072565,36.1,47073042,+,CD79A,IGA; MB-1;,NM_001783.2,GI:68348717,###############################################################################################################################################################################################################################################################,CD79A antigen isoform 1 precursor,positive,chr19:42380725,1.33040008428445,-0.895469193284389,-0.631634544419054,-0.61778340136027,-0.562350185122493,2.06867603536994,-0.556413491176248,-0.634607979793846,-0.641326270601752,-0.323097144799632,75.8917999267578,-0.0110997180325408,No,No,No,No,15,Active enhancer
cg05960024,0.081029885,NA,0.021,0.0035,1,0.9,0.89,0.91,9575,36,4,56070777,36.1,56070989,-,CLOCK,KIAA0334;,NM_004898.2,GI:25777594,###############################################################################################################################################################################################################################################################,clock,positive,chr4:56376020,-0.840683244315632,-1.00479057422657,1.1869098387224,-0.736775423293853,-0.742162420720073,-1.02168955901769,-0.539335782572963,-0.489848446884813,0.0539813060843643,-0.275920865682228,52.8784217834473,-1.13970486523222,Yes,No,No,No,17,Weak enhancer
cg06044899,-0.142865007,NA,0.0064,0.073,0.95,0.55,0.56,0.54,7117,36,4,91979252,36.1,91979292,-,TMSL3,,NM_183049.2,GI:72255572,go_component: cytoplasm; go_function: actin binding; go_process: cytoskeleton organization and biogenesis,thymosin-like 3,negative,chr4:91760229,-0.84396351672062,-1.05055412568242,-0.254822331179487,-0.580632940775189,-1.0318211752391,-1.06871494387639,0.480002830684853,-0.972511006148737,-0.577163330089584,3.15373005668766,4.5215277671814,0.749460340738296,Yes,Yes,No,No,25,Quiescent/low
cg06117855,-0.007113851,NA,0.013,0,0.93,0.11,0.15,0.1,7123,36,3,45042792,36.1,45042774,+,CLEC3B,TN; TNA; DKFZp686H17246;,NM_003278.1,GI:4507556,tetranectin (plasminogen-binding protein); tetranectin (plasminogen binding protein); go_component: extracellular space; go_function: sugar binding; go_process: skeletal development,C-type lectin domain family 3; member B,negative,chr3:45067788,-0.790325509688728,-0.848978778321195,0.313985144312516,0.429610776465781,-0.72413243874956,-0.368813925654811,0.0599939066916933,-0.34941158613313,-0.639796329614848,-0.400166480002088,85.4269638061523,3.15293638532048,Yes,No,No,No,17,Weak enhancer
cg06121469,0.027024582,NA,0.0019,0,0.51,0.035,0.032,0.039,80208,36,15,42743390,36.1,42743138,-,KIAA1840,FLJ21439; DKFZp762B1512;,NM_025137.2,GI:33636747,go_function: catalytic activity; go_function: ferric iron binding; go_process: aromatic compound metabolism,hypothetical protein LOC80208,positive,chr15:44956098,0.343711327113688,-0.235404550049374,-0.27211882303974,-0.746481952925575,-0.230954575716137,0.941345564367481,-0.78659217127434,2.05616043528733,-0.477845539944965,0.0327386153426836,63.2759819030762,0.17144217344015,No,No,Yes,No,2,Promoter
cg06144905,0.597211279,0.463910297,0.025,0.0026,0.9,0.22,0.22,0.22,51268,36,17,24393906,36.1,24394044,+,PIPOX,LPIPOX;,NM_016518.2,GI:60499000,go_component: peroxisome; go_function: oxidoreductase activity; go_function: sarcosine oxidase activity; go_function: L-pipecolate oxidase activity; go_process: electron transport; go_process: tetrahydrofolate metabolism,L-pipecolic acid oxidase,positive,chr17:27369780,-0.706237773720062,-0.62474150283067,0.0894036777015934,-0.10407222260195,-0.704690637944381,-0.527134166633492,0.204237480900703,-0.0818598653495372,-0.348935429026729,-0.439261680600165,81.1339950561523,1.89219644356059,Yes,No,No,No,15,Active enhancer
cg06361108,0.43315799,NA,0.00075,0,0.51,0.021,0.012,0.032,899,36,16,2418782,36.1,2419441,+,CCNF,FBX1; FBXO1;,NM_001761.1,GI:4502620,F-box only protein 1; go_component: nucleus; go_process: mitosis; go_process: cell division; go_process: regulation of progression through cell cycle,cyclin F,positive,chr16:2478781,-0.212920958772191,0.478509971366775,-0.0807906958137346,-0.427036592057552,0.539639851458379,1.45420783057109,-0.361706495169022,1.0933344723238,-0.638221647695754,-0.406708200500817,77.5737609863281,1.9166188450244,No,Yes,No,No,2,Promoter
cg06462291,0.015758987,NA,0.0039,0,0.67,0.059,0.056,0.062,51559,36,12,102759609,36.1,102759105,-,NT5DC3,FLJ11266; TU12B1-TY;,NM_001031701.1,GI:72534691,isoform 1 is encoded by transcript variant 1; TU12B1-TY protein,hypothetical protein LOC51559 isoform 1,positive,chr12:104235479,-0.414552795451526,-0.366644902255514,0.51379645930064,-0.297012653714092,0.0789085185075906,0.205762787349419,-0.407494440907942,0.409058874035449,-0.156901915126499,-0.439261680600165,77.8768530676787,3.14244569609087,No,No,Yes,No,2,Promoter
cg06493994,1.858006164,1.677018893,0.0038,0,0.52,0.098,0.058,0.15,10590,36,6,25760581,36.1,25760408,+,SCGN,SEGN; SECRET; setagin; DJ501N12.8;,NM_006998.3,GI:59814903,go_component: cytoplasm; go_function: calcium ion binding; go_process: biological process unknown,secretagogin precursor,positive,chr6:25652602,-0.706232563604443,-0.31998682564387,-0.115378691152961,2.83629920484891,-0.956298515986039,-0.785635892906341,2.30265554393472,0.407730146226736,-0.217024999770042,-0.439261680600165,20.4684753893617,2.96727805293777,Yes,Yes,No,No,24,Repressed polycomb
cg06513075,0.130551876,NA,0.00027,0,0.33,0.044,0.047,0.042,55226,36,11,34083290,36.1,34083725,+,NAT10,ALP; hALP; FLJ10774; FLJ12179; KIAA1709; DKFZp434C116;,NM_024662.1,GI:13399321,###############################################################################################################################################################################################################################################################,N-acetyltransferase-like protein,negative,chr11:34126714,1.40491853834887,-0.149537264769474,-0.378124997438589,-0.684201732681558,0.543285787974014,0.511651808984773,-0.181543510059855,0.123746684751191,-0.22475547406471,-0.123334965630365,64.6342544555664,0.554169515068045,No,No,Yes,No,2,Promoter
cg06557358,-0.141331243,-0.208235948,0.00097,0,0.52,0.044,0.036,0.055,124842,36,17,29931115,36.1,29931881,+,LOC124842,,NM_207313.1,GI:46560554,,hypothetical protein LOC124842,positive,chr17:32907002,-0.837027449390214,-0.292877701216472,-0.251379767670187,2.8950221150388,-0.688003385138951,0.0515490472169932,0.273076949697762,-1.05759956821443,1.96803623082688,-0.439261680600165,36.6407737731934,2.5457692161315,Yes,Yes,No,Yes,23,Bivalent promoter
cg06688848,-0.016307574,NA,0.0036,0,0.96,0.034,0.034,0.034,89970,36,16,55777598,36.1,55777742,+,RSPRY1,KIAA1972;,NM_133368.1,GI:45387948,go_function: protein binding; go_function: zinc ion binding,hypothetical protein LOC89970,negative,chr16:57220097,-0.334606500391872,-0.186502447029053,-0.618735568590973,-0.740482311264921,-0.41239247992949,-0.896614783809425,-0.476750579917167,-0.516250052549559,-0.602758590821035,0.504454840014376,79.4642715454102,-0.864716347278816,Yes,Yes,No,No,1,Active TSS
cg06738602,-0.151674548,NA,0.0052,0.01,0.87,0.1,0.094,0.1,5732,36,14,51850384,36.1,51850863,+,PTGER2,EP2;,NM_000956.2,GI:31881629,###############################################################################################################################################################################################################################################################,prostaglandin E receptor 2 (subtype EP2); 53kDa,positive,chr14:52780634,0.789395547916363,0.178557730082677,-0.102537653670713,0.221111494913038,0.05142592437948,0.365817988867765,-0.126733909267462,1.28596492196832,1.38320719366371,1.02432531330345,80.5722334902186,2.25512057662911,No,No,Yes,No,2,Promoter
cg06810647,0.374888117,0.008460559,0.0082,0,0.72,0.16,0.12,0.19,57585,36,16,1605095,36.1,1604902,+,CRAMP1L,TCE4;,NM_020825.2,GI:62079294,Crm (Cramped Drosophila)-like; T-complex expressed gene 4,Crm; cramped-like,positive,chr16:1665094,-0.585071374078162,-0.594381995082627,0.891013965380611,0.654479211122684,0.611567918445659,1.03476121605471,-0.108073472289471,-0.25356783740804,1.78266868468322,-0.190205395103247,73.8641510009766,0.468649208996098,Yes,Yes,No,No,3,Promoter
cg06836772,-0.238015601,NA,0.0036,0.025,0.83,0.13,0.14,0.13,5563,36,1,56882991,36.1,56883608,+,PRKAA2,AMPK; AMPK2; PRKAA;,NM_006252.2,GI:46877067,###############################################################################################################################################################################################################################################################,AMP-activated protein kinase alpha 2 catalytic subunit,negative,chr1:57110403,-0.711336182322174,-0.720114801027884,0.24001816076227,1.91483165796537,-0.830854528365147,0.186365359416846,-0.531626900746812,-0.389030843348059,1.79617605747725,-0.439261680600165,51.7528672253996,0.696337695686283,Yes,No,Yes,No,2,Promoter
cg06926735,0.001010208,NA,0.00014,0,0.3,0.033,0.034,0.033,7335,36,20,48166074,36.1,48165901,-,UBE2V1,CIR1; UEV1; CROC1; UBE2V; UEV-1; UEV1A; CROC-1;,NM_021988.3,GI:40806163,###############################################################################################################################################################################################################################################################,ubiquitin-conjugating enzyme E2 variant 1 isoform a,negative,chr20:48732667,-0.662158787670376,-0.43050165547909,0.0624242920345761,-0.723016917851861,-0.313540951948426,-0.445705321717396,-0.627305752345948,-0.0375121713180239,-0.622524564414522,-0.439261680600165,85.5158535964471,-1.01389077763714,Yes,No,No,Yes,2,Promoter
cg06952310,0.091760658,NA,0.016,0.05,0.93,0.6,0.57,0.63,1463,36,19,19188990,36.1,19188762,+,CSPG3,NCAN;,NM_004386.1,GI:4758083,go_function: sugar binding; go_function: calcium ion binding; go_function: hyaluronic acid binding; go_process: cell motility; go_process: cell adhesion,chondroitin sulfate proteoglycan 3 (neurocan),positive,chr19:19327990,-0.822973826425795,-0.920451537226788,0.388189566190824,0.332825588090403,-0.765428756390485,-0.851190116946537,0.386350068146892,-0.419939519023581,-0.149919383173754,-0.439261680600165,80.8281478881836,0.11271005632445,Yes,No,No,No,25,Quiescent/low
cg06993413,1.503184415,0.050943591,0.0039,0.0017,0.99,0.07,0.063,0.075,54878,36,15,63597257,36.1,63597095,-,DPP8,MSTP141; FLJ14920; FLJ20283; MGC26191;,NM_197960.1,GI:37577088,isoform 3 is encoded by transcript variant 3; dipeptidyl peptidase VIII; go_component: membrane; go_function: aminopeptidase activity; go_function: dipeptidyl-peptidase IV activity; go_function: serine-type endopeptidase activity; go_process: proteolysis,dipeptidyl peptidase 8 isoform 3,positive,chr15:65810204,-0.391596768799071,-0.263033762729149,-0.395422470072592,-0.563476741776282,-0.422781027944308,0.157400734338221,-0.188375228176815,-0.0489731975309129,-0.00742314397897668,-0.289943095905984,76.6960525512695,1.1656563828514,No,No,Yes,No,2,Promoter
cg07158339,-0.626329239,-0.490713553,0.011,0.03,0.94,0.33,0.37,0.28,2395,36,9,70840057,36.1,70840164,+,FXN,FA; X25; FARR; FRDA; MGC57199;,NM_000144.3,GI:31742514,###############################################################################################################################################################################################################################################################,frataxin isoform 1 preproprotein,negative,chr9:71650237,-0.849763236969572,-0.789377396301545,-0.340520789709587,-0.567720780524366,-0.830467014314567,0.26565324485924,-0.131908962978301,-0.479666370079285,-0.406979715985386,-0.400166480002088,60.5707969665527,2.9796015248641,Yes,No,Yes,No,16,Weak enhancer
cg07285276,0.192242573,NA,0.01,0.047,0.95,0.83,0.84,0.81,2889,36,9,133602836,36.1,133602746,-,RAPGEF1,C3G; GRF2; DKFZp781P1719;,NM_005312.2,GI:38373674,###############################################################################################################################################################################################################################################################,guanine nucleotide-releasing factor 2 isoform a,positive,chr9:134613015,-0.304133808872572,-0.0565564738300943,-0.148531700589585,-0.678222843907098,-0.400736217047838,0.165704155914898,-0.416964783965636,-0.625176762019354,-0.177441764295035,0.744237335571792,72.7847442626953,1.36874475088641,Yes,No,No,No,5,Transcribed
cg07291563,0.041640015,NA,0.00024,0,0.34,0.04,0.035,0.044,83743,36,19,53641253,36.1,53640874,+,GRWD1,GRWD; WDR28;,NM_031485.2,GI:31542861,glutamate rich WD repeat protein GRWD; WD repeat domain 28; go_component: nucleus,glutamate-rich WD repeat containing 1,positive,chr19:48949441,1.0095124108292,1.06820306218724,-0.237492876670882,-0.606728621706249,1.71836133244183,1.31695704650027,0.505272092343739,-0.12252350548613,-0.616727918951027,0.106434200398899,81.1354656837825,2.6386220709653,Yes,Yes,Yes,No,3,Promoter
cg07337598,0.088226928,NA,0.012,0.09,0.91,0.7,0.66,0.72,8416,36,1,149220567,36.1,149221178,+,ANXA9,ANX31;,NM_003568.1,GI:4502102,###############################################################################################################################################################################################################################################################,annexin A9,positive,chr1:150953943,-0.69205521511154,-0.7468277310626,-0.059602402700891,-0.232720584685083,-0.683160616705079,-0.560789199024356,0.326396369605423,-0.631275507949228,-0.293809411124705,-0.419642557742483,83.3469467163086,0.851424443781826,No,No,No,No,15,Active enhancer
cg07388493,-0.520727113,-0.629412185,0.016,0.00073,0.97,0.48,0.56,0.43,4725,36,1,39264046,36.1,39264593,+,NDUFS5,,NM_004552.1,GI:4758789,###############################################################################################################################################################################################################################################################,NADH dehydrogenase (ubiquinone) Fe-S protein 5; 15kDa (NADH-coenzyme Q reductase),negative,chr1:39491459,0.811256969142093,-0.516924743654492,-0.429056843732193,-0.708926435638673,-0.544963696780608,1.29776036544561,0.338653415544041,-0.0203197213921786,-0.602781745815396,-0.429456221072508,78.2092889990295,0.203113737849516,No,No,No,No,3,Promoter
cg07408456,-0.218776385,-0.125230448,0.025,0.027,0.96,0.38,0.47,0.34,114770,36,19,15451532,36.1,15451312,-,PGLYRP2,tagL; PGRPL; PGRP-L; PGLYRPL; HMFT0141; TAGL-like; tagl-beta; tagL-alpha;,NM_052890.2,GI:21361844,###############################################################################################################################################################################################################################################################,peptidoglycan recognition protein L precursor,negative,chr19:15590532,-0.497886288339857,-0.406713601637814,-0.281897514467016,-0.358445439753544,-0.567750782451644,-0.0779938698092621,-0.111567134984005,-0.335314156341825,-0.532457143682069,-0.439261680600165,62.0719346595821,1.71588239696825,Yes,No,No,No,17,Weak enhancer
cg07455279,0.005632264,NA,0.011,0.025,0.95,0.22,0.22,0.23,4696,36,19,59297515,36.1,59297972,+,NDUFA3,B9;,NM_004542.1,GI:4758771,###############################################################################################################################################################################################################################################################,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex; 3; 9kDa,positive,chr19:54605703,0.372726198086643,-0.698874512896565,-0.593595270439437,-0.66079873532905,-0.609072722436272,0.0816079373745321,-0.797314372700441,-0.243498369571878,-0.439550504778987,-0.352743788021822,58.2149696350098,2.89082913746311,Yes,No,Yes,No,2,Promoter
cg07498421,-0.059490426,NA,0.00075,0.0058,0.4,0.11,0.11,0.099,8738,36,12,92595354,36.1,92595282,+,CRADD,RAIDD; MGC9163;,NM_003805.3,GI:51988883,###############################################################################################################################################################################################################################################################,CASP2 and RIPK1 domain containing adaptor with death domain,negative,chr12:94071223,0.560226423279157,0.0971401195280197,-0.526654194569473,-0.743215682648995,0.512317461043387,-0.455758344620428,-0.338782243070446,0.446103048280647,-0.454910472524791,-0.148629717030849,72.8851089477539,0.0577882929172564,Yes,No,Yes,No,1,Active TSS
cg07595943,0.051178068,NA,0.0068,0,1,0.98,0.98,0.99,161931,36,16,82782402,36.1,82782245,+,LOC161931,,NM_139174.2,GI:31543071,go_component: intracellular; go_function: hydrolase activity; go_function: double-stranded RNA binding; go_function: adenosine deaminase activity; go_process: mRNA processing,hypothetical protein LOC161931,positive,chr16:84224901,-0.752538320042004,-0.43149577881041,0.180025843646708,-0.540014686596284,-0.825921071494251,-0.762589215808672,0.0933539296233532,-0.468004165466759,-0.612870142800999,-0.391299675808552,69.7226409912109,0.373321694676161,Yes,Yes,No,No,25,Quiescent/low
cg07663789,-0.074789714,NA,0.0013,0,0.58,0.039,0.037,0.04,4883,36,5,32747186,36.1,32747422,+,NPR3,NPRC; ANPRC;,NM_000908.2,GI:45505140,go_component: membrane; go_component: integral to membrane; go_function: receptor activity; go_function: peptide receptor activity; G-protein coupled; go_process: skeletal development,natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C),negative,chr5:32711429,-0.915691314895569,-0.902501363593499,-0.733156367774264,-0.289375004311354,-0.928636109013121,-0.353688303823659,-0.753689815079998,-0.901013503916999,1.08456296017806,-0.439261680600165,67.2705831361233,1.79148091642322,Yes,Yes,No,No,23,Bivalent promoter
cg07730301,-0.01177889,NA,0.019,0.023,0.89,0.32,0.39,0.3,221,36,11,67534528,36.1,67534366,+,ALDH3B1,ALDH4; ALDH7;,NM_000694.2,GI:71773289,isoform a is encoded by transcript variant 1; aldehyde dehydrogenase 7; go_function: oxidoreductase activity; go_function: aldehyde dehydrogenase [NAD(P)+] activity; go_process: metabolism; go_process: lipid metabolism; go_process: alcohol metabolism,aldehyde dehydrogenase 3B1 isoform a,negative,chr11:67777952,-0.0438405157964766,0.357456759470009,-0.162318626149756,0.171891482396298,0.0460208307674935,0.189540258461768,0.641839522707447,0.247257800714563,-0.289229048030834,-0.18145059487812,71.494384765625,1.59126855843989,Yes,No,No,No,2,Promoter
cg07770222,0.009940405,NA,0.037,0.035,0.96,0.48,0.49,0.47,286122,36,8,144191481,36.1,144192054,+,C8orf31,FLJ37131; MGC90155;,NM_173687.1,GI:27735122,synonyms: FLJ37131; MGC90155,hypothetical protein LOC286122,negative,chr8:144120106,-0.473695364830096,-0.618491994622052,-0.201768151331064,-0.584014721814486,-0.245820605655845,-0.831100490046523,-0.335184796822479,-0.622177683749088,-0.690393912523158,-0.439261680600165,54.0587348937988,1.14037884736166,No,No,No,No,1,Active TSS
cg07849904,-0.116542884,NA,0.00061,0.022,0.47,0.067,0.07,0.067,4330,36,22,26527796,36.1,26527486,-,MN1,MGCR; MGCR1; MGCR1-PEN; dJ353E16.2;,NM_002430.2,GI:55956909,###############################################################################################################################################################################################################################################################,meningioma  1,negative,chr22:28197796,-0.190737615942815,0.296629874016242,-0.515024303232207,-0.083484423922221,0.355248592311214,-0.438475158424601,0.143909392858846,-0.800389791755089,0.681786751108836,-0.23829035118827,70.0258483886719,0.736985748450762,No,Yes,No,No,1,Active TSS
cg08030082,0.012830322,NA,0.019,0.014,0.99,0.48,0.44,0.5,5443,36,2,25245343,36.1,25244956,-,POMC,MSH; POC; ACTH; CLIP;,NM_000939.1,GI:4505948,###############################################################################################################################################################################################################################################################,proopiomelanocortin,positive,chr2:25391839,-0.381400789350791,-0.426432955538729,0.0573071975597514,2.06386719855884,-0.408763433829926,-0.155494077561224,0.0406864390482918,0.0265747651681158,1.92910303843127,-0.429456221072508,67.2316970825195,1.71179352779533,No,Yes,No,No,24,Repressed polycomb
cg08090772,-0.341458098,-0.33190174,0.0029,0,0.96,0.055,0.05,0.074,137872,36,8,67507194,36.1,67507288,+,ADHFE1,ADH8; FLJ32430; HMFT2263; MGC48605;,NM_144650.1,GI:21389518,alcohol dehydrogenase 8; Fe-containing alcohol dehydrogenase 1,alcohol dehydrogenase; iron containing; 1,positive,chr8:67344640,0.56829437319574,0.182934682218412,-0.228995409573428,-0.222835910301203,0.978751012396171,0.476849696752715,0.470974030131725,-1.00960278167192,-0.523699103385882,-0.0361306884175906,85.577857590673,0.871679318491698,Yes,Yes,No,Yes,3,Promoter
cg08124722,0.008484904,NA,0.0094,0.0048,0.98,0.9,0.9,0.9,6354,36,17,29621827,36.1,29621353,+,CCL7,FIC; MARC; MCP3; NC28; MCP-3; SCYA6; SCYA7;,NM_006273.2,GI:13435401,###############################################################################################################################################################################################################################################################,chemokine (C-C motif) ligand 7 precursor,positive,chr17:32597714,-0.738037959784735,-0.911349867511909,-0.403917373413557,0.403483611479673,-0.927669053116993,-0.937993525785745,0.597465546764471,-0.958827309278251,0.0271546282441684,-0.281754773614581,46.625862121582,0.574214447111417,Yes,No,No,No,25,Quiescent/low
cg08186124,-0.070505215,NA,0.00021,0,0.36,0.038,0.041,0.037,54585,36,3,45858680,36.1,45858625,-,LZTFL1,,NM_020347.2,GI:56676319,go_function: Ras GTPase activator activity; go_process: negative regulation of Ras protein signal transduction,leucine zipper transcription factor-like 1,negative,chr3:45883676,-0.502898107818428,-0.138461614971479,-0.363157048045811,-0.481065731154333,-0.115185758031104,0.0664503279995454,0.185774807437152,1.77974493466738,-0.324530411894578,-0.219368311603451,67.8292197705504,1.1980197441668,Yes,Yes,No,No,2,Promoter
cg08251036,0.068634882,NA,0.0051,0.028,0.99,0.91,0.9,0.92,4249,36,2,134725393,36.1,134725638,+,MGAT5,GNT-V;,NM_002410.2,GI:6031185,###############################################################################################################################################################################################################################################################,alpha-1;3(6)-mannosylglycoprotein beta-1;6-N-acetyl-glucosaminyltransferase,positive,chr2:135008923,-0.523105785317008,-0.663976356601938,0.116787049286133,-0.505434841786727,-0.746534628752829,0.235052627360484,-0.524657993380277,-0.618650264457965,-0.559477643735721,-0.334601853550094,54.9811897277832,0.800760155116731,Yes,No,No,No,17,Weak enhancer
cg08331960,-0.42705014,-0.625384236,0.019,0.03,0.92,0.39,0.47,0.33,9351,36,16,2016598,36.1,2016930,+,SLC9A3R2,SIP1; OCTS2; SIP-1; TKA-1; E3KARP; NHERF2; NHE3RF2; NHERF-2; MGC104639;,NM_004785.3,GI:71897228,###############################################################################################################################################################################################################################################################,solute carrier family 9 isoform 3 regulator 2,negative,chr16:2076597,-0.708547049407467,-0.704509365434223,0.468350593864824,0.704568586004564,-0.368215422412494,0.111994604411892,-0.418441928428416,-0.519965734741452,0.917577441422426,-0.439261680600165,85.4624289800401,1.21467171748279,Yes,No,Yes,No,2,Promoter
cg08370996,0.812907628,NA,0.0021,0.0094,0.72,0.082,0.062,0.099,7026,36,15,94675035,36.1,94674950,+,NR2F2,ARP1; SVP40; COUPTFB; TFCOUP2; COUP-TFII;,NM_021005.2,GI:31377723,###############################################################################################################################################################################################################################################################,nuclear receptor subfamily 2; group F; member 2,positive,chr15:96874031,-0.590256092656743,-0.140616386646051,0.185668795038487,1.84312323303804,-0.819241687004049,1.07135032408286,1.16455937062913,1.27626365597188,1.41307619664498,-0.439261680600165,52.4284057617188,2.07198709926054,Yes,Yes,No,No,2,Promoter
cg08413469,0.140510611,NA,0.00031,0,0.61,0.045,0.044,0.044,55635,36,1,68735528,36.1,68735295,-,DEPDC1,DEP.8; SDP35; FLJ20354;,NM_017779.3,GI:41282232,cell cycle control protein SDP35; 5830484J08Rik; go_process: intracellular signaling cascade,DEP domain containing 1,positive,chr1:68962940,-0.0269051963162841,0.915957360221727,-0.02906050281308,0.586842461852928,-0.134632583200779,0.443037702556621,0.0587092555032189,0.559941173662214,-0.408309538193973,-0.439261680600165,68.5481796264648,-0.830223843943262,No,Yes,No,No,1,Active TSS
cg08434234,-0.211774018,NA,0.0012,0,0.64,0.053,0.047,0.061,9162,36,7,137181713,36.1,137182149,-,DGKI,DGK-IOTA;,NM_004717.2,GI:32483395,go_component: nucleus; go_component: cytoplasm; go_function: metal ion binding; go_function: transferase activity; go_function: diacylglycerol kinase activity; go_process: protein kinase C activation; go_process: intracellular signaling cascade,diacylglycerol kinase; iota,positive,chr7:137531173,-0.758272766548532,0.0120075772164896,0.483417295801574,1.79507564949295,-0.4441433826742,0.662217381642685,-0.870980567110918,-0.8374111478851,1.20711344653377,-0.439261680600165,75.5043792724609,1.20804697461426,Yes,Yes,No,No,23,Bivalent promoter
cg08771731,0.103386824,NA,3e-04,0,0.3,0.041,0.041,0.042,10409,36,5,17269434,36.1,17270750,+,BASP1,CAP23; NAP22; CAP-23; NAP-22; MGC8555;,NM_006317.3,GI:30795230,brain acid-soluble protein 1; neuronal tissue-enriched acidic protein; neuronal axonal membrane protein NAP-22; go_component: cytoskeleton; go_component: plasma membrane,brain abundant; membrane attached signal protein 1,positive,chr5:17216434,-0.620076875854854,-0.640212389224428,0.0299046383703327,0.648591555938357,-0.660314035923246,-0.189118610033241,1.34865338370421,-0.385816981032625,-0.106454231693012,-0.390533304595571,84.8590882983886,2.01686064332198,Yes,No,Yes,No,1,Active TSS
cg08965235,-0.220130796,NA,0.009,0.026,0.93,0.17,0.16,0.18,4054,36,11,65081734,36.1,65082006,-,LTBP3,LTBP2; LTBP-3; pp6425; DKFZP586M2123;,NM_021070.2,GI:18497287,latent TGF beta binding protein 3; go_function: calcium ion binding; go_function: growth factor binding,latent transforming growth factor beta binding protein 3,positive,chr11:65325158,0.349237443418372,0.0954793327632419,0.0805015951176235,-0.28900337325586,0.385648742954305,1.08337533645517,-0.0570969009258836,-0.596049361686113,-0.133618588627674,-0.254323603732096,86.4381713867188,-0.672929051390823,Yes,Yes,No,Yes,3,Promoter
cg09019938,-0.12172174,NA,0.00092,0,0.61,0.057,0.046,0.063,5592,36,10,52504504,36.1,52504299,+,PRKG1,PGK; CGKI; PRKG1B; PRKGR1B; MGC71944; cGKI-BETA; cGKI-alpha;,NM_006258.1,GI:10835241,###############################################################################################################################################################################################################################################################,protein kinase; cGMP-dependent; type I,positive,chr10:52834498,-0.797745643845988,-0.176810909326268,-0.143183813393569,1.36322410090774,-0.757891675787013,0.154742425438169,-0.0564551436367078,-1.0869405055938,0.621786705590258,-0.41994170954505,51.2907206280868,1.56073936902606,Yes,Yes,No,No,23,Bivalent promoter
cg09118625,0.307808351,NA,0.017,0.0074,0.97,0.67,0.63,0.71,9077,36,1,68285559,36.1,NA,-,DIRAS3,ARHI; NOEY2;,NT_032977.8,,###############################################################################################################################################################################################################################################################,DIRAS family; GTP-binding RAS-like 3,positive,chr1:68512971,-0.846185470720639,-0.348260514191323,0.526164937198931,0.533715368355691,-0.981318658990445,-0.699752996211925,0.860268958248729,1.07641009198008,-0.567833682061674,-0.439261680600165,74.8990478515625,0.914929829659855,Yes,Yes,No,Yes,23,Bivalent promoter
cg09133026,-0.196543481,NA,0.0042,0.067,1,0.85,0.87,0.82,83694,36,14,74457858,36.1,74458630,-,RPS6KL1,MGC11287;,NM_031464.2,GI:34147400,go_function: ATP binding; go_function: nucleotide binding; go_function: transferase activity; go_function: protein kinase activity; go_function: structural constituent of ribosome; go_process: protein amino acid phosphorylation,ribosomal protein S6 kinase-like 1,negative,chr14:75388105,-0.871135712166041,-0.42715685830698,-0.172780344004936,-0.394675783043774,-0.881724869471677,-0.698768595468609,-0.493924046505754,-0.931174502873528,-0.718067315478671,-0.170262395086499,81.609619140625,0.945528619798365,Yes,No,Yes,No,25,Quiescent/low
cg09191327,-0.278393765,-0.017810648,0.00097,0,0.68,0.049,0.043,0.052,59335,36,9,132529929,36.1,132529802,+,PRDM12,PFM9;,NM_021619.2,GI:15042948,###############################################################################################################################################################################################################################################################,PR domain containing 12,positive,chr9:133540108,-0.875083743528697,-0.305277435298906,1.14069775521092,2.23400548700611,-0.765429919290316,0.802833856410436,0.991525090799797,0.287259605239725,5.14162672686237,-0.40989114295842,73.2606735229492,0.979786658467213,Yes,Yes,No,No,24,Repressed polycomb
cg09418283,0.027502906,NA,0.00032,0,0.31,0.021,0.02,0.023,5074,36,12,78608849,36.1,78608921,-,PAWR,PAR4; Par-4;,NM_002583.2,GI:55769532,###############################################################################################################################################################################################################################################################,PRKC; apoptosis; WT1; regulator,positive,chr12:80084718,-0.648912792353976,0.204476182499345,0.327587224025257,1.51007216212465,-0.319404224636211,-0.136589383308615,0.238920997048299,-1.3537136691272,1.50491255958202,-0.322311024230525,74.5351715087891,1.8408511043796,Yes,Yes,No,No,1,Active TSS
cg09441152,-0.683075851,NA,0.002,0,0.94,0.042,0.044,0.041,80148,36,18,75813281,36.1,75812605,-,PQLC1,FLJ22378;,NM_025078.3,GI:34222340,go_function: electron transporter activity; go_process: electron transport,PQ loop repeat containing 1,negative,chr18:77712293,0.190404906812279,1.0607569175461,-0.183136507006631,-0.0221834714159846,0.672116709736448,0.538383042830885,-0.383245241572091,0.58860347672542,0.886105825426042,-0.384625577279236,61.0968894958496,2.97994384207113,No,Yes,No,No,2,Promoter
cg09509673,0.013745188,NA,0.016,0.032,0.98,0.85,0.83,0.86,2826,36,17,38087223,36.1,38087371,-,CCR10,GPR2;,NM_016602.1,GI:7705315,###############################################################################################################################################################################################################################################################,CC chemokine receptor 10,positive,chr17:40833697,-0.917405641076378,-0.749170699316256,-0.119617109268554,1.26610901211199,-0.723992762221052,0.266424704803622,-0.0614524648221845,-0.724676083177683,0.0661976030753178,-0.414329403600643,83.2161456367322,1.48511114251103,Yes,No,Yes,No,23,Bivalent promoter
cg09646392,-0.000417407,NA,0.049,0.017,1,0.39,0.42,0.36,10673,36,13,107719053,36.1,107719978,+,TNFSF13B,BAFF; BLYS; CD257; TALL1; THANK; ZTNF4; TALL-1; TNFSF20; delta BAFF;,NM_006573.3,GI:23510443,###############################################################################################################################################################################################################################################################,tumor necrosis factor (ligand) superfamily; member 13b,negative,chr13:108921052,0.104183824109307,-0.927106622562108,-0.383042226158841,-0.545392118781433,-0.824647160627948,-0.0515840980288901,0.634369296461068,-0.520810871059873,0.377141365408611,-0.375226810230148,40.0756797790527,-1.02908504046781,Yes,No,No,No,8,Weakly transcribed
cg09722397,-0.147296004,-0.002921084,0.0015,0,0.61,0.062,0.058,0.062,2905,36,17,70367538,36.1,70367602,-,GRIN2C,NR2C; NMDAR2C;,NM_000835.3,GI:55770853,###############################################################################################################################################################################################################################################################,N-methyl-D-aspartate receptor subunit 2C precursor,negative,chr17:72855943,-0.795990833948261,-0.350283285749276,-0.572118858174381,0.840486300726309,-0.909553471584147,-0.306818734591408,-0.714739171094328,-0.689522059610484,1.58255208382287,-0.429456221072508,72.9599456787109,1.65565062725274,Yes,Yes,No,No,23,Bivalent promoter
cg09722555,-0.346465927,NA,0.0035,0.087,0.98,0.9,0.91,0.88,10850,36,9,34652282,36.1,34652689,-,CCL27,ALP; ILC; CTAK; CTACK; PESKY; ESKINE; SCYA27;,NM_006664.2,GI:22165428,###############################################################################################################################################################################################################################################################,small inducible cytokine A27 precursor,negative,chr9:34662282,-0.305016414474764,-0.837147657825348,0.94917153912452,-0.575600872236132,-0.570780030983413,0.00184421784722033,-0.176779689720744,-1.01091840384857,-0.706154345257919,-0.360037927807614,71.7095947265625,0.674055643745649,Yes,No,No,Yes,17,Weak enhancer
cg09785172,-0.016561072,NA,0.0064,0,0.92,0.036,0.034,0.037,7466,36,4,6322559,36.1,6322478,+,WFS1,WFS; WFRS; DFNA6; DFNA14; DFNA38; DIDMOAD; WOLFRAMIN;,NM_006005.2,GI:13376995,###############################################################################################################################################################################################################################################################,wolframin,positive,chr4:6271658,-0.483510811042237,0.419122836909625,-0.120745698030273,-0.172162637466677,0.371797784109002,-0.292827411214392,-0.257735083946446,0.155709181573968,-0.383404739802405,-0.401517513216472,42.5183943750852,1.09146938478616,Yes,Yes,No,No,2,Promoter
cg09809672,-0.391318905,-0.189294522,0.042,0.0022,0.97,0.56,0.65,0.45,128178,36,1,234624305,36.1,234624303,+,EDARADD,,NM_080738.2,GI:22325373,###############################################################################################################################################################################################################################################################,EDAR-associated death domain isoform B,negative,chr1:236557682,-0.668923485094451,-0.760571131409788,-0.40735706896533,0.0249284635909791,-0.251474465062089,-0.396479319449502,0.159109612751101,0.413589881371345,0.0125464446185725,-0.316607015493572,41.7859328690907,-0.33286070767837,Yes,No,Yes,No,2,Promoter
cg09869858,0.066316642,NA,0.0013,0.027,0.98,0.93,0.93,0.93,8909,36,12,46406683,36.1,46405617,-,P11,PP11; MGC133268; PRSS26-PENDING;,NM_006025.2,GI:22209002,###############################################################################################################################################################################################################################################################,placental protein 11 precursor,positive,chr12:48120416,-0.786594903784947,-0.936048971059074,-0.16292837879087,-0.279938762612532,-0.77868196120165,-0.961892359620324,-0.732213807319112,-0.823138893055668,0.055612250930285,-0.429456221072508,81.2516809972444,0.264811713314177,No,No,No,No,25,Quiescent/low
cg09885951,0.095237498,NA,0.00081,0,0.82,0.032,0.031,0.032,1063,36,1,212843092,36.1,212843155,+,CENPF,CENF; PRO1779;,NM_016343.3,GI:55770833,centromere protein F (400kD); centromere protein F (350/400kD; mitosin); CENP-F kinetochore protein; AH antigen; cell-cycle-dependent 350K nuclear protein; go_component: chromatin; go_component: cytoplasm; go_component: kinetochore; go_component: spindle pole; go_component: nuclear matrix; go_component: nuclear envelope; go_component: outer kinetochore of condensed chromosome; go_component: outer kinetochore of condensed chromosome; go_component: outer kinetochore of condensed chromosome; go_function: dynein binding; go_function: chromatin binding; go_function: protein C-terminus binding; go_function: transcription factor binding; go_function: protein homodimerization activity; go_function: protein heterodimerization activity; go_process: mitosis; go_process: cell division; go_process: response to drug; go_process: cell proliferation; go_process: cell proliferation; go_process: kinetochore assembly; go_process: mitotic spindle checkpoint; go_process: metaphase plate congression; go_process: G2 phase of mitotic cell cycle; go_process: G2 phase of mitotic cell cycle; go_process: negative regulation of transcription; go_process: regulation of striated muscle development,centromere protein F (350/400kD),positive,chr1:214776469,-0.781375866122181,0.204780577970164,-0.453608837192799,-0.50054844120803,-0.32856961863629,-0.735859013508236,-0.506307019907687,1.02924779610426,0.398853280017186,-0.339525063068267,84.6473239698909,-0.00639510072148417,No,Yes,No,Yes,1,Active TSS
cg10045881,-0.046803147,NA,0.025,0.031,0.96,0.65,0.67,0.64,1117,36,1,111571814,36.1,111571804,+,CHI3L2,YKL39; YKL-39;,NM_001025197.1,GI:68533252,###############################################################################################################################################################################################################################################################,chitinase 3-like 2 isoform b,negative,chr1:111770291,-0.209777195705801,-0.25825420136721,-0.346316967101233,-0.548702973015318,-0.560058247219022,0.581994673145102,0.626011121810839,-0.178940840810873,-0.167558995047225,-0.356677519311724,55.7351875305176,-0.694276024247297,Yes,No,No,No,15,Active enhancer
cg10266490,-0.014675,NA,0.018,0,0.94,0.17,0.21,0.16,26027,36,1,54786297,36.1,54786489,+,ACOT11,BFIT; THEA; BFIT1; BFIT2; THEM1; STARD14; KIAA0707;,NM_015547.2,GI:25777708,###############################################################################################################################################################################################################################################################,thioesterase; adipose associated isoform BFIT1,negative,chr1:55013709,-0.74003732813563,-0.587562427760165,0.225604156301128,-0.311301873785113,-0.654521427522032,-0.254936239625161,-0.141198398951154,-0.407670362596301,-0.646237782432762,-0.439261680600165,66.0942535400391,2.35200090162099,Yes,No,No,No,17,Weak enhancer
cg10281002,0.468416918,0.644843308,0.0085,0,0.99,0.13,0.12,0.14,6910,36,12,113330782,36.1,113330630,-,TBX5,HOS;,NM_080718.1,GI:18201895,###############################################################################################################################################################################################################################################################,T-box 5 isoform 2,positive,chr12:114846399,-1.0012187748573,-1.00324239549001,0.834339654943081,1.61161276439949,-0.94874699215535,-0.626779866118496,0.459905455254533,-0.212660695411036,0.615511334373791,-0.419642557742483,54.7523340810267,1.63181884577427,No,Yes,No,Yes,23,Bivalent promoter
cg10345936,0.069971286,NA,0.0093,0.019,1,0.76,0.76,0.75,153201,36,5,150708005,36.1,150707312,-,SLC36A2,PAT2; TRAMD1; FLJ16051; MGC119658; MGC119660;,NM_181776.1,GI:32401452,proton/amino acid transporter 2; tramdorin; go_component: membrane; go_function: amino acid-polyamine transporter activity; go_process: amino acid transport,solute carrier family 36 (proton/amino acid symporter); member 2,negative,chr5:150727812,-0.823208705524846,-0.662772568324006,-0.565775457888675,0.285290617925875,-0.873420739823258,-1.00969722880639,0.0773290238179746,-0.500086563641229,0.00663688826108887,-0.41013236515889,62.7188377380371,-0.683845445063312,No,No,No,No,24,Repressed polycomb
cg10376763,-0.115358177,NA,0.0078,0.0057,0.99,0.91,0.9,0.92,7141,36,2,217432608,36.1,217433027,-,TNP1,TP1;,NM_003284.2,GI:34850064,###############################################################################################################################################################################################################################################################,transition protein 1 (during histone to protamine replacement),positive,chr2:217724363,-0.812991332983683,-1.0152244565926,-0.322276298295003,-0.116341583725249,-0.865795295065357,-1.09105248391336,-0.0349326930178658,-0.834047471696101,0.0884475316414058,-0.439261680600165,67.7066446813265,0.501388483856727,Yes,No,No,No,25,Quiescent/low
cg10377274,0.057139076,NA,0.0039,0.13,0.98,0.87,0.86,0.87,160065,36,11,125122098,36.1,125121398,+,PATE,,NM_138294.2,GI:56676310,go_function: hydrolase activity; go_function: calcium ion binding; go_function: phospholipase A2 activity; go_process: lipid catabolism,expressed in prostate and testis,positive,chr11:125616888,-0.771713272715039,-0.33142015516453,0.0871136682295593,0.0786052109102986,-0.850155871071653,-0.815406260170318,-0.713313830627036,-0.625288550899862,-0.519893047922125,-0.439261680600165,51.1574592590332,0.599463745313567,Yes,No,No,No,25,Quiescent/low
cg10486998,-0.389335841,NA,0.0027,0.0064,0.74,0.084,0.078,0.095,2587,36,18,73090775,36.1,73090721,+,GALR1,GALNR; GALNR1;,NM_001480.2,GI:6031165,###############################################################################################################################################################################################################################################################,galanin receptor 1,positive,chr18:74961787,-0.819165224129957,-0.495833377905632,0.816358868576267,2.32034694136581,-0.84902796940028,0.61240083305461,0.413734604301315,-1.26466082119782,1.31544830797687,-0.439261680600165,52.011302947998,2.02066978744656,No,Yes,No,No,23,Bivalent promoter
cg10523019,0.514646778,0.361338501,0.0048,0.0078,0.82,0.11,0.076,0.14,84236,36,2,227408702,36.1,227409017,+,RHBDD1,MGC117258; DKFZp547E052;,NM_032276.2,GI:33300638,synonyms: MGC117258; DKFZp547E052,hypothetical protein LOC84236,positive,chr2:227700458,1.33979433278843,0.290433250933627,0.102889454672933,-0.494285578465708,0.635393454405499,1.21934003127401,0.94027799535364,2.73225801660166,-0.656076304437354,-0.1529473730612,70.4534853129018,2.67652761846105,Yes,Yes,No,No,3,Promoter
cg10865119,-0.069157921,NA,0.0086,0.026,0.93,0.12,0.14,0.1,80069,36,6,169932037,36.1,169932342,+,C6orf208,FLJ13162; MGC120218; dJ182D15.1; RP1-266L20.3;,NM_025002.1,GI:13376514,synonyms: FLJ13162; MGC120218; dJ182D15.1; RP1-266L20.3,hypothetical protein LOC80069,negative,chr6:170190112,-0.753823175964492,-0.432196244115234,-0.23583502106351,0.598515604324808,-0.292350883145262,0.438264160661837,-0.333325228617506,0.39646057078081,-0.436647129988571,-0.439261680600165,51.3341407775879,2.96647000447929,No,Yes,No,No,2,Promoter
cg10920957,-0.399903548,NA,0.00085,0.014,0.51,0.057,0.052,0.061,57338,36,16,86192974,36.1,86194000,+,JPH3,JP3; HDL2; JP-3; TNRC22; CAGL237;,NM_020655.2,GI:21704282,junctophilin type 3; trinucleotide repeat containing 22; go_component: endoplasmic reticulum; go_component: integral to membrane; go_function: molecular function unknown; go_process: biological process unknown,junctophilin 3,positive,chr16:87635473,-0.859969793233483,-0.828300551485102,0.689717255086646,1.77158772350934,-0.903628793913892,-0.861865028734688,-0.211811722605223,-0.627338983152859,0.983035363025879,-0.439261680600165,72.2714138649348,1.00109498784584,Yes,No,Yes,No,24,Repressed polycomb
cg10940099,0.093135749,NA,0.0024,0,0.94,0.024,0.026,0.023,8763,36,6,109810631,36.1,109810340,-,CD164,MGC-24; MUC-24; endolyn;,NM_006016.3,GI:34222157,###############################################################################################################################################################################################################################################################,CD164 antigen; sialomucin,negative,chr6:109703938,3.37619578275806,-0.270719782692099,-0.490785214146396,-0.747289020998907,1.53780679169748,0.560081283335951,-0.610030778137405,0.565026989999287,-0.243755780282917,-0.052290811220803,47.7886772155762,0.333490795035957,Yes,Yes,No,No,1,Active TSS
cg11025793,-0.012053497,-0.074857504,0.0071,0,0.72,0.12,0.13,0.12,8677,36,19,13123015,36.1,13121987,-,STX10,SYN10; hsyn10;,NM_003765.1,GI:4507284,go_component: membrane; go_component: Golgi stack; go_component: Golgi membrane; go_component: integral to membrane; go_function: protein transporter activity; go_process: intracellular protein transport,syntaxin 10,negative,chr19:13262015,1.47562969354796,0.626922808999324,-0.106914980090196,-0.629943216322773,0.356221303317859,0.574777984142968,-0.144889402951362,-0.0106415448104419,-0.587735379033774,-0.375263264986535,82.1673889160156,2.89453797406454,Yes,Yes,No,No,3,Promoter
cg11299964,-0.157897406,NA,0.0081,0,0.77,0.18,0.2,0.17,79109,36,9,127509604,36.1,127509334,-,MAPKAP1,MIP1; SIN1; SIN1b; SIN1g; MGC2745;,NM_001006620.1,GI:56788398,###############################################################################################################################################################################################################################################################,mitogen-activated protein kinase associated protein 1 isoform 4,negative,chr9:128469783,0.521024540844031,-0.175230728878167,-0.105836553142797,-0.677393640979881,0.107566509441602,0.421743973823049,-0.60511638935467,-0.346371793363189,-0.327473264758655,-0.375040508637146,71.1265487670898,0.0413010441686404,No,No,Yes,No,2,Promoter
cg11314684,-0.076158602,NA,0.022,0.0086,0.87,0.39,0.44,0.35,10000,36,1,242072911,36.1,242073176,-,AKT3,PKBG; PRKBG; STK-2; RAC-gamma; RAC-PK-gamma; DKFZP434N0250;,NM_181690.1,GI:32307162,###############################################################################################################################################################################################################################################################,v-akt murine thymoma viral oncogene homolog 3 isoform 2,negative,chr1:244006288,-0.608474287919237,-0.989654670012781,-0.231176176948279,-0.715426933399128,-0.774508558958253,-0.513741163930823,0.0970419966718016,0.673807921289553,0.731486416610783,1.48636606521554,71.1806793212891,-1.28702741395917,Yes,No,No,No,18,Weak enhancer
cg11388238,-0.35058529,-0.475300518,0.0018,0.016,0.63,0.056,0.068,0.05,130535,36,2,201083343,36.1,201083037,-,KCTD18,FLJ31322; FLJ37818; 6530404F10Rik;,NM_152387.2,GI:45387952,go_component: membrane; go_component: voltage-gated potassium channel complex; go_function: voltage-gated potassium channel activity; go_process: potassium ion transport,potassium channel tetramerisation domain containing 18,negative,chr2:201375098,0.13109261102923,0.0422100770231694,-0.432315597075594,-0.554732987457984,0.523339111104091,0.503738214213245,0.336053472176257,0.536551239785729,0.0862636534972336,-0.398543058691116,75.2324447631836,1.43863739985363,Yes,No,Yes,No,2,Promoter
cg11653266,-0.176347192,NA,0.00013,0,0.33,0.033,0.032,0.033,64978,36,17,71412934,36.1,71413069,-,MRPL38,RPML3; MRP-L3; HSPC262; MGC4810;,NM_032478.2,GI:26667164,go_function: structural constituent of ribosome,mitochondrial ribosomal protein L38,negative,chr17:73901339,0.502560601790109,-0.144914541657585,-0.663745176255564,-0.658318414319606,0.342551670751864,0.920755479292597,-0.330377721656633,0.984763336157438,-0.491107821340818,-0.364680950867865,84.6898196593782,-0.237987304514541,Yes,Yes,No,No,2,Promoter
cg11932564,0.700001079,NA,0.0026,0,0.54,0.032,0.031,0.034,115650,36,22,40652092,36.1,40652728,-,TNFRSF13C,BAFFR; CD268; BAFF-R; MGC138235;,NM_052945.2,GI:17978517,B cell-activating factor receptor; go_component: membrane; go_component: integral to membrane; go_function: receptor activity; go_process: immune response,BAFF receptor,positive,chr22:42322146,-0.0311452051225859,-0.241694826328065,0.039283402904116,0.303951816933028,-0.0152313559830149,0.541363400362424,-0.356346892105722,1.61221524702419,-0.0448424066826948,0.495634762570098,75.3587799072266,1.53383030571625,Yes,Yes,No,No,2,Promoter
cg12351433,0.079279219,NA,0.0056,0.029,0.78,0.2,0.18,0.22,3973,36,2,48836461,36.1,48836321,-,LHCGR,LHR; LCGR; LGR2; hLHR;,NM_000233.1,GI:4557716,###############################################################################################################################################################################################################################################################,luteinizing hormone/choriogonadotropin receptor precursor,positive,chr2:48982957,-0.641380067160808,-0.181064105760883,-0.19761531092425,2.15002059873855,-0.901721275766427,-0.529503371571257,0.527955260448078,-0.286903773237917,-0.257491622560601,-0.429456221072508,40.8205680847168,1.9129498910994,Yes,Yes,No,No,24,Repressed polycomb
cg12373771,0.533301546,NA,0.0048,0.013,0.75,0.11,0.062,0.14,27439,36,22,15981381,36.1,15982143,-,CECR6,,NM_031890.2,GI:54607075,,cat eye syndrome chromosome region; candidate 6,positive,chr22:17601381,-0.776761186542121,0.237248255351957,-0.742070477898586,0.0210080192734995,-0.537840839804628,-0.140413260859747,-0.0172227796761734,0.131939827257856,0.00715843759179422,-0.366174789911907,43.7607367651124,0.754670142226616,Yes,Yes,No,No,23,Bivalent promoter
cg12413566,-0.045644385,-0.215453029,0.012,0.011,0.99,0.9,0.9,0.89,165904,36,3,39210370,36.1,39209081,-,CMYA1,Xin; DKFZp451D042; DKFZp779C1947;,NM_194293.2,GI:40255271,synonyms: Xin; DKFZp451D042; DKFZp779C1947,cardiomyopathy associated 1,negative,chr3:39235366,-0.793625414437912,-0.754209590493683,-0.190622241071065,-0.422636752027093,-0.70070308371211,-0.0698946273445445,0.269878220213305,-0.571922229191435,-0.382394527841131,-0.439261680600165,60.149467896345,2.3203359583313,No,No,No,No,25,Quiescent/low
cg12616277,-0.002979815,NA,0.0026,0.017,0.71,0.084,0.083,0.086,83850,36,3,139636453,36.1,139636114,+,FAM62C,CHR3SYT;,NM_031913.1,GI:46195742,chr3 synaptotagmin,family with sequence similarity 62 (C2 domain containing); member C,negative,chr3:138153763,-0.322585468281007,0.923501434085094,0.571468932037467,2.24930287951754,-0.579536593051791,1.53344900424866,1.37391086701159,-0.922030377983672,0.538842308809643,-0.343691372487235,65.1436996459961,1.67259594325154,Yes,Yes,No,No,23,Bivalent promoter
cg12768605,-0.188560769,NA,0.005,0,0.95,0.13,0.12,0.14,284348,36,19,49016791,36.1,49016626,-,LYPD5,PRO4356; FLJ30469;,NM_182573.1,GI:32698975,metastasis-associated protein; go_function: kinase activity; go_function: receptor activity,LY6/PLAUR domain containing 5,positive,chr19:44324951,-0.703803964174599,-0.120352368109546,-0.188709313774846,1.80516890695925,-0.75511665925079,0.707177222565125,1.53885957843016,0.293418421121085,0.482280847924972,-0.439261680600165,75.1276931762695,1.20459671847766,Yes,Yes,No,No,23,Bivalent promoter
cg12830694,0.339726781,0.333855071,0.015,0.027,0.98,0.91,0.91,0.91,94274,36,19,43439636,36.1,43439012,-,PPP1R14A,CPI-17; PPP1INL;,NM_033256.1,GI:15147249,17-kDa PKC-potentiated inhibitory protein of PP1; 17-KDa protein; go_function: protein phosphatase inhibitor activity,protein phosphatase 1; regulatory (inhibitor) subunit 14A,positive,chr19:38747796,-0.781213714034628,-0.890571420721148,-0.366712140916949,1.12279582025212,-0.817246356254397,-0.575019518293699,0.459885318241666,-0.40796464660866,-0.301312817615242,-0.429456221072508,81.3805999755859,0.810541748475068,Yes,No,Yes,No,23,Bivalent promoter
cg12941369,-0.131067992,-0.028672434,0.012,0.0033,0.76,0.3,0.35,0.27,10015,36,3,33814393,36.1,33814561,+,PDCD6IP,AIP1; Alix; HP95; DRIP4; MGC17003;,NM_013374.3,GI:48255927,programmed cell death 6-interacting protein; ALG-2 interacting protein 1; dopamine receptor interacting protein 4; go_component: cytosol; go_function: signal transducer activity; go_process: apoptosis; go_process: protein transport,programmed cell death 6 interacting protein,negative,chr3:33839389,0.0947623717492243,-0.750190001128885,0.271920454860676,-0.414411711925538,-0.390212802051911,0.00608120865865058,0.0263736891862304,-0.336000158478282,-0.321884924653332,-0.37401928239881,67.3643503736082,0.928753846688595,No,No,Yes,No,3,Promoter
cg12946225,0.133612754,0.530482912,0.0017,0.0083,0.46,0.09,0.069,0.11,10362,36,19,3524751,36.1,3525522,+,HMG20B,SOXL; HMGX2; BRAF25; BRAF35; PP7706; pp8857; FLJ26127; SMARCE1r;,NM_006339.1,GI:5454079,###############################################################################################################################################################################################################################################################,high-mobility group 20B,positive,chr19:3573751,-0.410865415423785,0.282875233021402,-0.344264225656692,-0.636837680975943,-0.231131583162157,-0.0124455049352928,-0.163401097721757,0.256019924005151,-0.555220912535963,0.182720769807999,81.8332290649414,0.854100105594327,Yes,Yes,No,Yes,3,Promoter
cg12985418,-0.431303727,NA,8.2e-05,0,0.13,0.041,0.041,0.039,57534,36,18,17574536,36.1,17575543,+,MIB1,MIB; ZZZ6; DIP-1; ZZANK2; FLJ90676; DKFZp686I0769; DKFZp761M1710;,NM_020774.2,GI:62868229,###############################################################################################################################################################################################################################################################,mindbomb homolog 1,negative,chr18:19320538,-0.406688400067361,-0.610079632317533,-0.440898866806954,-0.513695739544444,-0.512906897490503,-0.555076667131005,-0.597222071319008,-0.186912485891642,-0.234528810318826,-0.395923759642166,56.9254604539372,-1.37543929163695,Yes,No,Yes,No,2,Promoter
cg13038560,0.261380978,0.306105836,0.016,0.0092,1,0.88,0.89,0.88,79568,36,2,200527358,36.1,200528285,+,FLJ22555,DKFZp666A212;,NM_024520.1,GI:13375659,synonym: DKFZp666A212,hypothetical protein LOC79568,positive,chr2:200819113,-0.806243078666003,-0.748316856809658,0.76659567321256,-0.666031555347348,-0.596794729613216,0.0916057698232965,-0.488801716350635,-0.252920110668417,-0.33916908934218,-0.3674754738413,63.5343742370605,1.29640279759088,Yes,No,Yes,No,4,Promoter
cg13129046,-0.205992326,-0.030879589,0.01,0.023,0.84,0.15,0.19,0.14,219738,36,10,71059702,36.1,71060020,+,C10orf35,,NM_145306.1,GI:21687152,go_component: membrane; go_component: integral to membrane,hypothetical protein LOC219738,negative,chr10:71389696,-0.330121692054673,-0.470656009449183,-0.446310336882497,0.239006010048203,-0.657045798347716,-0.127767819616469,0.370888140364852,0.14303140380555,0.185123789478709,-0.429456221072508,65.1074272403099,2.49282781453217,No,No,Yes,No,23,Bivalent promoter
cg13216057,-0.138857398,NA,0.0027,0,0.94,0.057,0.049,0.065,27122,36,11,11987219,36.1,11987493,-,DKK3,REIC;,NM_015881.5,GI:66346686,###############################################################################################################################################################################################################################################################,dickkopf homolog 3 precursor,positive,chr11:12030643,-0.512640891119742,-0.642736777634942,-0.0467858290001557,2.24346257070775,-0.600893063419227,0.158792451710848,-0.336018891046452,-0.902331479316646,-0.473143564091243,-0.439261680600165,86.3080849588066,0.722788118032424,Yes,Yes,No,No,23,Bivalent promoter
cg13269407,-0.091238949,-0.038113525,0.014,0.013,0.84,0.1,0.15,0.095,55267,36,22,44828771,36.1,44828688,-,FLJ10945,,NM_018280.1,GI:8922784,,hypothetical protein LOC55267,negative,chr22:46450107,0.688568469706363,0.247439900601071,-0.317652580732852,-0.668510095572657,0.775271248163751,-0.045803301634146,-0.263944956548232,-0.804021365725795,-0.718067315478671,-0.354148808979738,83.8355941772461,2.03470307123151,No,Yes,No,No,3,Promoter
cg13302154,-0.003525343,NA,0.034,0,0.96,0.35,0.45,0.31,4256,36,12,14930699,36.1,14930095,-,MGP,NTI; GIG36; MGLAP;,NM_000900.2,GI:49574513,###############################################################################################################################################################################################################################################################,matrix Gla protein,negative,chr12:15039432,-0.886251129177764,-1.03443911385593,-0.294077714722564,-0.025510674399921,-0.910402553018407,-0.626506266707923,-0.431422642174092,-0.534834668309736,-0.535855990780493,-0.399486911621619,38.5402046355821,-0.658912008257597,Yes,No,No,No,25,Quiescent/low
cg13319175,0.013848218,NA,0.025,0.025,0.97,0.86,0.86,0.86,832,36,1,19619151,36.1,19618832,-,CAPZB,CAPB; CAPZ; CAPPB; MGC104401; MGC129749; MGC129750;,NM_004930.1,GI:4826658,###############################################################################################################################################################################################################################################################,F-actin capping protein beta subunit,positive,chr1:19746564,-0.626554464655241,-0.759694510183647,4.7261307756223,-0.615384695371085,-0.612530323135897,-0.24842397313278,-0.445989534757376,-1.04995655846013,-0.602069644300081,-0.171402968481304,79.2277867609723,0.920154018351053,Yes,No,No,No,6,Transcribed
cg13460409,0.412023313,0.275569549,0.0088,0,0.88,0.2,0.15,0.26,53820,36,21,37301440,36.1,37300733,+,DSCR6,RIPPLY3;,NM_018962.1,GI:9506556,go_component: cellular component unknown; go_function: molecular function unknown; go_process: biological process unknown,Down syndrome critical region protein 6,positive,chr21:38379570,-0.372990122723327,-0.396617952477625,-0.554127803178499,1.00496930719236,-0.446453132617083,1.03860187916434,-0.129104224769613,-0.946510093221268,1.10351907735522,-0.439261680600165,71.5848461921673,1.72815442035178,Yes,No,Yes,No,23,Bivalent promoter
cg13547237,-0.201508653,-0.382640829,0.01,0.00016,0.89,0.26,0.28,0.25,83638,36,11,65444453,36.1,65443107,-,Bles03,P5326;,NM_031450.2,GI:31543378,synonym: P5326,basophilic leukemia expressed protein BLES03,negative,chr11:65687877,0.219458221688626,0.0623860898780977,0.856186344319849,-0.567949572873601,-0.120481909016358,0.9180537157152,-0.798630653216795,-0.537360624972474,-0.211127903619859,1.3336661811257,85.201774597168,4.22583708534913,Yes,No,Yes,No,4,Promoter
cg13682722,0.110100933,0.21846543,0.0019,0.0096,0.83,0.069,0.06,0.076,55051,36,14,89868321,36.1,89868032,-,C14orf102,FLJ10008; FLJ14051;,NM_199043.1,GI:39932580,isoform 2 is encoded by transcript variant 2; go_function: binding,hypothetical protein LOC55051 isoform 2,positive,chr14:90798568,-0.344966999337974,-0.346517425730184,-0.742070477898586,-0.737964146906075,-0.584421320827718,-0.681874861114585,0.472257190156652,-0.128883288932311,0.0330887186947375,-0.439261680600165,62.108379040573,-0.62925300392456,No,No,Yes,No,1,Active TSS
cg13828047,-0.448971744,-0.158465037,0.013,0.016,0.92,0.31,0.32,0.3,4351,36,15,72969183,36.1,72969463,+,MPI,PMI; PMI1;,NM_002435.1,GI:4505234,###############################################################################################################################################################################################################################################################,mannose-6- phosphate isomerase,negative,chr15:75182130,-0.0407652831173312,-0.442372594404513,-0.207961903933648,-0.625840623248751,-0.380724883006925,0.390335465682709,-0.424821339190284,0.443265337982874,-0.3641998341306,-0.439261680600165,79.4144973754883,0.123158986082005,No,No,Yes,No,2,Promoter
cg13836627,0.029983661,NA,0.00091,0.013,0.52,0.066,0.057,0.078,7082,36,15,27901015,36.1,27901998,-,TJP1,ZO-1; DKFZp686M05161;,NM_003257.2,GI:28416399,###############################################################################################################################################################################################################################################################,tight junction protein 1 isoform a,positive,chr15:30113723,-0.812374221648993,-0.79176484956475,-0.149557849518628,1.92808301537365,-0.736317047363274,0.190123511195164,2.62547406743592,0.796266003380668,1.53497743832521,-0.439261680600165,74.4930801391602,0.799205449144696,Yes,Yes,Yes,No,3,Promoter
cg13854874,0.049613334,NA,0.0045,0,0.95,0.13,0.12,0.14,8208,36,21,36679395,36.1,36679559,+,CHAF1B,CAF1; MPP7; CAF-1; CAF1A; CAF1P60; CAF-IP60; MPHOSPH7;,NM_005441.2,GI:45827788,###############################################################################################################################################################################################################################################################,chromatin assembly factor 1 subunit B,positive,chr21:37757525,-0.845143322089804,-0.668907672363206,0.0927785604049253,-0.551559626280575,-0.600901402063037,-0.672978957129423,-0.49152442227876,0.0919221990382531,0.730472029558529,-0.372013374427128,78.1656795701481,1.53575414877094,Yes,Yes,No,No,2,Promoter
cg13899108,0.033651673,NA,0.009,0.032,0.87,0.45,0.42,0.47,5143,36,19,18205322,36.1,18205016,-,PDE4C,DPDE1; MGC126222; PDE4C-791;,NM_000923.1,GI:4505664,###############################################################################################################################################################################################################################################################,phosphodiesterase 4C; cAMP-specific (phosphodiesterase E1 dunce homolog; Drosophila),positive,chr19:18344322,-0.904238538632994,-0.883609369405861,0.336875500056836,3.08085406454347,-1.00163397305815,-0.710802786775916,7.14900705003954,0.746236654508607,0.453446029017617,-0.382461416128268,85.2197629971397,1.82339932275959,Yes,No,Yes,No,24,Repressed polycomb
cg13931228,-0.12067687,-0.360016319,0.0016,0,0.57,0.057,0.067,0.05,51678,36,7,24578943,36.1,24579610,+,MPP6,VAM1; p55T; PALS2; VAM-1;,NM_016447.2,GI:21361597,MAGUK protein p55T; protein associated with Lin7 2; VELI-associated MAGUK 1; go_component: membrane; go_function: protein binding; go_process: protein complex assembly,membrane protein; palmitoylated 6,negative,chr7:24612418,-0.104832304768705,-0.0185045375121291,-0.233050563641755,0.208573291988557,0.222242155194384,0.99823376205622,-0.617376465541039,0.859589356967844,-0.411531126928561,-0.391238946446698,56.7177989132089,2.28410513485109,No,No,No,No,2,Promoter
cg13975369,0.378716214,0.320199312,0.01,0.0041,0.71,0.24,0.22,0.26,95681,36,7,129867789,36.1,129868090,-,TSGA14,Cep41; DKFZp762H1311;,NM_018718.1,GI:16306478,centrosomal protein 41 kDa; testis specific protein A14; go_component: centrosome,testis specific; 14,positive,chr7:130080553,0.00806893744548109,0.0586468427843776,-0.0180209995849705,-0.574036009176327,-0.226030272790696,0.0728754881574382,0.026641134338018,0.0194125532733287,-0.447468122999254,-0.439261680600165,79.0464616618549,1.68383385695198,Yes,Yes,No,No,2,Promoter
cg14060828,-0.303565965,NA,0.009,0.027,0.94,0.18,0.18,0.18,113091,36,19,54618088,36.1,54618510,-,TIP39,,NM_178449.2,GI:31341960,,tuberoinfundibular 39 residue protein precursor,negative,chr19:49926276,-0.693330566826113,-0.455921771836676,0.101762958142363,2.1055593138637,-0.532849204671071,2.27451894632011,-0.039799351498489,1.12113046209699,3.91832573069378,-0.439261680600165,82.3516387939453,0.654570448946592,Yes,No,Yes,No,2,Promoter
cg14163776,-0.119511769,NA,0.008,0.0026,0.98,0.19,0.22,0.18,23527,36,3,196645869,36.1,196645041,-,CENTB2,ACAP2; CNT-B2; KIAA0041;,NM_012287.3,GI:40254841,centaurin beta2; Arf GAP with coiled coil; ANK repeat and PH domains 2; go_function: metal ion binding; go_function: GTPase activator activity; go_process: regulation of GTPase activity,centaurin; beta 2,negative,chr3:195164580,-0.434374223822228,-0.709499170743153,-0.620586238338107,-0.640802856871285,-0.384222469326788,0.579435609236268,-0.688554410702997,-0.289773482171697,-0.514740216624034,-0.439261680600165,67.8989136046602,-0.209317574873379,No,No,Yes,No,2,Promoter
cg14175438,-0.336713957,NA,0.0038,0.015,0.58,0.17,0.2,0.15,10447,36,7,120823965,36.1,120823577,-,FAM3C,GS3786;,NM_014888.1,GI:7661713,go_component: extracellular region; go_function: cytokine activity; go_process: biological process unknown,predicted osteoblast protein,negative,chr7:121036729,-0.365049505990795,-0.248830127905983,-0.387012948961381,-0.417828576081607,0.029813131832424,0.180716365613023,-0.0361745791781473,0.701198900544464,-0.248225791708422,-0.371116772631782,62.0123100280762,-0.509504363147228,No,No,Yes,No,2,Promoter
cg14258236,0.086897539,NA,0.012,0.035,1,0.87,0.85,0.88,81696,36,6,29431309,36.1,29432033,-,OR5V1,6M1-21; hs6M1-21;,NM_030876.4,GI:45594309,###############################################################################################################################################################################################################################################################,olfactory receptor; family 5; subfamily V; member 1,positive,chr6:29323330,-0.794887725552025,-0.904671916063991,0.224184647155821,1.22597190963457,-0.941602588915869,-1.13824519964725,1.11624986946993,-0.0517414173799193,-0.197322983138171,-0.439261680600165,18.3378016455215,-0.517461908643678,Yes,No,No,No,25,Quiescent/low
cg14308452,0.003142044,NA,0.014,0.015,0.97,0.83,0.84,0.83,163154,36,19,5735184,36.1,5735610,-,MGC24975,,NM_153359.1,GI:23503298,,hypothetical protein LOC163154,positive,chr19:5784184,-0.663691319574227,-0.877316281315824,4.20658415524955,-0.483921772561973,-0.800329025971774,-0.932004693412133,0.830634351403737,-0.928495408268794,-0.160323883039234,-0.407381983140628,75.1245956420898,1.19343984873041,Yes,No,Yes,No,7,Transcribed
cg14329157,0.251930765,NA,0.0046,0.022,0.68,0.14,0.12,0.15,164781,36,2,228444379,36.1,228444571,+,WDR69,FLJ25955;,NM_178821.1,GI:32189424,synonym: FLJ25955,hypothetical protein LOC164781,positive,chr2:228736135,-0.603376154562618,-0.612143558717701,0.085727935643964,1.61649174345078,-0.295652023641665,-0.435986497386889,0.618420068792857,-0.918573773191402,0.132409515471327,-0.439261680600165,45.0663642883301,1.52811080204224,Yes,No,Yes,No,16,Weak enhancer
cg14408969,-0.140373287,NA,0.00014,0,0.35,0.049,0.05,0.048,114926,36,8,42515275,36.1,42515913,+,C8orf40,,NM_138436.2,GI:34147538,,hypothetical protein LOC114926,negative,chr8:42396118,-0.287936557652255,-0.151327947119939,-0.411002696785462,-0.657509428873718,0.475194266947822,0.176206309695809,-0.493484724215986,0.581959355147603,-0.289654808431195,0.353883281471604,75.6090621948242,0.138738861443564,Yes,No,Yes,No,3,Promoter
cg14409958,-0.050383781,NA,0.0068,0,0.77,0.11,0.12,0.1,5168,36,8,120720833,36.1,120720251,-,ENPP2,ATX; PDNP2; LysoPLD; PD-IALPHA;,NM_006209.2,GI:20070229,###############################################################################################################################################################################################################################################################,ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin),negative,chr8:120651652,-0.0925446388835778,-0.631194571877233,-0.438088405527606,-0.574310716221086,0.481412182310477,0.527904514848539,0.122922197675148,-0.120358134856617,-0.375152635828744,-0.367245580649547,49.1892505560135,-0.237926547188002,Yes,No,No,No,2,Promoter
cg14423778,-0.087120888,NA,0.029,0.054,0.96,0.33,0.34,0.3,4154,36,3,153468123,36.1,153468519,+,MBNL1,EXP; MBNL; EXP35; EXP40; EXP42; KIAA0428; DKFZp686P06174;,NM_021038.3,GI:46411162,###############################################################################################################################################################################################################################################################,muscleblind-like 1 isoform a,negative,chr3:151985433,0.0167337022053105,-0.904702604166918,-0.11242346058765,-0.673381409170661,-0.161091948115212,0.377769660747744,-0.516258032350476,-0.191772690161963,-0.238889925793827,0.226222120186955,80.7328321880236,-1.59413798540005,Yes,No,Yes,No,3,Promoter
cg14424579,3.067470269,3.026873503,0.00047,0,0.4,0.032,0.029,0.035,60509,36,2,27127813,36.1,27128053,+,FLJ21839,,NM_021831.3,GI:34147509,go_function: carboxypeptidase A activity; go_process: proteolysis and peptidolysis,hypothetical protein LOC60509,positive,chr2:27274309,0.337088194666979,0.653379482436784,-0.611156678596861,-0.657173109688644,0.106715576388906,-0.269680549575233,-0.0287658760281146,3.04083591393821,-0.0880332106774927,-0.327341173165814,77.9371265592123,4.45544048580775,Yes,Yes,Yes,No,1,Active TSS
cg14501253,-0.066922165,NA,0.00063,0,0.49,0.058,0.053,0.063,286032,36,8,12853385,36.1,12853236,+,FLJ36980,,NM_182598.1,GI:32699012,,hypothetical protein LOC286032,positive,chr8:12809014,-0.582118625828543,-0.320130890305296,-0.0480342927297848,1.71248105021388,-0.532901403399542,-0.0449641538180147,1.01049757032948,-0.202880562721842,0.243057269378156,-0.429456221072508,73.2421722412109,1.01862368674512,Yes,Yes,No,No,1,Active TSS
cg14597908,-0.030798249,NA,0.0065,0.022,0.91,0.43,0.44,0.42,2778,36,20,56848355,36.1,56848190,+,GNAS,XL; AHO; GSA; GSP; POH; XL2; GPSA; NESP; GNAS1; PHP1A; PHP1B; GNASXL; NESP55; C20orf45; MGC33735; XLalphas; dJ309F20.1.1; dJ806M20.3.3;,NM_000516.3,GI:18426896,###############################################################################################################################################################################################################################################################,guanine nucleotide binding protein; alpha stimulating activity polypeptide 1 isoform a,negative,chr20:57414960,-0.622478377134648,-0.77245989493252,-0.0894521120097974,0.762678761793272,-0.795429719136852,-0.27975396357815,1.08976920443306,-0.309727520149377,0.380424109232859,-0.439261680600165,66.8029937744141,1.71866083265252,Yes,No,Yes,No,24,Repressed polycomb
cg14654875,-0.122182935,-0.036208905,0.0057,0.015,0.89,0.43,0.44,0.43,146434,36,16,3433998,36.1,3433491,-,ZNF597,FLJ33071;,NM_152457.1,GI:22748966,go_component: nucleus; go_function: DNA binding; go_function: zinc ion binding; go_function: metal ion binding; go_process: transcription; go_process: regulation of transcription; DNA-dependent,zinc finger protein 597,negative,chr16:3493997,0.314270958013492,0.444801304387523,0.609512686146723,-0.159579103746248,0.0953529522708912,-0.164577924179979,1.49345396086271,-0.281316584525521,-0.429283760312185,-0.056854960240456,68.8000259399414,2.15154701666508,Yes,No,Yes,No,3,Promoter
cg14658362,-0.168603536,NA,0.00054,0,0.61,0.039,0.038,0.038,11030,36,8,30361203,36.1,30361486,+,RBPMS,HERMES;,NM_006867.2,GI:57164967,isoform A is encoded by transcript variant 4; go_function: RNA binding; go_function: nucleotide binding; go_function: protein binding; go_process: RNA processing,RNA-binding protein with multiple splicing isoform A,positive,chr8:30241661,-0.561831822787889,-0.631658295420481,0.4556169731056,3.06024314850263,-0.566181052350849,0.78164334484112,-0.626510449852942,-0.565273015029881,10.1673925975634,-0.439261680600165,79.8116575892727,1.85625040242143,No,Yes,No,No,1,Active TSS
cg14723032,0.000900283,NA,0.012,0.052,0.95,0.72,0.69,0.74,83394,36,17,6401296,36.1,6400601,-,PITPNM3,NIR1; RDGBA3;,NM_031220.1,GI:13654295,###############################################################################################################################################################################################################################################################,PITPNM family member 3,positive,chr17:6460572,-0.608248173056471,-0.710510261861132,-0.374045429183201,3.35042411691389,-0.891392856708862,-0.622592743241211,-0.00485653005822002,-0.609424043160942,-0.129235609427573,-0.439261680600165,55.2438776677386,1.59008048155746,No,No,Yes,No,24,Repressed polycomb
cg14727952,-0.136027886,NA,0.0025,0,0.83,0.065,0.071,0.061,329,36,11,101723568,36.1,101723176,+,BIRC2,API1; MIHB; HIAP2; RNF48; cIAP1; Hiap-2;,NM_001166.3,GI:41349435,###############################################################################################################################################################################################################################################################,baculoviral IAP repeat-containing protein 2,negative,chr11:102218358,3.11704767747023,0.429697844524969,-0.538760137625858,-0.568648449345786,2.33921558424298,1.16906143429762,0.234064816067349,-0.128482711661882,-0.0438794659611731,2.37863082207898,81.503439068497,1.63810683527882,Yes,No,Yes,No,3,Promoter
cg14894144,0.053377439,NA,0.013,0.017,0.93,0.35,0.32,0.37,3909,36,18,19524552,36.1,19523560,+,LAMA3,E170; LOCS; LAMNA; lama3a;,NM_000227.2,GI:38045907,###############################################################################################################################################################################################################################################################,laminin alpha 3 subunit isoform 2,positive,chr18:21270554,-0.805271212328035,-0.564407078916703,-0.138426841485095,1.60601987738956,-0.904848638111577,-0.722561183357249,0.704419040607276,0.437377830200618,0.35476456213927,-0.439261680600165,71.0489102028255,2.20916135335149,Yes,No,Yes,No,23,Bivalent promoter
cg14992253,0.035824163,NA,0.0016,0,0.5,0.072,0.067,0.078,56063,36,1,32460154,36.1,32460535,-,C1orf91,AASL548; PRO1105; FLJ90779; RP4-622L5; dJ622L5.7; RP4-622L5.3;,NM_019118.2,GI:21361813,synonyms: AASL548; PRO1105; FLJ90779; RP4-622L5; dJ622L5.7; RP4-622L5.3,hypothetical protein LOC56063,positive,chr1:32687567,-0.25309971593694,-0.0557468203852149,-0.261000238811388,-0.616129934417205,-0.0910195826659586,0.251792535344228,-0.814972138123323,-0.594538915654916,-0.15071201545233,-0.16926218653959,84.0684792383056,1.63777971410331,Yes,Yes,No,No,3,Promoter
cg15185286,-0.241642003,NA,0.00023,0,0.58,0.03,0.031,0.028,51390,36,6,143423368,36.1,143423716,+,AIG1,AIG-1; FLJ10485; dJ95L4.1; RP1-95L4.1; DKFZp686F03136;,NM_016108.2,GI:40316940,androgen induced protein; CGI-103 protein; androgen induced protein (AIG-1); C-terminus truncated; go_component: integral to membrane,androgen-induced 1,negative,chr6:143381675,1.10970710271813,1.29229655828871,-0.0643331471303677,-0.309022079316481,1.2215627667576,-0.00586930656424584,0.122700365560498,1.12218780803526,-0.579057394388983,-0.32198682778258,53.1938269750733,1.51184251656761,Yes,Yes,No,No,1,Active TSS
cg15262928,-0.078482669,NA,0.00019,0.013,0.41,0.044,0.044,0.044,10440,36,1,200191195,36.1,200191271,+,TIMM17A,TIM17; TIM17A;,NM_006335.1,GI:5454119,###############################################################################################################################################################################################################################################################,translocase of inner mitochondrial membrane 17 homolog A,negative,chr1:201924572,1.52214369112473,0.559646063297293,-0.569693398214995,-0.49744766444468,0.48507942613406,0.17430878772759,-0.362891368354821,0.22779473600468,-0.353490576050841,0.17994278105952,85.2259653904789,0.644709885720942,No,Yes,No,No,3,Promoter
cg15341340,-0.468757862,NA,0.0066,0.015,0.99,0.059,0.058,0.059,1777,36,19,12853237,36.1,12853335,-,DNASE2,DNL; DNL2; DNASE2A;,NM_001375.2,GI:58331228,###############################################################################################################################################################################################################################################################,deoxyribonuclease II; lysosomal precursor,positive,chr19:12992237,0.938978583160238,1.02677733675263,0.259976730345733,-0.479923457589604,0.87527865773714,0.278317947661257,0.557058408722526,0.196751050221817,-0.47680058176522,0.518853872455471,84.4015426635742,2.41720618390166,Yes,Yes,No,Yes,1,Active TSS
cg15381769,-0.119627233,NA,0.00079,0,0.68,0.032,0.03,0.04,5796,36,6,128883665,36.1,128883416,-,PTPRK,R-PTP-kappa; DKFZp686C2268;,NM_002844.2,GI:18860901,###############################################################################################################################################################################################################################################################,protein tyrosine phosphatase; receptor type; K precursor,positive,chr6:128841972,-0.426515852498048,-0.018365870681116,-0.369060123228123,1.26412302200062,0.130830859159659,-0.104284413887539,-0.214754885050838,-0.435965161415242,1.04648742058503,-0.439261680600165,65.6091766357422,3.07637688795325,No,Yes,No,No,1,Active TSS
cg15547534,0.382897521,0.137235675,0.0026,0,0.94,0.046,0.043,0.05,221908,36,7,99872346,36.1,99872030,-,MGC22793,,NM_145030.1,GI:21450760,,hypothetical protein LOC221908,positive,chr7:100034410,-0.00227509541163697,-0.478775820115491,-0.365432356905198,-0.78874984394269,-0.487935035815716,0.120536361897704,-0.629242594672296,0.0408872614418333,-0.398381028304666,-0.366063314480246,81.2833339282105,2.64697816127386,No,No,Yes,No,2,Promoter
cg15661409,0.043744933,0.008380636,0.025,0.031,1,0.84,0.84,0.85,55195,36,14,57030729,36.1,57030323,-,C14orf105,FLJ10650;,NM_018168.1,GI:8922570,synonym: FLJ10650,hypothetical protein LOC55195,positive,chr14:57960976,-0.936081281448312,-1.0234320446649,-0.560363912366582,-0.367216825079671,-0.942563439756545,-1.11910074526806,-0.0476228500633707,-0.89373877280593,-0.551590402612814,-0.380761958859885,28.9179134368896,0.00137688812590967,No,No,No,No,25,Quiescent/low
cg15703512,-0.730702811,NA,0.00044,0.018,0.26,0.061,0.063,0.06,255762,36,16,21920066,36.1,21919929,-,MGC50721,,NM_173806.2,GI:31341127,go_function: protein binding,hypothetical protein LOC255762,negative,chr16:22012565,-0.726727072862541,-0.618295273732586,-0.438788267626034,-0.27776878731445,-0.589956661791493,0.60790457393193,-0.290699318086234,0.253268154110669,-0.0110421637310868,-0.392487814557924,69.9300302519763,3.23703180152163,No,No,No,No,16,Weak enhancer
cg15804973,-0.108169109,NA,0.017,0,0.84,0.26,0.34,0.22,4217,36,6,137156206,36.1,137155349,-,MAP3K5,ASK1; MEKK5; MAPKKK5;,NM_005923.3,GI:21536459,###############################################################################################################################################################################################################################################################,mitogen-activated protein kinase kinase kinase 5,negative,chr6:137114513,-0.474393333376869,-0.920225244497677,-0.267852304258839,-0.720048997728945,-0.346012869465789,0.112205197613906,-0.566007262245446,0.204792179487031,-0.407962884571092,0.228918739518778,58.1489388425451,1.06651503906142,No,No,Yes,No,2,Promoter
cg15974053,-0.009486551,NA,0.0061,0,0.64,0.044,0.039,0.049,51171,36,19,54031601,36.1,54031746,-,DHRS10,retSDR3;,NM_016246.2,GI:59889577,retinal short-chain dehydrogenase/reductase 3; go_function: oxidoreductase activity; go_process: metabolism,dehydrogenase/reductase (SDR family) member 10,positive,chr19:49339789,-0.471275877313685,-0.572523736382053,-0.34187529096948,1.17636445863029,-0.321144440155476,1.34778796140089,-0.154532770031882,-0.422899454842193,-0.115710198649097,-0.40989114295842,82.6505813598633,1.44120998414097,Yes,No,Yes,No,2,Promoter
cg15988232,0.036324808,NA,0.014,0.025,0.95,0.44,0.38,0.48,10675,36,3,47596131,36.1,47595193,-,CSPG5,NGC; MGC44034;,NM_006574.2,GI:39753966,###############################################################################################################################################################################################################################################################,chondroitin sulfate proteoglycan 5 (neuroglycan C),positive,chr3:47621127,-0.887917133545449,-0.675731719962944,-0.172091029743285,2.13494307386948,-0.731031301300314,-0.481981544358309,0.462041797019744,-0.501529730447398,2.17451147392789,-0.398249033695123,77.9027938842773,1.95535552404089,Yes,Yes,No,No,24,Repressed polycomb
cg16034652,0.006495541,NA,0.015,0,0.99,0.47,0.47,0.46,57578,36,14,92868062,36.1,92869318,+,KIAA1409,FLJ43337;,NM_020818.2,GI:73808096,synonym: FLJ43337,hypothetical protein LOC57578,negative,chr14:93798309,-0.652000939215172,-0.730949539906726,-0.158574995200646,-0.505104781050765,-0.480017536611297,-0.0382072027393629,-0.604563687610691,-0.228629502444848,-0.285668685273348,-0.215339166991342,45.8462011855737,-0.370149352088083,Yes,No,Yes,No,9,Transcribed/regulatory
cg16150435,0.017495382,NA,0.0035,0.062,0.96,0.79,0.78,0.78,29113,36,6,31188508,36.1,31188311,-,C6orf15,STG;,NM_014070.1,GI:7662666,taste bud-specific protein precursor,STG protein,positive,chr6:31080529,-0.913558255297105,-0.58384296859189,-0.111753895209092,0.0647973139237571,-0.819447907558637,-0.774934612768483,0.584040462418453,-0.500824468346234,-0.104550699702424,-0.439261680600165,72.0062282876184,1.82153756432329,No,No,No,No,25,Quiescent/low
cg16168311,-0.196860712,NA,0.0036,0.0048,0.53,0.11,0.11,0.11,128240,36,1,154828571,36.1,154828194,+,APOA1BP,AIBP; MGC119143; MGC119145;,NM_144772.1,GI:21426826,apoA-I binding protein; go_function: molecular function unknown,apolipoprotein A-I binding protein,negative,chr1:156561947,0.390111989872774,0.505042939456896,-0.00533290059960054,-0.513761004484485,1.69595303018543,1.44909240022239,-0.28643044816912,0.191367649699021,-0.0928279152488117,0.370499404329462,84.3008193969727,3.44789368649874,Yes,No,Yes,No,3,Promoter
cg16241714,2.551903028,3.297841715,0.00019,0,0.15,0.014,0.013,0.013,1052,36,8,48813064,36.1,48813323,-,CEBPD,CELF; CRP3; C/EBP-delta; NF-IL6-beta;,NM_005195.2,GI:28872797,go_component: nucleus; go_function: DNA binding; go_process: transcription; go_process: regulation of transcription; DNA-dependent; go_process: transcription from RNA polymerase II promoter,CCAAT/enhancer binding protein delta,positive,chr8:48650511,0.703473014091764,0.830615181725703,0.737697077723042,0.000105556962746824,2.02790161228155,0.141711682679571,0.202532104596663,-0.0530431250568468,-0.382126527091971,3.76538416193042,63.7355748887669,0.420590413734317,Yes,Yes,No,No,1,Active TSS
cg16358826,-0.012966376,NA,0.00099,0.039,0.78,0.12,0.12,0.12,2557,36,4,46691021,36.1,46690337,-,GABRA4,,NM_000809.2,GI:34452722,###############################################################################################################################################################################################################################################################,gamma-aminobutyric acid A receptor; alpha 4 precursor,negative,chr4:46996264,-0.738914885887211,-0.133141175554346,-0.471960882254052,0.916339524690484,-0.752935731269572,-0.13906402621371,-0.353169730120801,-1.06805296727697,-0.148278436979431,-0.439261680600165,67.0374221801758,1.58673045977537,Yes,No,Yes,No,23,Bivalent promoter
cg16408394,-1.719195146,NA,0.0053,0,0.97,0.032,0.033,0.032,6256,36,9,136358896,36.1,136358231,+,RXRA,NR2B1;,NM_002957.3,GI:21536318,###############################################################################################################################################################################################################################################################,retinoid X receptor; alpha,negative,chr9:137219075,0.522814336471516,0.824058247982836,-0.345716506743719,0.174335249461921,0.897611189407841,0.459667297062582,0.00582110410796336,0.41931208575365,0.802116124066648,-0.0774627230130809,76.8960723876953,3.12650582111753,Yes,No,Yes,No,3,Promoter
cg16419345,0.282563693,NA,0.0021,0,0.95,0.052,0.055,0.049,51,36,17,71487684,36.1,71487020,-,ACOX1,ACOX; MGC1198; PALMCOX;,NM_004035.4,GI:34304338,###############################################################################################################################################################################################################################################################,acyl-Coenzyme A oxidase isoform a,negative,chr17:73976089,2.44107670742738,0.460248523910792,-0.138950744023081,-0.631673597907232,0.485208848873415,0.948967080268904,-0.304221046466512,-0.205700320977365,-0.174317755374483,-0.307568188673901,83.1089859008789,2.7141116369206,Yes,No,Yes,No,3,Promoter
cg16494477,-0.066439934,NA,0.00052,0.012,0.27,0.074,0.069,0.078,8817,36,5,170779856,36.1,170779272,+,FGF18,ZFGF5; FGF-18;,NM_033649.1,GI:16306545,go_component: extracellular space; go_function: growth factor activity; go_process: morphogenesis; go_process: cell-cell signaling; go_process: signal transduction; go_process: positive regulation of cell proliferation,fibroblast growth factor 18 precursor,positive,chr5:170847251,-0.758377464946575,0.294744618253502,0.208101371962886,0.953529652545635,-0.544674232182422,0.388687977065451,0.412898526103151,-0.919668338698948,2.1152342194497,-0.395279525922037,60.9095840454102,2.04399103264064,Yes,Yes,No,No,23,Bivalent promoter
cg16547529,0.167493846,0.093427143,0.014,0.0039,0.97,0.52,0.48,0.56,283212,36,11,74818329,36.1,74818755,-,FLJ33790,,NM_173583.1,GI:27734800,,hypothetical protein LOC283212,positive,chr11:75140681,-0.749899769199314,-1.0111465242819,0.398523344654492,2.08442119511634,-0.885808426524513,-0.400574227877546,6.05977352688853,-1.14324199193404,0.895428485212055,-0.403319001792731,79.9827855935418,1.43240351310605,Yes,No,Yes,No,23,Bivalent promoter
cg16579101,-0.096067716,NA,0.0024,0,0.91,0.057,0.052,0.057,4839,36,12,6547419,36.1,6547741,-,NOL1,p120; NSUN1; NOP120;,NM_006170.2,GI:76150622,###############################################################################################################################################################################################################################################################,nucleolar protein 1; 120kDa,positive,chr12:6677158,1.43402145375432,1.2337988077304,0.499753568982428,-0.563988097588095,0.759792974073802,0.243870329761699,0.220702710285098,0.27789250184553,-0.592994023831999,0.104329693176093,83.1329650878906,3.3793932657398,Yes,Yes,No,No,3,Promoter
cg16744741,-0.3462842,-0.497488212,0.052,0.053,0.96,0.52,0.64,0.38,5593,36,4,82345049,36.1,82345239,-,PRKG2,cGKII; PRKGR2;,NM_006259.1,GI:5453977,###############################################################################################################################################################################################################################################################,protein kinase; cGMP-dependent; type II,negative,chr4:82126025,-0.782345457484826,-0.0224385210875934,-0.0108625595401348,0.398868163939827,-0.964439466708582,-0.701330266790762,1.21652416625357,-0.984791498013265,-0.604463220696711,-0.439261680600165,50.111328125,2.48960575619032,Yes,No,No,No,25,Quiescent/low
cg16899442,-0.153803786,NA,0.0052,0.021,0.51,0.16,0.19,0.15,124093,36,16,716459,36.1,716460,-,C16orf25,JFP10; FLJ34512;,NM_173476.2,GI:40255165,isoform 2 is encoded by transcript variant 2,hypothetical protein LOC124093 isoform 2,negative,chr16:776458,-0.464047553427762,-0.361972861967952,-0.429736324452826,0.0893854351306139,-0.620450768624896,-0.394909134229726,0.186966627038437,-0.47135450973492,0.603194548764072,-0.332525440331317,82.0216600223075,2.52133110308227,Yes,No,Yes,No,23,Bivalent promoter
cg16984944,-5.94e-06,NA,0.0034,0,0.46,0.1,0.1,0.1,55773,36,3,101462115,36.1,101462546,+,TBC1D23,NS4ATP1; FLJ11046; DKFZp667G062;,NM_018309.1,GI:8922841,HCV nonstructural protein 4A-transactivated protein 1,hypothetical protein LOC55773,negative,chr3:99979425,0.0199730955013734,-0.401528466388173,-0.228387064215291,-0.445325262937928,-0.0946731499667957,-0.0536970949821434,-0.540372329941383,0.726929168283756,-0.546299679035692,-0.36950827113988,80.1926341258974,-1.56602565407453,No,No,Yes,No,2,Promoter
cg17063929,-0.001985558,NA,0.024,0.014,0.89,0.14,0.1,0.15,50507,36,11,88864447,36.1,88864301,-,NOX4,KOX; KOX-1; RENOX;,NM_016931.2,GI:20149638,go_component: membrane; go_function: nucleotide binding; go_function: oxidoreductase activity; go_function: electron transporter activity; go_process: electron transport,NADPH oxidase 4,positive,chr11:89224799,-0.816948461167752,-0.337291405571407,0.104887377027522,1.55839638394342,-1.01102369607424,-0.808358281353096,2.08651934595323,-1.00506561072831,1.04249196695952,-0.439261680600165,42.7747039794922,1.34241621169996,Yes,No,Yes,No,23,Bivalent promoter
cg17099569,0.115572976,NA,0.031,0,1,0.66,0.65,0.65,2736,36,2,121266336,36.1,121266329,+,GLI2,THP2;,NM_005270.2,GI:13518226,###############################################################################################################################################################################################################################################################,GLI-Kruppel family member GLI2 isoform delta,positive,chr2:121549866,-0.772735261111383,-0.759653382398955,-0.484262046558113,-0.172601355720564,-0.807714250065949,-1.04707756247386,-0.141479900962569,-0.469345039376288,-0.647409603739383,-0.439261680600165,79.6421127319336,0.204904392173969,Yes,No,No,No,25,Quiescent/low
cg17274064,-0.000157189,NA,0.0092,0.014,0.64,0.16,0.19,0.15,2078,36,21,38955762,36.1,38955488,-,ERG,p55; erg-3;,NM_004449.3,GI:46255021,###############################################################################################################################################################################################################################################################,v-ets erythroblastosis virus E26 oncogene like isoform 2,negative,chr21:40033892,-0.762648344869987,-0.988548852864249,-0.0494652008848186,0.116102934686554,-0.71732355572779,-0.501227653746434,-0.168199015696037,-0.600429875061888,0.119793038531082,-0.380024367076427,67.1256103515625,0.239047237997992,No,No,Yes,No,23,Bivalent promoter
cg17285325,0.137315506,NA,0.0017,0,0.86,0.04,0.04,0.04,1890,36,22,49315209,36.1,49315321,-,ECGF1,TP; MNGIE; PDECGF; hPD-ECGF;,NM_001953.2,GI:7669488,###############################################################################################################################################################################################################################################################,endothelial cell growth factor 1 (platelet-derived),positive,chr22:50968343,0.899935472749383,0.471484578560053,0.292098294751563,-0.484309256209155,0.685460221528905,0.689770554993157,-0.148121071600368,-1.2924923570463,-0.605372473319972,3.35431808354359,80.6040122396036,2.62409379920671,Yes,Yes,No,No,23,Bivalent promoter
cg17324128,-0.569717328,-0.851186251,0.0065,0.0097,0.83,0.14,0.18,0.12,83937,36,10,44775506,36.1,44775225,+,RASSF4,AD037; MGC44914;,NM_032023.3,GI:30474868,isoform a is encoded by transcript variant 1; tumor suppressor RASSF4; go_function: protein binding; go_function: oxidoreductase activity; go_process: signal transduction,Ras association domain family 4 isoform a,negative,chr10:45455500,-0.30491443210385,1.10679771376942,0.243242673322838,-0.404061542475291,0.667774928649077,1.60538060771857,-0.0334456045270199,0.124724847304158,-0.460766058100804,-0.233000653718202,58.9142754571396,2.09519967609449,Yes,No,Yes,No,3,Promoter
cg17338403,-0.645058713,-0.009380072,0.0075,0.0042,0.99,0.11,0.1,0.11,28232,36,15,90196840,36.1,90197950,+,SLCO3A1,OATP-D; OATP3A1; SLC21A11;,NM_013272.2,GI:7706713,solute carrier family 21 (organic anion transporter); member 11; go_component: membrane; go_component: integral to membrane; go_function: transporter activity; go_process: ion transport,solute carrier organic anion transporter family; member 3A1,negative,chr15:92395836,0.0251014717039515,-0.416856160111865,-0.11795365457029,-0.297819049928827,0.582706265256231,0.44320595674011,-0.196215921012137,-0.357845654187787,0.0268106680276342,-0.163833667681127,28.3511333465576,0.458287314481339,No,No,Yes,No,2,Promoter
cg17408647,-0.094843228,NA,0.00087,0.01,0.96,0.041,0.04,0.041,55744,36,7,43735574,36.1,43735634,-,FLJ10803,,NM_018224.1,GI:8922676,,hypothetical protein LOC55744,positive,chr7:43769049,0.531615108778235,1.94674212896038,0.664088735344678,-0.436461171357343,0.876246816691442,-0.178814652289316,-0.223270173197422,0.976836909751142,-0.283632222258768,0.502347596099474,67.9782943725586,2.74872249036427,Yes,Yes,No,No,3,Promoter
cg17589341,-0.065957735,NA,0.019,0.02,0.91,0.46,0.51,0.44,6563,36,18,41558077,36.1,41558155,+,SLC14A1,JK; UT1; UTE; HUT11; RACH1; UT-B1; HsT1341;,NM_015865.1,GI:7706676,###############################################################################################################################################################################################################################################################,RACH1,negative,chr18:43304079,-0.655662896512273,-0.859541794516605,1.6664430577536,-0.263643595548518,-0.646960809445328,-0.374153881635171,0.461787901961029,-0.265132771862851,-0.292231222524522,-0.364575009440636,84.3160629272461,0.771608711339965,Yes,No,No,No,16,Weak enhancer
cg17655614,0.156624167,NA,0.01,0.02,0.9,0.3,0.27,0.33,999,36,16,67328445,36.1,67328696,+,CDH1,UVO; CDHE; ECAD; LCAM; Arc-1; CD324;,NM_004360.2,GI:14589887,###############################################################################################################################################################################################################################################################,cadherin 1; type 1 preproprotein,positive,chr16:68770944,-0.782645369347943,-0.75526907984678,-0.0791768478976721,2.02906485102823,-0.78522541686405,-0.0042165715140865,1.72326702770515,-0.979032899744217,2.97703316128368,-0.419739589678116,59.6993980407715,1.11162144283504,No,No,Yes,No,24,Repressed polycomb
cg17686885,-0.057992142,NA,0.0026,0.02,0.94,0.13,0.14,0.13,10040,36,17,50332768,36.1,50333203,+,TOM1L1,SRCASM;,NM_005486.1,GI:4885638,###############################################################################################################################################################################################################################################################,target of myb1-like 1,negative,chr17:52977769,-0.541434492867792,-0.58426546951131,-0.0189067812138916,1.35303227842755,-0.395077009692673,-0.151892381213989,0.491869663366635,0.394035236386319,-0.20013619179971,-0.412431969506814,25.2052097320557,2.00423352198877,Yes,No,Yes,No,2,Promoter
cg17729667,0.146830197,NA,0.0022,0.013,0.65,0.094,0.07,0.12,22981,36,20,25514382,36.1,25514153,-,KIAA0980,NLP; FLJ11792; dJ691N24.1;,NM_025176.4,GI:55749677,go_function: calcium ion binding,hypothetical protein LOC22981,positive,chr20:25566382,-0.444833625558843,-0.294448756957132,0.662577110296887,0.378909834648739,-0.499432552929989,-0.0233753776561914,-0.110817638717086,-0.341343820139213,0.273589706697903,-0.439261680600165,69.2866984531469,1.32817515490638,No,Yes,No,No,22,Poised promoter
cg17853587,-0.022992725,NA,0.00058,0,0.38,0.062,0.06,0.064,9348,36,4,119173834,36.1,119174948,+,NDST3,,NM_004784.1,GI:4758765,go_function: transferase activity; go_function: sulfotransferase activity; go_process: protein amino acid sulfation; go_process: protein amino acid deacetylation,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,positive,chr4:118954386,-0.731836605423397,-0.954494042104788,0.231804051798672,1.74918619164669,-0.794212737463148,-0.371738667900739,1.4645446231401,-0.804253752385436,0.328960045322598,-0.439261680600165,43.387118779513,1.40503982933102,No,No,Yes,No,23,Bivalent promoter
cg17960516,0.066620539,NA,0.0023,0.012,0.62,0.066,0.067,0.065,285489,36,4,3434802,36.1,3434836,+,FLJ33718,FLJ90556;,NM_173660.2,GI:31542769,synonym: FLJ90556,hypothetical protein LOC285489,positive,chr4:3465004,-0.447549996389083,-0.631733370654268,-0.0591043180914396,0.409782354053531,-0.869402866148375,-0.412192576056434,-0.399606068052735,-1.103897149138,0.276140288748445,-0.439261680600165,72.9846649169922,1.16719157134255,No,Yes,No,No,24,Repressed polycomb
cg18031008,0.264553633,NA,0.0056,0,0.98,0.048,0.057,0.043,54460,36,1,148532935,36.1,148532893,+,MRPS21,MDS016; RPMS21; MRP-S21;,NM_018997.1,GI:16950592,mitochondrial 28S ribosomal protein S21; go_component: ribosome; go_component: mitochondrion; go_component: mitochondrial small ribosomal subunit; go_function: structural constituent of ribosome; go_process: protein biosynthesis,mitochondrial ribosomal protein S21,negative,chr1:150266311,0.577270259950331,0.923428474044925,-0.297118497088574,-0.657960369318407,0.500270828130203,0.91689519708946,0.943252451560156,0.254267679691198,0.199489179845573,0.841562335671917,79.9818137304444,1.8251224529533,Yes,No,Yes,No,3,Promoter
cg18055007,0.037915414,NA,0.0085,0,0.86,0.13,0.13,0.13,23564,36,6,31806205,36.1,31806018,-,DDAH2,G6a; DDAH; NG30; DDAHII;,NM_013974.1,GI:7524353,###############################################################################################################################################################################################################################################################,dimethylarginine dimethylaminohydrolase 2,positive,chr6:31698226,0.0420366599472789,-0.285845921080802,3.08872072200282,-0.606464337373739,-0.306163888051754,0.738329735069451,-0.512763864362764,0.0761558994186378,-0.578703743555945,-0.107875141526797,84.471305847168,3.40172035766939,Yes,Yes,No,No,9,Transcribed/regulatory
cg18139769,-0.089986969,NA,0.0048,0.055,0.9,0.51,0.52,0.5,8910,36,7,94124891,36.1,94123414,-,SGCE,ESG; DYT11;,NM_003919.1,GI:10835046,###############################################################################################################################################################################################################################################################,sarcoglycan; epsilon,negative,chr7:94286955,-0.814569495596325,-0.23538262215225,-0.172775958972608,-0.271336332513521,-0.687468672258291,-0.497521053622117,0.712278502928186,-0.307330818661753,0.521980414175112,-0.429456221072508,66.1882019042969,0.35124174023155,Yes,No,Yes,No,2,Promoter
cg18180783,0.121873904,0.093105189,0.0035,0,0.99,0.92,0.91,0.92,58529,36,10,75072326,36.1,75071521,-,MYOZ1,CS-2; FATZ; MYOZ; myozenin;,NM_021245.2,GI:21359948,calsarcin-2; go_component: nucleus; go_function: structural molecule activity,myozenin 1,positive,chr10:75402320,-0.762904978569001,-0.980398463710511,0.320942608103178,-0.0202126301518285,-0.914329127818694,-1.03221929937413,-0.534660214470566,-0.742160687132978,-0.209879022243636,-0.419642557742483,83.8630547083524,1.34364207614871,No,No,No,No,25,Quiescent/low
cg18328933,-0.37048069,-0.177608179,0.02,0.021,0.96,0.63,0.65,0.61,25864,36,3,51983578,36.1,51984124,+,ABHD14A,DORZ1; DKFZP564O243;,NM_015407.3,GI:34147328,go_function: hydrolase activity; go_process: aromatic compound metabolism,abhydrolase domain containing 14A,negative,chr3:52008538,-0.471727480554978,-0.187491263324784,-0.369819203570893,-0.67151598937454,-0.21991815553786,0.657239183288466,-0.0238879664022804,-0.127352274397853,-0.458091972314534,-0.357709200863914,84.3925842323208,2.35499431864741,Yes,No,Yes,No,2,Promoter
cg18440048,0.356369685,0.249750042,0.0045,0.027,0.59,0.13,0.12,0.15,7621,36,22,22423826,36.1,22423279,-,ZNF70,Cos17; MGC48959;,NM_021916.2,GI:31340618,zinc finger protein N27C7-1; go_component: nucleus; go_function: zinc ion binding; go_function: metal ion binding; go_function: transcription factor activity; go_process: transcription; go_process: regulation of transcription; DNA-dependent,zinc finger protein 70,positive,chr22:24093826,0.00195506137850368,-0.253831843335483,-0.0801934248705216,-0.370255517128887,-0.243531812197445,-0.0353932829263591,-0.724462905092446,0.431261355001848,-0.386094989229703,-0.326979470973109,75.1502380371094,1.44256710931096,No,No,Yes,No,2,Promoter
cg18573383,0.554265536,NA,0.0016,0,0.49,0.07,0.055,0.089,3747,36,12,73889668,36.1,73889778,-,KCNC2,KV3.2;,NM_139137.2,GI:24497455,###############################################################################################################################################################################################################################################################,Shaw-related voltage-gated potassium channel protein 2 isoform KV3.2b,positive,chr12:75603401,-0.844306895242857,-0.859427534422046,0.402489030503736,2.64217849192901,-0.982061520575318,-0.517713273244223,1.35529447239996,-0.918648635925474,0.198849658914245,-0.439261680600165,54.2549971107236,2.41953549216917,Yes,No,Yes,No,24,Repressed polycomb
cg18956095,-0.478583455,NA,0.00051,0.02,0.35,0.081,0.082,0.081,11244,36,8,124356292,36.1,124355728,-,ZHX1,,NM_007222.3,GI:63079679,###############################################################################################################################################################################################################################################################,zinc fingers and homeoboxes 1,negative,chr8:124287111,0.598916829337943,2.06737688596334,-0.159754302352064,-0.348208371149525,0.320653553035287,0.059056266030853,0.0623122560939046,0.113880447869095,-0.368924391444744,-0.397390867180267,77.3977813720703,-0.0615313478395981,Yes,Yes,No,No,1,Active TSS
cg18983672,0.201888482,0.030218972,0.012,0.0016,1,0.88,0.86,0.89,2301,36,1,47653843,36.1,47654331,+,FOXE3,ASMD; FKHL12; FREAC8;,NM_012186.1,GI:11386196,Forkhead; drosophila; homolog-like 12; forkhead (Drosophila)-like 12; go_component: nucleus; go_function: transcription factor activity; go_process: development; go_process: transcription; go_process: regulation of transcription; DNA-dependent,forkhead box E3,positive,chr1:47881256,-0.87084356296626,-0.900909349167929,-0.237674992805722,0.449494518658714,-0.838810983268438,-0.797396498167433,-0.103396281824564,-0.507882716879677,0.427828546585655,-0.439261680600165,63.279670715332,1.37596332756638,No,No,Yes,No,24,Repressed polycomb
cg18984151,0.315009523,0.086714287,0.0042,0.014,0.78,0.19,0.18,0.2,54859,36,3,47530480,36.1,47530188,-,TMEM103,FLJ20211;,NM_001031703.1,GI:72534695,isoform 1 is encoded by transcript variant 1,hypothetical protein LOC54859 isoform 1,positive,chr3:47555476,-0.519930511360226,-0.292451410520807,-0.389795384007284,-0.636618411469084,-0.0837241231596898,-0.505756562342209,-0.755326014499852,0.219614467428052,-0.151336165243954,-0.439261680600165,79.290196406871,0.617474331288254,No,No,Yes,No,2,Promoter
cg19008809,0.590929745,0.327085225,0.0041,0,0.96,0.045,0.042,0.048,51460,36,3,53055722,36.1,53055110,-,SFMBT1,RU1; SFMBT; DKFZp434L243;,NM_001005158.1,GI:53692190,Scm-related gene containing four mbt domains; Scm-related gene product containing four mbt domains; go_component: nucleus; go_process: regulation of transcription,Scm-like with four mbt domains 1,positive,chr3:53080682,0.385236423230219,0.724282241428093,-0.000877219225227297,0.504121527424748,0.321153238543524,1.11900589807828,-0.121010209641727,0.552649033749317,0.0580767412101549,-0.0949355212617172,79.4098774060941,3.18747797781034,Yes,Yes,No,No,2,Promoter
cg19044674,-0.055931441,NA,9e-04,0.0069,0.28,0.07,0.069,0.071,64175,36,1,43005215,36.1,43005270,-,LEPRE1,P3H1; GROS1; MGC117314;,NM_022356.2,GI:21361917,###############################################################################################################################################################################################################################################################,leucine proline-enriched proteoglycan (leprecan) 1,negative,chr1:43232628,0.456996623090947,1.65692557292363,0.290683936530995,-0.504546759216144,1.01116633342893,-0.261440470039375,0.112506708059544,0.290702737723384,-0.286117448024629,0.469630002517546,67.8418448964259,1.02863651408957,Yes,Yes,No,No,1,Active TSS
cg19046959,-0.069773889,NA,0.0092,0.013,0.96,0.07,0.1,0.063,1296,36,1,36338443,36.1,36338437,-,COL8A2,FECD; PPCD; PPCD2; FLJ00201; MGC116970; MGC116972;,NM_005202.1,GI:32964829,###############################################################################################################################################################################################################################################################,collagen; type VIII; alpha 2,negative,chr1:36565856,-0.832605808148685,-0.883161218562488,-0.454766975987719,-0.586334263637984,-0.58697299552137,-0.462049834159204,-0.362208835304553,-0.114629471679301,-0.099864638643399,-0.425963805033255,84.5154037475586,2.54255160907054,Yes,No,No,No,16,Weak enhancer
cg19167673,-0.47038013,-0.651470434,0.0021,0,0.67,0.077,0.064,0.086,5155,36,22,37970781,36.1,37970936,-,PDGFB,SIS; SSV; PDGF2; c-sis; FLJ12858;,NM_033016.1,GI:15451785,###############################################################################################################################################################################################################################################################,platelet-derived growth factor beta isoform 2; preproprotein,positive,chr22:39640835,-0.588904636160357,-0.19171315838725,0.173896869110478,0.873858351222145,-0.589288193492118,0.419580929445195,-0.774673504536605,0.243041220741522,0.728793920085333,-0.439261680600165,82.569953918457,0.706671084823927,No,Yes,No,No,23,Bivalent promoter
cg19273182,-0.754588838,NA,0.00049,0,0.35,0.049,0.042,0.056,64895,36,2,60836921,36.1,60836887,+,PAPOLG,FLJ11805; FLJ12972; FLJ13482; FLJ14187;,NM_022894.2,GI:16306567,###############################################################################################################################################################################################################################################################,poly(A) polymerase gamma,positive,chr2:60983417,0.881992695339685,0.272393578317577,0.689327573382766,-0.641928856074346,0.249361474156842,0.114494462570573,-0.259184337058604,0.373880664440466,0.00401830300804978,0.972306856947097,51.0097046088697,0.61048472618276,Yes,Yes,No,No,3,Promoter
cg19305227,0.019259662,NA,0.0078,0.032,0.97,0.84,0.83,0.85,9153,36,15,43331627,36.1,43331726,+,SLC28A2,CNT2; HCNT2; SPNT1; HsT17153;,NM_004212.1,GI:4759131,###############################################################################################################################################################################################################################################################,solute carrier family 28 (sodium-coupled nucleoside transporter); member 2,positive,chr15:45544335,-0.837660353352023,-0.799250969363824,1.24660229634101,-0.260351831435609,-0.922760108305536,-1.03357134098745,0.787778206474952,-0.772834490933901,-0.512405687501475,-0.412016760520864,47.7615656959743,1.74736622373764,No,No,No,No,25,Quiescent/low
cg19346193,0.149635977,NA,0.013,0.029,0.97,0.87,0.88,0.86,7390,36,10,127503180,36.1,127501757,-,UROS,,NM_000375.1,GI:4557872,go_function: lyase activity; go_function: uroporphyrinogen-III synthase activity; go_process: heme biosynthesis; go_process: uroporphyrinogen III biosynthesis,uroporphyrinogen III synthase,positive,chr10:127513190,-0.635748416006817,-0.909272990939787,-0.398918856239412,-0.647205169315433,-0.476710208867886,0.315833011858586,-0.401226143176236,-0.346662721802722,-0.299724921011114,0.0467951041361341,53.2107543945312,-0.923938447267042,Yes,No,Yes,No,9,Transcribed/regulatory
cg19420968,0.098912421,NA,0.003,0.33,0.99,0.93,0.93,0.91,3061,36,1,31857551,36.1,31857228,+,HCRTR1,OX1R;,NM_001525.1,GI:4557636,###############################################################################################################################################################################################################################################################,orexin receptor 1,negative,chr1:32084964,-0.814380878055316,-0.763134165489823,-0.127871255364031,0.905349304482995,-0.838720904751382,-0.864631038989208,0.328519887348604,-0.341573398154674,0.0842028753340739,-0.322721065787638,83.028076171875,0.424798358447606,Yes,No,Yes,No,25,Quiescent/low
cg19478743,0.122668557,NA,0.00064,0.0056,0.98,0.05,0.046,0.053,58191,36,17,4589396,36.1,4589863,-,CXCL16,SRPSOX; CXCLG16; SR-PSOX;,NM_022059.1,GI:11545764,###############################################################################################################################################################################################################################################################,chemokine (C-X-C motif) ligand 16,positive,chr17:4642647,1.26716492433166,0.987266163133086,0.55865918899284,0.0627893827848968,0.996127104253162,0.953243742346405,-0.20513789117817,0.798539416405758,-0.0574291043561836,1.2661879122039,73.798137655282,2.73681040254588,Yes,Yes,No,No,2,Promoter
cg19514928,-0.005027927,NA,0.00062,0,0.62,0.055,0.052,0.059,148534,36,1,95356224,36.1,95355572,+,TMEM56,FLJ31842; MGC102912;,NM_152487.1,GI:22749022,go_component: integral to membrane,transmembrane protein 56,positive,chr1:95583636,-0.645257755567296,-0.376934213356551,-0.545759624526172,1.6311293600562,-0.434858748113734,0.457871614270179,0.2230374687003,0.622944915326817,0.999261962335158,-0.411949067188063,76.8307872971989,0.628853027213843,Yes,No,Yes,No,3,Promoter
cg19569684,-0.286095083,NA,0.014,0.0013,0.97,0.85,0.87,0.82,51237,36,5,138754318,36.1,138753501,-,PACAP,FLJ32987; MGC29506;,NM_016459.2,GI:24475968,caspase-2 binding protein; HSPC190,proapoptotic caspase adaptor protein,negative,chr5:138726419,-0.322632308827718,-0.840231536718345,0.0619557136397328,-0.510116822011641,-0.502631386335392,0.0132336498127929,-0.391586648709241,-0.666299125073152,-0.389868589110382,-0.429456221072508,83.683900676166,1.68136570991137,Yes,No,Yes,No,15,Active enhancer
cg19692710,0.021362462,NA,0.017,0.00099,0.97,0.8,0.79,0.81,374407,36,11,73339568,36.1,73339012,+,DNAJB13,TSARG5; TSARG6; FLJ46748;,NM_153614.2,GI:39204546,1700014P03Rik; go_function: unfolded protein binding; go_function: heat shock protein binding; go_process: protein folding,testis spermatogenesis apoptosis-related protein 6,positive,chr11:73661920,-0.841539920257081,-0.9113433480753,-0.431619689739643,-0.57221899701803,-0.814133501459631,-0.712267942536439,-0.440423460753266,-0.54444585076524,-0.196466670770121,-0.439261680600165,81.9406967163086,1.40403508089051,Yes,No,No,No,25,Quiescent/low
cg19706682,-0.103539266,NA,0.0026,0,0.64,0.091,0.093,0.09,123872,36,16,82736832,36.1,82736423,+,LRRC50,FLJ25330; DKFZp434A119;,NM_178452.3,GI:40255219,synonyms: FLJ25330; DKFZp434A119,leucine rich repeat containing 50,negative,chr16:84179331,-0.655268378091044,-0.656494763553418,-0.659621474411314,-0.605526838009441,-0.152722689787339,-0.0934587871391881,-0.287710542716509,-0.117807394171065,-0.483610583525928,-0.439261680600165,69.1508251199699,0.893084716136269,Yes,No,Yes,No,23,Bivalent promoter
cg19722847,-0.452037396,-0.672425548,0.0083,0.017,0.68,0.12,0.16,0.1,10526,36,12,30740381,36.1,30740018,-,IPO8,RANBP8;,NM_006390.2,GI:53759102,###############################################################################################################################################################################################################################################################,importin 8,negative,chr12:30849114,0.114975526415464,1.10080211548674,-0.538851880662462,-0.645880072255751,0.59579350769078,-0.117209359015612,-0.144476977291248,0.17090979137804,0.250792430091882,-0.408965597034034,48.0704498291016,0.0892444572338755,No,No,Yes,No,2,Promoter
cg19724470,-0.104549906,-0.146940496,0.015,0,0.86,0.2,0.26,0.16,29126,36,9,5440936,36.1,5440559,+,CD274,B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1;,NM_014143.2,GI:20070268,programmed cell death 1 ligand 1; go_component: membrane; go_component: integral to membrane; go_function: receptor activity; go_process: immune response; go_process: cell proliferation; go_process: cell surface receptor linked signal transduction,CD274 antigen,negative,chr9:5450936,-0.26123882531421,-0.156493776763048,-0.47316551460135,-0.535916352128187,0.334108770591603,0.576968180459059,-0.588742811464563,-0.554057690655723,-0.330909422952092,-0.251910945547864,78.7725677490234,1.20401768470816,Yes,No,Yes,No,3,Promoter
cg19761273,-0.88692879,-0.93416923,0.011,0.026,0.97,0.19,0.26,0.16,1453,36,17,77825385,36.1,77824862,-,CSNK1D,HCKID;,NM_001893.3,GI:20544143,###############################################################################################################################################################################################################################################################,casein kinase 1; delta isoform 1,negative,chr17:80232096,-0.55282444542343,-0.172766260890696,-0.356794709446247,-0.411713521916751,-0.505027173329306,0.505396362141139,-0.580034955388029,-0.0308613933252618,-0.129011386209024,-0.399100220379728,84.229362487793,1.62221233885746,No,No,Yes,No,2,Promoter
cg19853760,-0.241884461,-0.072551939,0.031,0.018,0.98,0.5,0.61,0.46,3956,36,22,36401623,36.1,36401589,+,LGALS1,GBP;,NM_002305.2,GI:6006015,galectin; Lectin; galactose-binding; soluble; 1; go_component: cytoplasm; go_function: sugar binding; go_function: signal transducer activity; go_process: regulation of apoptosis; go_process: positive regulation of I-kappaB kinase/NF-kappaB cascade,beta-galactoside-binding lectin precursor,negative,chr22:38071677,0.29236716594942,-0.0947320713536717,0.0897948448737415,-0.621439682406247,-0.149139402991624,0.215392369281275,-0.00164977605570188,-0.324533341015697,0.00959730056601361,1.59746377750505,85.5859570586473,1.75206763798404,Yes,No,Yes,No,9,Transcribed/regulatory
cg19945840,0.62850032,0.763203816,0.0081,0.011,0.96,0.42,0.39,0.47,126792,36,1,1157899,36.1,1157508,+,B3GALT6,beta3GalT6;,NM_080605.2,GI:37537720,###############################################################################################################################################################################################################################################################,UDP-Gal:betaGal beta 1;3-galactosyltransferase polypeptide 6,positive,chr1:1168036,-0.504272046993056,0.746451871721169,-0.447923108801136,-0.736986033024052,0.63444780572833,0.585999059850261,0.767784786719303,1.3839104669787,-0.687682964260768,0.0407953822919273,83.4127349853516,-0.640842540663496,Yes,Yes,No,No,3,Promoter
cg20100381,-0.120248941,NA,0.00085,0,0.33,0.08,0.081,0.08,8883,36,16,65421909,36.1,65422380,-,APPBP1,HPP1; A-116A10.1;,NM_003905.3,GI:66363682,###############################################################################################################################################################################################################################################################,amyloid beta precursor protein-binding protein 1 isoform a,negative,chr16:66864408,0.173235287641632,0.521661171535089,-0.586701952363227,-0.562505215617751,1.07734901650502,0.0561030098886875,-0.534959947800622,-0.135899121473466,-0.313358556012861,0.0625009067986528,81.7926003701075,1.47353407288303,Yes,Yes,No,No,3,Promoter
cg20240860,-0.052478619,NA,0.0074,0.015,0.68,0.16,0.19,0.15,84680,36,11,44043999,36.1,44044433,+,PHACS,ACS;,NM_032592.1,GI:14211920,###############################################################################################################################################################################################################################################################,1-aminocyclopropane-1-carboxylate synthase,negative,chr11:44087423,0.382691323275708,-0.405537813023482,-0.366150902155354,-0.638395615667159,0.136730556682402,0.423342188853239,-0.0632109352052638,0.378284326920768,0.175054099550911,-0.379138009435991,53.7952050948678,0.951945836357866,No,No,Yes,No,2,Promoter
cg20295671,-0.028008213,NA,0.0064,0,0.98,0.0092,0.0086,0.0094,29799,36,22,20420486,36.1,20420071,-,YPEL1,FKSG3; MGC64992;,NM_013313.3,GI:40549458,DiGeorge syndrome-related protein; yippee (Drosophila) homolog-like 1; go_component: nucleus,yippee-like 1,positive,chr22:22090486,-0.273966145825208,0.730067857144164,-0.29596180835066,-0.459283506791434,0.191851665097094,0.454676795727266,-0.369872414712593,2.23696037068624,0.0204276694118576,-0.331738746583438,81.8465778036902,0.558196453813942,No,Yes,No,No,2,Promoter
cg20305610,-0.164360384,NA,0.00026,0,0.34,0.045,0.042,0.047,10611,36,4,95592325,36.1,95592061,+,PDLIM5,L9; ENH; LIM;,NM_006457.2,GI:58533152,###############################################################################################################################################################################################################################################################,PDZ and LIM domain 5 isoform a,positive,chr4:95373302,2.00134322480351,1.6477725948344,-0.0882037569782591,-0.272495242585927,2.47561873935361,0.155475747494166,-0.346322714246615,0.332893312384174,-0.0481372022008597,0.676006825058306,73.4235302551726,1.76366479007964,Yes,Yes,No,No,3,Promoter
cg20524216,-0.389841338,NA,0.00034,0,0.22,0.032,0.028,0.035,54859,36,3,47530104,36.1,47530188,-,TMEM103,FLJ20211;,NM_001031703.1,GI:72534695,isoform 1 is encoded by transcript variant 1,hypothetical protein LOC54859 isoform 1,positive,chr3:47555100,0.0956665574258669,0.617440560074186,0.367845831904257,-0.513654068668652,0.507428439010595,-0.234469071432308,-0.369990474990898,0.0523422332365689,-0.263259574076921,-0.208373005031194,79.2991104125977,-1.65106375684366,Yes,Yes,No,No,1,Active TSS
cg20692569,0.744776072,0.797530652,0.015,0.012,0.86,0.37,0.32,0.42,8326,36,7,72486417,36.1,72486045,+,FZD9,FZD3;,NM_003508.2,GI:62865872,###############################################################################################################################################################################################################################################################,frizzled 9,positive,chr7:72848481,-0.716537914744626,0.164277725853112,-0.057227797924983,1.04323117127313,-0.106081316366111,0.0291456919437219,1.40517297807034,1.28283062484533,-0.0324958867161526,-0.429456221072508,76.9285806670153,0.446254332359852,Yes,Yes,No,No,23,Bivalent promoter
cg20761322,0.116737935,NA,0.0017,0,0.4,0.088,0.073,0.11,10518,36,15,76210619,36.1,76210933,-,CIB2,KIP2;,NM_006383.2,GI:44921612,2810434I23Rik; go_function: calcium ion binding; go_function: protein binding,DNA-dependent protein kinase catalytic subunit-interacting protein 2,positive,chr15:78423564,-0.371832188968248,-0.519256828676639,-0.225532127619982,-0.543835761404021,-0.42458155143531,-0.694227405889891,-0.330946936987485,-0.382578325009145,-0.221269715194678,-0.414048295584201,68.4233559777314,0.741433700626383,Yes,No,Yes,No,1,Active TSS
cg20795863,0.094275521,NA,0.011,0.0016,1,0.91,0.9,0.91,4759,36,2,233604363,36.1,233605626,+,NEU2,SIAL2; MGC129579;,NM_005383.1,GI:4885514,cytosolic sialidase; N-acetyl-alpha-neuraminidase 2; go_component: cytoplasm; go_function: exo-alpha-sialidase activity; go_function: hydrolase activity; acting on glycosyl bonds; go_process: carbohydrate metabolism,sialidase 2,positive,chr2:233896119,-0.855027794821251,-0.977065368672176,-0.400326920861185,-0.553391044687528,-0.821279295079476,-1.11367889336995,-0.424306506026162,-0.793152912375628,-0.368318245571903,-0.439261680600165,50.3657264709473,-0.175551919477713,No,No,No,No,25,Quiescent/low
cg20828084,0.14446198,0.179830965,0.015,0.0031,0.96,0.84,0.83,0.84,57214,36,15,78857906,36.1,78858767,+,KIAA1199,TMEM2L; IR2155535;,NM_018689.1,GI:38638697,transmembrane protein 2-like; go_process: sensory perception of sound,KIAA1199,positive,chr15:81070851,-0.834594001960989,-0.887894233999048,-0.0103512883731575,0.9584601393544,-0.753354621508889,-0.703416038856193,-0.313702419907842,-0.255836170016679,0.491963324268379,-0.365890150013085,73.2571563720703,1.07865523233522,No,No,Yes,No,24,Repressed polycomb
cg20914508,-0.003601976,NA,0.0027,0.02,0.82,0.12,0.12,0.14,2596,36,3,116825023,36.1,116825142,+,GAP43,B-50; PP46;,NM_002045.2,GI:28872807,###############################################################################################################################################################################################################################################################,growth associated protein 43,positive,chr3:115342333,-0.52572493388725,-0.663161792024777,-0.342069603672973,0.616413494570011,-0.931307343800159,-0.253491456726812,0.22299140644778,-0.229195470036414,-0.04883118698492,-0.439261680600165,52.1320750267428,2.46930214409864,Yes,No,No,No,23,Bivalent promoter
cg20947775,-0.216873362,NA,0.00031,0,0.34,0.054,0.053,0.055,79966,36,4,83939264,36.1,83938949,-,SCD5,SCD2; SCD4; ACOD4; FADS4; HSCD5; FLJ21032;,NM_024906.1,GI:13376362,###############################################################################################################################################################################################################################################################,stearoyl-CoA desaturase 4 isoform b,positive,chr4:83720240,-0.643550828753028,0.124318552444506,0.115225902717053,0.62935882269118,-0.248247573441744,0.0168140021657296,-0.241594787093884,0.434456639101049,1.1021048387018,-0.439261680600165,70.6010208129883,0.925498584430824,No,Yes,No,No,23,Bivalent promoter
cg20999813,-0.387628988,NA,0.00014,0,0.22,0.033,0.031,0.033,9100,36,16,83291515,36.1,83291085,+,USP10,UBPO; KIAA0190;,NM_005153.1,GI:24307888,go_function: ubiquitin thiolesterase activity; go_function: cysteine-type endopeptidase activity; go_process: ubiquitin cycle; go_process: ubiquitin-dependent protein catabolism,ubiquitin specific protease 10,positive,chr16:84734014,2.03651039738427,2.9110952751936,-0.305078857089491,-0.441621710869622,2.35560517027443,0.576910307008417,0.0770841725288966,-0.271304133844393,-0.710437181734968,0.231742485316481,85.738525390625,2.84522743309175,Yes,Yes,No,No,3,Promoter
cg21096399,0.119679089,NA,0.0091,0.0086,0.81,0.16,0.14,0.19,4162,36,11,118693355,36.1,118693050,-,MCAM,CD146; MUC18;,NM_006500.2,GI:71274106,melanoma adhesion molecule; go_component: plasma membrane; go_component: integral to plasma membrane; go_function: protein binding; go_process: cell adhesion; go_process: morphogenesis,melanoma cell adhesion molecule,positive,chr11:119188145,-0.885275994895048,-0.810304586721575,0.0250119264304149,1.72591597236378,-0.535483810389296,-0.140111780353384,-0.396465027738628,0.395901920714288,1.73881282968385,-0.439261680600165,80.0774154663086,1.12730004891791,Yes,No,Yes,No,2,Promoter
cg21211748,-0.166397828,NA,0.00091,0.022,0.72,0.065,0.067,0.063,1870,36,1,23730622,36.1,23730300,-,E2F2,E2F-2;,NM_004091.2,GI:34485718,###############################################################################################################################################################################################################################################################,E2F transcription factor 2,negative,chr1:23858035,-0.404750632865398,-0.667256310373413,-0.206759326684894,-0.511677473024644,-0.334541566505866,0.259363278901185,-0.379738196516766,0.545355761553234,-0.417928267460496,-0.429456221072508,84.9415130615234,1.82196452218091,No,Yes,No,No,2,Promoter
cg21305265,-0.045368222,NA,0.0036,0,0.98,0.038,0.04,0.036,157313,36,8,25372488,36.1,25372428,+,CDCA2,FLJ25804;,NM_152562.2,GI:44681483,synonym: FLJ25804,cell division cycle associated 2,negative,chr8:25316571,-0.214207828876237,0.893179132984077,0.231939702746864,-0.622524047499685,1.09305896581918,0.0382167646342637,-0.187529132293615,0.101231209166404,-0.00493655581548861,-0.439261680600165,50.75965021376,0.335520180782083,Yes,Yes,No,No,1,Active TSS
cg21370143,-0.054401836,NA,0.0063,0.14,1,0.84,0.85,0.83,4607,36,11,47330784,36.1,47330806,-,MYBPC3,FHC; CMH4; MYBP-C;,NM_000256.2,GI:13325073,###############################################################################################################################################################################################################################################################,protein C; cardiac,negative,chr11:47374208,-0.788035452704983,-0.726248688976052,0.124997023205201,-0.28326672365671,-0.902181667140195,-0.756576340398612,-0.341995909372382,-0.916809852256137,-0.718067315478671,-0.387350498907043,82.7134475708008,1.06052762570249,Yes,No,No,Yes,25,Quiescent/low
cg21378206,0.195972049,0.558785974,0.0063,0.3,1,0.92,0.91,0.92,26525,36,2,113533514,36.1,113532686,+,IL1F5,FIL1; FIL1D; IL1L1; IL1HY1; IL1RP3; MGC29840; FIL1(DELTA);,NM_012275.2,GI:27894308,###############################################################################################################################################################################################################################################################,interleukin 1 family; member 5,positive,chr2:113817043,-0.652354466444979,-0.962378518145754,0.033038482608609,0.17612397765671,-0.902823722922572,-0.844916016392812,0.643013101174621,-0.48962701803419,-0.718067315478671,-0.439261680600165,63.0097160339355,1.65208762238548,Yes,No,No,No,25,Quiescent/low
cg21395782,-0.123872644,NA,0.0015,0,0.95,0.045,0.044,0.045,51079,36,19,19487814,36.1,19487596,+,NDUFA13,B16.6; CDA016; CGI-39; GRIM19; GRIM-19;,NM_015965.3,GI:21361821,###############################################################################################################################################################################################################################################################,cell death-regulatory protein GRIM19,negative,chr19:19626814,1.40123791656743,0.703463913685697,-0.130646623766489,-0.566211303313382,1.80952192792422,1.09763813187336,-0.490397447446199,0.511272999526431,-0.613407153708987,-0.153687737345691,77.5005035400391,2.45273570179639,Yes,Yes,No,No,3,Promoter
cg21460081,-0.150206847,NA,0.0022,0,0.65,0.066,0.062,0.07,3214,36,17,44011011,36.1,44010742,-,HOXB4,HOX2; HOX2F; HOX-2.6;,NM_024015.3,GI:45580720,homeobox protein Hox-B4; homeo box 2F; go_component: nucleus; go_function: transcription factor activity; go_process: development; go_process: regulation of transcription; DNA-dependent,homeo box B4,positive,chr17:46656012,-0.382754001274385,0.0236247812109846,0.264917182879681,0.521121903647103,0.326107246384023,-0.0926576441257509,-0.341949003896084,0.107053857829244,2.19592750038868,-0.429456221072508,82.2417907714844,3.81579414603092,Yes,No,Yes,No,3,Promoter
cg21801378,0.205911023,NA,0.0021,0,0.61,0.043,0.027,0.069,60677,36,15,70399179,36.1,70399579,-,BRUNOL6,CELF6;,NM_052840.3,GI:70780380,RNA-binding protein BRUNOL-6; CUG-BP and ETR-3 like factor 6; Bruno (Drosophila) -like 6; RNA binding protein; go_function: nucleotide binding; go_function: nucleic acid binding,bruno-like 6; RNA binding protein,positive,chr15:72612125,-0.656377514392631,-0.319982602151801,-0.419059913358983,-0.419308159751044,-0.844157825685883,-0.302203295951572,-0.412133504531521,1.60022877589173,-0.489025144563282,-0.356570358654508,74.9072799682617,3.76630234658268,Yes,Yes,No,No,22,Poised promoter
cg21870884,0.135875207,0.079569625,0.017,0.0063,0.95,0.21,0.15,0.25,2848,36,1,199109052,36.1,199108789,+,GPR25,,NM_005298.2,GI:38194223,###############################################################################################################################################################################################################################################################,G protein-coupled receptor 25,positive,chr1:200842429,-0.049780351006984,-0.0613291203192264,0.02368398337994,2.71356863530217,-0.306606117213544,0.633090641859652,0.9792894034547,-0.901037232811712,0.400596705326382,-0.346525105772542,67.6318791073159,1.63281491355647,Yes,Yes,No,No,23,Bivalent promoter
cg21950518,-0.002510616,NA,0.0019,0.02,0.56,0.085,0.086,0.084,3572,36,5,55326503,36.1,55326520,-,IL6ST,CD130; GP130; CDw130; IL6R-beta; GP130-RAPS;,NM_002184.2,GI:28610146,###############################################################################################################################################################################################################################################################,interleukin 6 signal transducer isoform 1 precursor,negative,chr5:55290746,1.24181313501068,2.00276447219269,-0.178451394205725,-0.649242494230617,2.03055061540473,0.0758802451393482,-0.258315387836074,-0.0575030112175103,-0.497171580290588,6.17143136956823,80.6065292358398,0.563774460283875,Yes,Yes,No,No,3,Promoter
cg22006386,0.027954025,NA,0.0018,0,0.54,0.044,0.044,0.046,57828,36,19,43519218,36.1,43518298,+,C19orf15,FLJ46353; DKFZP434A1022;,NM_021185.3,GI:40556268,go_component: integral to membrane,hypothetical protein LOC57828,positive,chr19:38827378,-0.177946960974973,1.08446996512059,-0.381108956735788,-0.755917925874466,0.133850182874815,0.627990874393024,-0.215922260065691,1.40328074932163,-0.551446619422529,-0.356747619312134,80.3702072752384,2.18906798279406,Yes,No,Yes,No,2,Promoter
cg22171829,-0.133887348,-0.013845279,0.019,0,0.83,0.25,0.32,0.23,5166,36,7,95063456,36.1,95063739,-,PDK4,,NM_002612.2,GI:33589822,go_component: mitochondrion; go_function: ATP binding; go_function: [pyruvate dehydrogenase (lipoamide)] kinase activity; go_process: glucose metabolism; go_process: protein amino acid phosphorylation,pyruvate dehydrogenase kinase; isoenzyme 4,negative,chr7:95225520,-0.415852854979929,-0.0387996158335783,0.207696070994698,1.52523869422836,-0.338728532822622,-0.371497071824834,0.506685470173846,1.48733390014969,0.0434151582779897,-0.370555869905162,18.046501140642,1.79600474200861,Yes,Yes,No,No,2,Promoter
cg22190114,0.122000415,NA,0.0062,0,1,0.89,0.9,0.9,126205,36,19,61151046,36.1,61151010,+,NALP8,NOD16;,NM_176811.2,GI:33667039,NACHT; LRR and PYD containing protein 8; go_function: ATP binding; go_function: nucleotide binding,NACHT; leucine rich repeat and PYD containing 8,negative,chr19:56459234,-0.56365614035128,-0.561989439802436,-0.285269446346472,0.563898988908279,-0.844697267110054,-0.885455989809987,2.22531304149666,-0.466867171955749,0.643283326736034,-0.439261680600165,50.1254043579102,-0.0535056162390961,Yes,No,No,No,21,Heterochromatin
cg22197830,-0.214854921,-0.17248215,0.026,0.033,0.95,0.68,0.76,0.65,79770,36,5,134237683,36.1,134237326,+,C5orf14,UNQ335; FLJ22625;,NM_024715.2,GI:21362011,2310047H23Rik; go_function: isomerase activity; go_function: electron transporter activity; go_process: electron transport,disulfide isomerase,negative,chr5:134209784,1.38278213586627,-0.0192998018275991,-0.458836966886123,-0.628693022951957,0.230822473624975,-0.369897245099637,-0.20915181239985,0.13572067944077,0.169647678856541,-0.326111287191707,77.7107925415039,1.67520804999757,Yes,No,Yes,No,2,Promoter
cg22289837,-0.057604916,NA,0.017,0.024,0.87,0.3,0.28,0.31,761,36,8,86537530,36.1,86537710,+,CA3,CAIII;,NM_005181.2,GI:6996001,go_component: cytoplasm; go_function: lyase activity; go_function: zinc ion binding; go_function: metal ion binding; go_function: carbonate dehydratase activity; go_process: one-carbon compound metabolism,carbonic anhydrase III,positive,chr8:86350278,-0.815012166156945,-0.456246779093241,-0.318867831602694,1.74276853300963,-0.813561773204851,-0.654217994236435,1.03845685531657,1.57834785377704,0.0385450973547671,-0.439261680600165,10.803129196167,1.13005093798529,Yes,No,Yes,No,23,Bivalent promoter
cg22432269,-0.047520857,NA,0.00026,0,0.46,0.025,0.023,0.026,23191,36,15,20444138,36.1,20444125,+,CYFIP1,SHYC; FLJ45151; P140SRA-1;,NM_014608.2,GI:57013277,isoform a is encoded by transcript variant 1; selective hybridizing clone (mouse); cytoplasmic FMRP interacting protein 1,cytoplasmic FMR1 interacting protein 1 isoform a,positive,chr15:22892697,0.231524075324417,1.28233341684294,0.44234739065864,1.34654223109893,0.646760889513879,-0.0681734648597607,-0.150364012633235,0.144838589615758,1.12059239880565,-0.0932462469441604,50.1074519930338,0.286675066544067,Yes,Yes,No,No,1,Active TSS
cg22449114,0.009556913,NA,0.011,0.012,0.91,0.27,0.23,0.29,6939,36,20,538243,36.1,538910,-,TCF15,EC2; PARAXIS;,NM_004609.3,GI:48255908,###############################################################################################################################################################################################################################################################,basic helix-loop-helix transcription factor 15,positive,chr20:590243,-0.843023890793834,0.112231387037047,0.157183688358209,3.15047402751159,-0.87404420167721,0.161139513989415,1.40923036103257,0.0767693316438469,1.82485353307114,-0.421717258179465,66.0764236450195,0.380408094759552,Yes,Yes,No,No,23,Bivalent promoter
cg22568540,0.020951084,NA,0.017,0.11,1,0.92,0.94,0.9,1,36,19,63556658,36.1,63556669,-,A1BG,A1B; ABG; GAB; HYST2477; DKFZp686F0970;,NM_130786.2,GI:21071029,alpha-1B-glycoprotein; go_component: extracellular space; go_function: molecular function unknown; go_process: biological process unknown,alpha 1B-glycoprotein,negative,chr19:58864846,-0.66383082950224,-0.801624169022529,0.486814782887501,-0.440306178292046,-0.810171183888452,-0.885009523986994,0.524925479043439,-1.04857466038716,-0.618250018727591,-0.340917544203649,73.3314361572266,1.3684787721718,Yes,No,No,Yes,25,Quiescent/low
cg22613010,-0.00136474,NA,0.00078,0.016,0.43,0.069,0.075,0.066,1181,36,3,185561866,36.1,185561961,-,CLCN2,CLC2; ECA3; EGI3; EGMA; CIC-2;,NM_004366.2,GI:5803001,###############################################################################################################################################################################################################################################################,chloride channel 2,negative,chr3:184079172,-0.32588552048187,1.00074675420258,0.130145437882905,0.0445496725536582,0.378337837252525,1.17140284728488,0.939370323594204,0.698247861897255,-0.303740642263144,-0.439261680600165,73.2968826293945,1.95160369608805,Yes,No,Yes,No,3,Promoter
cg22637507,-0.161364515,NA,0.0012,0,0.66,0.048,0.046,0.05,221120,36,11,43858983,36.1,43858971,+,ALKBH3,DEPC1; DEPC-1; MGC118790; MGC118792; MGC118793;,NM_139178.1,GI:21040274,prostate cancer antigen-1,hypothetical protein LOC221120,negative,chr11:43902407,0.574946950226339,1.66399076444926,-0.495420556475682,-0.512754369759023,-0.0210572656642482,-0.0395451736338373,-0.0104217753025504,0.60961776716158,0.909409804728993,0.0748465361082016,55.3026597838747,8.85293403500574,Yes,Yes,No,No,1,Active TSS
cg22679120,0.008321411,NA,0.018,0,0.99,0.6,0.6,0.6,29886,36,7,2319928,36.1,2320625,-,SNX8,,NM_013321.1,GI:23943857,go_function: protein binding; go_function: phosphoinositide binding; go_process: protein transport; go_process: intracellular signaling cascade,sorting nexin 8,positive,chr7:2353402,-0.320850098610909,-0.293985872505499,-0.397678548278442,-0.587951887855197,-0.435425714448775,0.00969870523525523,-0.470707700759953,0.0408128731836596,-0.590725406339881,-0.343369922841547,80.1839795766626,2.79848405335952,Yes,No,Yes,No,3,Promoter
cg22736354,1.718507337,2.262766484,0.0086,0.011,0.95,0.17,0.091,0.25,378884,36,6,18230698,36.1,18230830,-,NHLRC1,EPM2A; EPM2B; MGC119262; MGC119264; MGC119265; bA204B7.2;,NM_198586.2,GI:40255282,go_component: nucleus; go_component: endoplasmic reticulum; go_function: protein binding; go_function: zinc ion binding; go_function: metal ion binding,malin,positive,chr6:18122719,-0.264179047178066,2.22502551099419,0.46814201147935,-0.0211699649515184,-0.224444193783212,0.576974848792652,0.80480138557168,-1.11524567178196,-0.537551457565519,-0.3801077624592,77.9241409301758,3.10955605999348,Yes,Yes,No,No,2,Promoter
cg22809047,0.160173786,NA,0.03,0.0026,0.96,0.6,0.54,0.65,6160,36,2,100984693,36.1,100985183,+,RPL31,MGC88191;,NM_000993.2,GI:15812219,60S ribosomal protein L31; go_component: ribosome; go_function: structural constituent of ribosome; go_process: protein biosynthesis,ribosomal protein L31,positive,chr2:101618261,0.627322375947084,0.0679403956368639,-0.234194389554762,-0.411281912487648,0.147555123444637,0.875859244582864,0.464251438565064,1.41411209206323,-0.121881533384926,-0.371207912818655,68.1565551757812,0.504480647950689,Yes,Yes,No,No,2,Promoter
cg22901840,0.078584998,0.095064103,0.013,0.038,0.97,0.62,0.59,0.65,9077,36,1,68285365,36.1,NA,-,DIRAS3,ARHI; NOEY2;,NT_032977.8,,###############################################################################################################################################################################################################################################################,DIRAS family; GTP-binding RAS-like 3,positive,chr1:68512777,-0.887070455333761,-0.463283298349745,0.627710315431261,0.801803335387102,-0.870021843430439,-0.539515310940086,1.99737285577595,1.30239486271768,-0.579769328984851,-0.439261680600165,74.8990478515625,2.38583646884531,Yes,Yes,No,Yes,23,Bivalent promoter
cg22920873,0.114374788,0.655583459,0.00037,0,0.63,0.018,0.018,0.018,154791,36,7,138675693,36.1,138676615,+,HSPC268,,NM_197964.1,GI:37537547,,hypothetical protein LOC154791,positive,chr7:139025153,0.688844211732904,0.06012719901248,0.0191920902265186,-0.679093260322715,-0.277757361429411,-0.384545738560168,0.180539607484316,0.702990635956856,-0.425132428585527,-0.33592173320732,69.1057739257812,0.894492021191781,Yes,Yes,No,No,1,Active TSS
cg22947000,-0.385598354,-0.358490445,0.02,0,0.89,0.25,0.32,0.21,53630,36,16,79829782,36.1,79829797,+,BCMO1,BCO; BCDO; BCMO; BCDO1; FLJ10730;,NM_017429.2,GI:74027269,beta-carotene 15; 15prime-dioxygenase 1; go_function: iron ion binding; go_function: oxidoreductase activity; go_function: beta-carotene 15;15prime-monooxygenase activity,beta-carotene 15; 15prime-monooxygenase 1,negative,chr16:81272281,-0.303877574852078,-0.779896671411751,-0.525206249709694,-0.231744932792975,-0.482531026977397,-0.43595917362638,-0.515150549628451,3.95299985368913,0.0568918612707956,-0.429456221072508,63.9353332519531,0.254477506770895,Yes,No,No,No,2,Promoter
cg23092072,0.999917662,NA,0.0044,0,0.99,0.036,0.037,0.035,4299,36,4,88146730,36.1,88147164,+,AFF1,AF4; AF-4; PBM1; MLLT2;,NM_005935.1,GI:5174572,###############################################################################################################################################################################################################################################################,myeloid/lymphoid or mixed-lineage leukemia trithorax homolog 2,negative,chr4:87927706,0.507341222975364,0.00991690516628816,-0.375595639051047,-0.733081661097611,0.767350179247972,0.270946257056237,-0.618236421747708,0.320842417075602,-0.342162187339256,1.11456336828031,66.3867874145508,1.01627872617779,Yes,No,Yes,No,1,Active TSS
cg23124451,-0.118914538,NA,0.052,0,0.96,0.43,0.58,0.39,23492,36,22,37878077,36.1,37878484,-,CBX7,,NM_175709.2,GI:46852393,go_component: nucleus; go_component: chromatin; go_function: chromatin binding; go_process: transcription; go_process: chromatin modification; go_process: chromatin assembly or disassembly; go_process: regulation of transcription; DNA-dependent,chromobox homolog 7,negative,chr22:39548131,1.22258854721765,0.98158642636862,0.315166671227466,-0.39972251501912,0.591285392409604,0.653358009411531,-0.156023961555536,-0.181388925962197,-0.718067315478671,-0.311618273117353,78.4133834838867,1.52626902000129,Yes,Yes,Yes,No,2,Promoter
cg23180365,-0.17318824,NA,0.00012,0,0.21,0.02,0.02,0.018,2720,36,3,33113631,36.1,33113634,-,GLB1,,NM_000404.1,GI:10834965,###############################################################################################################################################################################################################################################################,galactosidase; beta 1,negative,chr3:33138627,0.917783957957637,0.810426428576127,0.98396255311834,-0.459572579020713,1.13949690558651,0.189838201183851,-0.226809666522048,0.979637772015401,0.407819711739385,0.404506289767533,65.2825622558594,1.86215836913219,Yes,Yes,No,No,1,Active TSS
cg23517605,0.128377865,0.310108799,0.0031,0.0084,0.72,0.13,0.11,0.16,347733,36,6,3173364,36.1,3172870,-,TUBB2B,MGC8685; bA506K6.1; DKFZp566F223; RP11-506K6.1; TUBB-PARALOG;,NM_178012.3,GI:42476191,###############################################################################################################################################################################################################################################################,tubulin; beta polypeptide paralog,positive,chr6:3228365,-0.709524402776645,-0.176369955574385,-0.242921947234701,2.21401098456922,-0.568283418321747,0.217900840127505,-0.56163690190107,0.167243777219895,2.03925551863586,-0.439261680600165,73.9113897575702,0.291704446715432,Yes,Yes,No,Yes,2,Promoter
cg23662675,0.600765489,0.352078709,0.00041,0,0.23,0.031,0.031,0.031,23613,36,20,45419003,36.1,45418881,-,PRKCBP1,RACK7; ZMYND8; PRO2893; MGC31836;,NM_183047.1,GI:34335261,###############################################################################################################################################################################################################################################################,protein kinase C binding protein 1 isoform a,positive,chr20:45985596,0.439435440060733,-0.644040011867857,-0.574609018364226,-0.678400678882483,-0.373976733006004,0.115874877576932,-0.213848756809719,0.0520975942920836,-0.61363449186497,-0.278507076225834,84.6642892319068,1.06235483634082,Yes,No,No,No,3,Promoter
cg23786576,-0.359681997,NA,0.00019,0.0085,0.41,0.039,0.04,0.039,64756,36,1,46906183,36.1,46906615,-,ATPAF1,ATP11; ATP11p; FLJ22351;,NM_022745.2,GI:48976052,homolog of yeast ATP11; go_component: mitochondrion; go_process: protein complex assembly,ATP synthase mitochondrial F1 complex assembly factor 1,negative,chr1:47133596,0.27917184155076,0.306170959392798,-0.507078567871187,-0.296542334270028,0.435401954666409,-0.338876191817805,-0.323833711165179,-0.547129041045275,-0.509751156502341,-0.154239110011778,61.3598846758988,2.71959017686339,Yes,No,Yes,No,3,Promoter
cg23941599,0.266499641,NA,0.004,0.023,0.48,0.13,0.13,0.13,56929,36,5,114908695,36.1,114908490,-,FEM1C,FEM1A; KIAA1785; EUROIMAGE686608; EUROIMAGE783647;,NM_020177.2,GI:36030993,synonyms: FEM1A; KIAA1785; EUROIMAGE686608; EUROIMAGE783647,feminization 1 homolog a,positive,chr5:114880796,-0.17395248801217,-0.71849272364348,-0.66562362590737,-0.633354963317254,-0.472698018369041,-0.516924058127298,0.156766426339374,1.2370108708814,-0.718067315478671,-0.439261680600165,77.5828170776367,-0.444011163651493,No,No,Yes,No,1,Active TSS
cg24058132,-0.243414212,-0.077071346,0.022,0.0012,0.97,0.46,0.53,0.4,2581,36,14,87529619,36.1,87529596,-,GALC,,NM_000153.1,GI:4557612,galactocerebrosidase; Galactosylceraminidase; go_component: lysosome; go_function: galactosylceramidase activity; go_function: hydrolase activity; acting on glycosyl bonds; go_process: carbohydrate metabolism; go_process: galactosylceramide catabolism,galactosylceramidase precursor,negative,chr14:88459866,1.94275965048586,-0.182005730458561,-0.11604277405706,-0.653876790094831,0.612967660817719,0.541038279263995,-0.287857761159422,1.27167731352402,-0.387177297260154,0.0416205255430931,27.6294593811035,0.560405333186277,Yes,No,Yes,No,2,Promoter
cg24081819,-0.00950238,NA,0.0028,0.0083,0.59,0.072,0.077,0.071,2053,36,8,27404857,36.1,27404562,+,EPHX2,CEH; SEH;,NM_001979.4,GI:56682950,###############################################################################################################################################################################################################################################################,epoxide hydrolase 2; cytoplasmic,negative,chr8:27348940,-0.0347476918116989,-0.367785480083602,-0.460937636943704,0.233543141304472,0.112599817076956,0.644960206776142,0.120645503370981,1.28050579096991,0.0258284288464829,-0.0427462575618935,65.8944625854492,1.38190798720425,Yes,No,Yes,No,2,Promoter
cg24116886,0.187704497,NA,0.0093,0.0067,1,0.88,0.87,0.89,140850,36,20,85877,36.1,86186,+,DEFB127,DEF-27; DEFB27; hBD-27; DEFB-27; C20orf73; bA530N10.2;,NM_139074.2,GI:30061486,beta defensin 27; beta-defensin 27; go_component: cellular component unknown; go_function: nucleic acid binding; go_process: innate immune response; go_process: defense response to bacteria,beta defensin 127 preproprotein,positive,chr20:137877,-0.840222464737457,-0.747739898876537,-0.0677008543235664,0.676488154211421,-0.900149057903903,-0.784242968289631,-0.446835793482413,-0.464055314530557,-0.242246101363127,-0.439261680600165,64.8183441162109,-0.199989138119467,No,No,No,No,25,Quiescent/low
cg24126851,0.000792206,NA,0.012,0.13,0.96,0.78,0.8,0.76,8642,36,11,6634719,36.1,6633656,-,DCHS1,FIB1; CDH25; PCDH16; FLJ11790; KIAA1773;,NM_003737.2,GI:73623031,###############################################################################################################################################################################################################################################################,dachsous 1 precursor,positive,chr11:6678143,-0.76570958021207,-0.736322513555741,0.0020506366564014,0.399667280921451,-0.836801325167049,-1.06996156968238,-0.313195570785642,-0.301993107938544,-0.163441817885553,-0.429456221072508,73.0681610107422,-0.347536698978404,No,No,Yes,No,24,Repressed polycomb
cg24254120,0.372917726,NA,0.0068,0,0.99,0.054,0.053,0.054,5983,36,13,33290869,36.1,33290234,+,RFC3,RFC38; MGC5276;,NM_002915.2,GI:31795536,###############################################################################################################################################################################################################################################################,replication factor C 3 isoform 1,positive,chr13:34392869,-0.500771101303465,0.17824246805906,0.104478722103488,-0.182093384823031,0.207492448583828,0.424995058348345,0.0648075431992318,-0.410534826607833,-0.327672333266815,-0.379667471591471,52.319766998291,1.01171237485535,Yes,No,Yes,No,3,Promoter
cg24262469,0.152852459,0.13428669,0.0089,0.023,0.98,0.26,0.25,0.26,25976,36,3,157874388,36.1,157875073,+,TIPARP,DDF1; PARP7; PARP-1; PARP-7; DKFZP434J214; DKFZp686N0351; DKFZp686P1838;,NM_015508.2,GI:38524593,go_component: nucleus; go_function: protein binding; go_function: nucleic acid binding; go_function: NAD+ ADP-ribosyltransferase activity; go_process: protein amino acid ADP-ribosylation,TCDD-inducible poly(ADP-ribose) polymerase,positive,chr3:156391694,0.477334340454154,-0.028743288340937,0.00228125582204372,-0.560065657775974,-0.611363252191279,-0.203337543079921,0.223882877437596,0.335191311650806,0.100846473923278,-0.154178810832735,69.6634987809712,-0.210193277005885,Yes,No,Yes,No,2,Promoter
cg24450312,-0.001508834,NA,0.0044,0,0.38,0.061,0.069,0.059,83593,36,1,204747781,36.1,NA,+,RASSF5,RAPL; Maxp1; NORE1; RASSF3; MGC10823;,NT_021877.18,,###############################################################################################################################################################################################################################################################,Ras association (RalGDS/AF-6) domain family 5 isoform B,positive,chr1:206681158,-0.151218100207798,0.77783881073844,-0.133853654369633,-0.0905042532458516,0.271664428323091,0.412799885676838,-0.544945964818178,-0.0327293513243212,1.60942966573437,0.0181617459506906,78.3797607421875,0.115249370822979,Yes,Yes,No,No,23,Bivalent promoter
cg24471894,-0.057512039,NA,0.018,0,0.97,0.17,0.22,0.15,9933,36,9,2828508,36.1,2828507,-,KIAA0020,XTP5; MGC8749; RP11-526D20.2;,NM_014878.3,GI:33620772,###############################################################################################################################################################################################################################################################,KIAA0020 isoform 2,negative,chr9:2838508,-0.597477818431203,-0.973527006364799,-0.176669454299867,-0.596382697527725,-0.69311998078581,-0.506850359151683,-0.542017467434053,-0.16171560186978,0.17691161389059,0.0119972707393741,35.524857499653,-0.874901218738604,Yes,No,No,No,5,Transcribed
cg24580001,0.339639763,0.247742587,0.0092,0.12,0.99,0.9,0.9,0.89,283234,36,11,63863108,36.1,63864271,+,FLJ37970,BRLZ; FLJ00354; DKFZp434G0920;,NM_032251.3,GI:40795670,brain leucine zipper protein; go_function: protein binding; go_function: transcription factor activity; go_process: regulation of transcription; DNA-dependent,hypothetical protein LOC283234,positive,chr11:64106532,-0.331306869492816,-0.960132110282514,1.663421269391,-0.654771988968253,-0.853164183887295,-0.67621647389283,-0.0109883254130103,-0.893733449527688,-0.435144084995782,-0.294743433109755,82.8539710104317,0.6935403890889,No,No,No,Yes,25,Quiescent/low
cg24834740,-0.087006506,NA,5e-04,0,0.5,0.037,0.035,0.038,26051,36,20,36867966,36.1,36867762,+,PPP1R16B,TIMAP; ANKRD4; KIAA0823;,NM_015568.2,GI:34335276,TGF-beta-inhibited membrane-associated protein; CAAX box protein TIMAP; ankyrin repeat domain protein 4; go_component: plasma membrane; go_function: protein phosphatase binding; go_process: signal transduction,protein phosphatase 1 regulatory inhibitor subunit 16B,positive,chr20:37434552,3.93132445365725,1.95434110659605,0.181524021056586,-0.534796186999575,3.01674886238408,1.42671749298807,0.015149465629204,0.496978992023814,-0.395031930110785,2.30692483859041,49.8846382749943,2.12355605180678,Yes,Yes,No,No,2,Promoter
cg24888049,-0.129936396,NA,0.021,0.034,0.95,0.59,0.67,0.54,2242,36,15,89227671,36.1,89228713,+,FES,FPS;,NM_002005.2,GI:13376997,###############################################################################################################################################################################################################################################################,V-FES feline sarcoma viral/V-FPS fujinami avian sarcoma viral oncogene homolog,negative,chr15:91426667,-0.548621890414329,-0.593644549122654,0.491062971059056,-0.67326901672872,-0.701186990220085,-0.102846437494475,-0.177794213203303,-0.605749582071469,-0.388540819763914,-0.0487285887236008,83.2223237910473,2.6697811038428,Yes,No,Yes,No,15,Active enhancer
cg24899750,-0.307424926,-0.256103442,0.011,0.033,0.97,0.58,0.61,0.56,6629,36,20,16658314,36.1,16658629,+,SNRPB2,MGC24807; MGC45309;,NM_003092.3,GI:38149917,###############################################################################################################################################################################################################################################################,small nuclear ribonucleoprotein polypeptide B,negative,chr20:16710314,0.601996079655562,-0.518377749183896,-0.392299285937903,-0.47748455976805,-0.58288133977339,-0.49645694464934,0.832829088626973,-0.0153988724863923,-0.23102860861549,-0.412492327752646,31.1015763080625,2.60980172601695,No,No,Yes,No,2,Promoter
cg25070637,-0.279922439,-0.44666326,2e-04,0.021,0.29,0.061,0.058,0.062,6383,36,8,97575044,36.1,97575058,+,SDC2,HSPG; HSPG1; SYND2;,NM_002998.3,GI:55925658,fibroglycan; heparan sulfate proteoglycan core protein; go_component: membrane; go_component: integral to membrane; go_component: integral to plasma membrane; go_function: cytoskeletal protein binding; go_process: biological process unknown,syndecan 2 precursor,positive,chr8:97505868,-0.325859739511883,-0.368354374947936,-0.377524823027408,2.21567680009571,-0.277883900953207,0.77012276616156,0.139638887442233,2.49769379837627,1.35334583200582,-0.3152935777502,61.2654647827148,0.219708618799445,Yes,Yes,No,No,2,Promoter
cg25101936,-0.057744615,NA,0.017,0.0089,0.99,0.6,0.61,0.59,7704,36,11,113434374,36.1,113435641,+,ZBTB16,PLZF; ZNF145;,NM_006006.4,GI:66932930,###############################################################################################################################################################################################################################################################,promyelocytic leukemia zinc finger protein,negative,chr11:113929164,-0.744166179200082,-0.652417385846803,0.229301154190926,1.47121119505072,-0.79612762456613,-0.595712960333974,0.403709629309949,-0.171594819259726,-0.221597991572083,-0.429456221072508,42.1991653442383,1.12795397616754,No,No,Yes,No,24,Repressed polycomb
cg25148589,0.179969129,NA,0.0076,0.011,0.74,0.16,0.13,0.21,2891,36,4,158361386,36.1,158361297,+,GRIA2,GLUR2; GLURB; HBGR2;,NM_000826.2,GI:74275353,###############################################################################################################################################################################################################################################################,glutamate receptor; ionotropic; AMPA 2,positive,chr4:158141936,-0.902939475477341,-0.385466116233126,-0.463370691238838,2.14227883061654,-0.913143804510145,-0.229592440693766,3.30711738903037,-1.16498313495344,-0.268302454601585,-0.439261680600165,55.0417289733887,0.68612924075547,Yes,No,Yes,No,23,Bivalent promoter
cg25159610,0.224446911,NA,0.0023,0,0.94,0.044,0.043,0.041,10769,36,5,57792559,36.1,57791844,-,PLK2,SNK;,NM_006622.1,GI:5730054,###############################################################################################################################################################################################################################################################,polo-like kinase 2,negative,chr5:57756802,-0.431575602207835,0.2796864170442,-0.302576505615194,-0.636801466365138,-0.158409390813077,-0.39360167522346,0.739263941738823,-0.491654393471549,-0.324474915433669,-0.378356477648115,53.0514945983887,0.54094648462549,No,Yes,No,No,16,Weak enhancer
cg25166896,-0.002315093,NA,0.0013,0.014,0.87,0.049,0.055,0.045,128989,36,22,18389063,36.1,18388631,+,C22orf25,DKFZp761P1121;,NM_152906.2,GI:38488711,synonym: DKFZp761P1121,hypothetical protein LOC128989,negative,chr22:20009063,1.28012800854276,0.911423343652679,-0.151510477348027,-0.541138547879903,1.80898498729272,1.54882741753405,-0.472810681376494,0.429735107906053,-0.021304832672895,-0.219207893884314,81.8441162109375,3.30687135833337,Yes,Yes,No,No,3,Promoter
cg25411725,-0.028135965,NA,0.0066,0.021,0.95,0.84,0.85,0.84,9390,36,3,38281676,36.1,38282335,+,SLC22A13,OCTL1; OCTL3; ORCTL3;,NM_004256.1,GI:4758851,organic cationic transporter-like 3; go_component: membrane fraction; go_component: integral to plasma membrane; go_function: transporter activity; go_function: organic cation transporter activity; go_process: transport,organic cation transporter like 3,negative,chr3:38306672,-0.7241296857286,-0.879961439524489,0.0170979697899977,-0.440429701450563,-0.850535964814503,-0.853007483355604,0.206377753304798,-0.187466049565773,-0.509523399583534,-0.429456221072508,63.9291602346368,-0.412605842749028,No,No,No,No,25,Quiescent/low
cg25505610,1.50223047,1.772906777,0.001,0,0.71,0.031,0.03,0.032,10480,36,11,32561760,36.1,32561967,+,hfl-B5,GA17;,NM_006360.3,GI:52851442,fetal lung protein B5,B5 receptor,positive,chr11:32605184,0.10300088046765,-0.0337863945244858,-0.277459442561964,-0.486108508668827,0.0326538199159973,-0.253247057979917,0.208371949954686,0.197892237712798,-0.54719935245935,-0.161901845567878,43.7226104736328,1.2141148962118,No,Yes,No,No,3,Promoter
cg25552492,-0.176029721,NA,0.0019,0,0.59,0.083,0.06,0.1,203190,36,8,22069944,36.1,22070289,-,LGI3,LGIL4;,NM_139278.2,GI:45643139,synonym: LGIL4,leucine-rich repeat LGI family; member 3,positive,chr8:22013999,-0.866584369912558,-0.590952660148364,-0.0392138322356413,1.21920759991211,-0.517934523636392,-0.326234936066689,-0.22431074480097,-0.973765024959207,0.701998444788448,-0.439261680600165,82.1239700317383,0.762767571796398,Yes,No,Yes,No,24,Repressed polycomb
cg25564800,-0.004461622,NA,0.011,0,0.65,0.15,0.17,0.14,3836,36,3,123716824,36.1,123716335,-,KPNA1,RCH2; SRP1; IPOA5; NPI-1;,NM_002264.1,GI:4504894,###############################################################################################################################################################################################################################################################,karyopherin alpha 1,negative,chr3:122234134,-0.432977432157475,-0.533445421891747,-0.501312182103775,-0.742293896689657,-0.709343524102344,0.315818874521068,-0.3485859826343,-0.425858885215728,-0.417863232431692,-0.419642557742483,65.7930374145508,0.716382490578917,No,No,Yes,No,2,Promoter
cg25657834,-0.120291759,NA,0.0017,0.019,0.78,0.098,0.1,0.1,23620,36,2,11727816,36.1,11727876,-,NTSR2,NTR2;,NM_012344.2,GI:21735622,###############################################################################################################################################################################################################################################################,neurotensin receptor 2,negative,chr2:11810365,-0.62106850263337,-0.334741936018752,-0.241634930577431,2.15698645097318,-0.843099974512583,-0.357479471066077,1.92040943759124,-0.345229543130167,0.173926988611187,-0.439261680600165,67.3603766196386,0.175028155363102,No,Yes,No,No,24,Repressed polycomb
cg25683012,-1.392021375,NA,2e-04,0,0.29,0.025,0.023,0.026,11176,36,12,55316380,36.1,55316417,-,BAZ2A,TIP5; KIAA0314; DKFZp781B109;,NM_013449.2,GI:32261302,###############################################################################################################################################################################################################################################################,bromodomain adjacent to zinc finger domain; 2A,positive,chr12:57030113,0.362813677105773,-0.0881166735251377,-0.327036875649454,-0.572094474298057,-0.156864117732262,0.0319340567494274,-0.371827367956222,-0.132937235868564,-0.626332013298765,0.114569039651845,82.3731460571289,1.12160365209359,Yes,No,Yes,No,3,Promoter
cg25771195,0.304478062,0.514254835,0.01,0.037,0.92,0.51,0.48,0.54,29105,36,16,56721315,36.1,56720797,-,GTL3,,NM_013242.2,GI:42716281,go_process: development,transcription factor IIB,positive,chr16:58163814,-0.216972204111814,-0.248575118222478,-0.273854442513679,-0.510898952366753,-0.167063001740467,0.22428238271742,1.8125597418614,1.29712168207029,-0.405018931493716,-0.40261920029986,55.2519721984863,2.4572302954323,No,No,Yes,No,2,Promoter
cg25781123,0.019974651,NA,0.0011,0,0.4,0.06,0.057,0.062,25917,36,3,9379598,36.1,9379736,+,THUMPD3,DKFZP434F091;,NM_015453.1,GI:14149689,go_function: protein binding,THUMP domain containing 3,positive,chr3:9404598,0.263551311144438,-0.363955940088174,-0.268651061283868,-0.767488679707685,0.268970155932621,0.448722071505203,0.0933783870677221,0.878418938357468,-0.305749880569433,0.842341246723908,63.8737209253478,0.353925892327835,Yes,No,Yes,No,3,Promoter
cg25809905,-0.216624999,-0.348900512,0.02,0.0019,0.96,0.69,0.77,0.61,3674,36,17,39823254,36.1,39822399,-,ITGA2B,GTA; CD41; GP2B; HPA3; CD41B; GPIIb;,NM_000419.2,GI:6006009,###############################################################################################################################################################################################################################################################,integrin alpha 2b precursor,negative,chr17:42467728,-0.56671232533176,-0.740660562986785,0.529908270872909,-0.295689457295397,-0.91737057201037,-0.500618940869301,0.738415613821132,-0.219125784562442,-0.143006548097668,-0.264261062935039,79.3639068603516,0.985623543336049,No,No,No,No,13,Active enhancer
cg25928579,-0.030298685,NA,0.0011,0,0.81,0.079,0.08,0.079,3218,36,17,44047533,36.1,44047300,-,HOXB8,HOX2; HOX2D; Hox-2.4;,NM_024016.2,GI:25121964,homeobox protein Hox-B8; homeo box 2D; go_component: nucleus; go_function: transcription factor activity; go_process: development; go_process: regulation of transcription; DNA-dependent,homeo box B8,negative,chr17:46692534,-0.924753989525862,-0.487683146647513,-0.566761896803627,2.02223444342619,-0.935759714588219,-0.684648865437683,0.132136554459728,-0.870811120204101,5.29770704176899,-0.439261680600165,80.6714445765774,1.94655208878914,Yes,No,Yes,No,24,Repressed polycomb
cg26003813,-0.192765894,NA,0.0036,0.015,0.84,0.081,0.076,0.085,5347,36,16,23597303,36.1,23597702,+,PLK1,PLK; STPK13;,NM_005030.3,GI:34147632,###############################################################################################################################################################################################################################################################,polo-like kinase,positive,chr16:23689802,-0.420530188773532,-0.447550917828025,-0.326573198627881,-0.682138185783571,-0.39318869359568,-0.30225344371088,-0.525712215977384,0.258793062666147,-0.114072226393777,-0.376723683513819,50.9182014465332,2.50389297407881,Yes,No,Yes,No,3,Promoter
cg26005082,0.283314043,0.547567138,0.00048,0,0.39,0.057,0.049,0.066,284424,36,19,4720660,36.1,4720152,+,C19orf30,PGSF1; PGSF1a; PGSF1b;,NM_174947.2,GI:29126235,pituitary gland specific factor 1a,hypothetical protein LOC284424,positive,chr19:4769660,-0.80966950271879,-0.754303912736326,-0.291583125756816,-0.48440365565017,-0.968609060727079,-0.824414728941586,0.200641238558272,1.08212173082887,-0.265871933664683,-0.419642557742483,82.9242975515618,3.3209277715731,No,No,No,No,19,DNase
cg26043391,-0.361822974,NA,0.00063,0.014,0.41,0.065,0.068,0.064,23219,36,1,222368797,36.1,222368436,+,FBXO28,Fbx28; FLJ10766; KIAA0483;,NM_015176.1,GI:7662157,go_process: ubiquitin cycle,F-box protein 28,negative,chr1:224302174,2.24105366064667,1.49702882691964,0.485001173772224,-0.499341244545267,3.32800658244431,1.33569420149311,0.141055887459216,-0.189537501916792,-0.126628201669026,0.621728620463474,80.6885375976562,2.14480541319931,Yes,Yes,No,No,3,Promoter
cg26045434,-0.296285378,NA,0.0031,0.029,0.79,0.1,0.097,0.12,55806,36,8,22043806,36.1,22043975,-,HR,AU; ALUNC; HSA277165;,NM_005144.3,GI:62750351,isoform a is encoded by transcript variant 1; hairless (mouse) homolog; go_component: nucleus; go_function: metal ion binding; go_function: transcription factor activity; go_process: transcription; go_process: regulation of transcription; DNA-dependent,hairless protein isoform a,positive,chr8:21987861,-0.543446280511613,-0.554394319283189,0.241911166697958,2.97767444540482,-0.67191793908238,1.28276868644625,-0.287165528018034,-0.751769305395184,3.86003945903823,-0.439261680600165,81.774284362793,2.0896233139508,Yes,Yes,No,No,23,Bivalent promoter
cg26162695,-0.043863368,NA,0.0074,0,0.98,0.018,0.02,0.016,60528,36,17,12862038,36.1,12862049,-,ELAC2,ELC2; HPC2; FLJ10530; FLJ42848;,NM_018127.4,GI:34147640,###############################################################################################################################################################################################################################################################,elaC homolog 2,negative,chr17:12921313,-0.00521708591158598,0.584161227011847,-0.327060411302131,-0.320236435954649,0.335075238556883,-0.787543098527422,0.100951588927711,-0.0203550809027977,-0.22767487460916,0.987579666521825,53.2693870430278,2.18442849075464,Yes,Yes,No,No,1,Active TSS
cg26297688,0.959651842,0.883216148,0.001,0,0.83,0.054,0.054,0.054,90488,36,12,105873223,36.1,105873835,+,C12orf23,MGC17943;,NM_152261.1,GI:22748614,synonym: MGC17943,hypothetical protein LOC90488,positive,chr12:107349093,0.153616617228193,-0.00937703752998745,-0.301015240902028,-0.316680216762117,0.397917428803005,0.575156338496383,0.62980806792516,1.70519967198954,0.636500338380434,-0.335942669034265,50.4744110107422,1.63961057278611,No,No,Yes,No,2,Promoter
cg26372517,0.126025756,NA,0.017,0.01,0.85,0.23,0.16,0.28,339488,36,1,35811746,36.1,35811558,+,TFAP2E,AP2E; MGC49007;,NM_178548.2,GI:31341730,adaptor-related protein complex 2; epsilon subunit; go_component: nucleus; go_function: transcription factor activity; go_process: regulation of transcription; DNA-dependent,transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon),positive,chr1:36039159,-0.425922417611972,-0.286025262449441,0.779726335708513,1.60245047807394,-0.0683990680426255,0.604235084429623,0.143911548311058,-1.09514377843973,1.79059460499544,-0.31599441915745,72.5873947143555,2.22191253777415,Yes,Yes,No,Yes,23,Bivalent promoter
cg26394940,-0.166268862,-0.344126844,0.021,0,0.91,0.076,0.11,0.064,55267,36,22,44828125,36.1,44828688,-,FLJ10945,,NM_018280.1,GI:8922784,,hypothetical protein LOC55267,negative,chr22:46449461,-0.18278784639318,-0.358584201912414,0.100641930822196,-0.630623238549537,-0.162141471682579,-0.271791120056453,-0.672589004689667,-0.947152771528809,-0.669429153245953,-0.380967708289412,83.8309696796826,2.49400228487154,Yes,No,Yes,No,1,Active TSS
cg26453588,0.127052431,0.188751514,0.017,0.0049,0.95,0.43,0.36,0.47,638,36,22,41835965,36.1,NA,+,BIK,BP4; NBK; BBC1; BIP1;,NT_011520.11,,apoptosis-inducing NBK; go_component: membrane; go_component: integral to membrane; go_function: protein binding; go_function: protein binding; go_process: apoptotic program; go_process: regulation of apoptosis; go_process: induction of apoptosis,BCL2-interacting killer,positive,chr22:43506021,-0.779016955351759,-0.594760808282961,0.917429451142737,0.054407856450555,-0.759589351422086,-0.415974394105772,-0.759168726498741,-0.66528346005494,0.526033328081642,-0.418557385628422,79.8085861206055,2.0037680094128,No,Yes,Yes,No,23,Bivalent promoter
cg26456957,-0.159361013,NA,0.00024,0,0.37,0.043,0.043,0.042,54776,36,19,60321175,36.1,60320739,-,PPP1R12C,p84; DKFZp434D0412;,NM_017607.1,GI:14149715,myosin-binding subunit 85,protein phosphatase 1; regulatory subunit 12C,negative,chr19:55629363,0.0666059299627625,0.551790517430742,-0.0972105988653901,-0.581973683835657,0.382155554424254,0.310163760234056,-0.15568216487822,0.412535060898979,-0.296992394246314,-0.439261680600165,72.8351014058786,0.929520417220647,No,No,Yes,No,3,Promoter
cg26614073,-0.506521375,-0.740945549,0.027,0.018,0.97,0.44,0.56,0.39,22937,36,3,47492823,36.1,47492449,-,SCAP,KIAA0199;,NM_012235.2,GI:66932901,###############################################################################################################################################################################################################################################################,SREBP cleavage-activating protein,negative,chr3:47517819,0.78061014593826,-0.309291909826814,-0.179270790314263,-0.510013673736148,0.365745628417428,0.577053601859859,-0.444636745585833,0.235619900203306,-0.203439265891027,-0.421187151034055,79.9630584716797,2.04446684878779,Yes,No,Yes,No,3,Promoter
cg26620959,-0.040743067,NA,0.0016,0.017,0.56,0.072,0.067,0.076,23345,36,6,153000182,36.1,153000227,-,SYNE1,8B; CPG2; MYNE1; MYNE-1; SYNE-1; SYNE-1B; FLJ30878; KIAA0796; KIAA1262; KIAA1756; dJ398G3.1; dJ398G3.2; nesprin-1; RP3-398G3.1; RP11-809I23.2; DKFZp781J13156;,NM_015293.1,GI:19526752,###############################################################################################################################################################################################################################################################,nesprin 1 isoform beta,positive,chr6:152958489,-0.240388825907199,-0.382002529442168,0.154601384940009,1.45141937561171,-0.408133120523015,0.331141885594751,-0.228764176121561,-1.06798079552543,0.566179995484157,-0.342397795403595,55.1782686323894,2.29846889486241,Yes,No,Yes,No,23,Bivalent promoter
cg26723847,-0.144822054,NA,0.0052,0,0.86,0.08,0.077,0.08,23310,36,11,133600862,36.1,133599636,-,hCAP-D3,KIAA0056; MGC104671;,NM_015261.2,GI:76880473,go_function: binding,KIAA0056 protein,negative,chr11:134095652,0.09519508389425,0.0966263423729079,0.361269925842193,-0.411544858802085,0.173747009452031,1.60847065468841,0.0310223486527368,0.0793302180043246,0.336961854042463,-0.160234429701882,41.8876760772933,1.7073110022303,Yes,No,Yes,No,3,Promoter
cg26824091,0.549029142,NA,0.00091,0,0.73,0.059,0.062,0.056,2739,36,6,38778415,36.1,38778895,-,GLO1,GLYI;,NM_006708.1,GI:5729841,###############################################################################################################################################################################################################################################################,glyoxalase I,negative,chr6:38670437,0.645974981743721,0.573953160927696,-0.291033916336923,-0.351099754501045,0.102692525114569,0.18696319325233,0.91737389151638,0.377488132975895,-0.0561750060380046,-0.0298818382714528,56.700428056598,1.24825357159679,Yes,No,Yes,No,3,Promoter
cg26842024,0.358161798,0.051522717,0.0014,0.018,0.52,0.092,0.078,0.11,10365,36,19,16297122,36.1,16296651,+,KLF2,LKLF;,NM_016270.2,GI:49574523,###############################################################################################################################################################################################################################################################,Kruppel-like factor,positive,chr19:16436122,3.12300173101109,2.56215244409302,8.01380677161379,0.091100165136227,2.23740913018214,0.0103602727579312,0.569449594360639,0.0265916639835961,-0.113139503994812,5.01246174753904,82.8037948608398,2.0860517898795,Yes,Yes,No,No,1,Active TSS
cg26845300,0.254089345,0.474605378,0.0026,0,0.86,0.046,0.033,0.07,51429,36,6,158163821,36.1,158164282,+,SNX9,SDP1; WISP; MST155; SH3PX1; MSTP155; SH3PXD3A;,NM_016224.3,GI:23111056,###############################################################################################################################################################################################################################################################,sorting nexin 9,positive,chr6:158243833,1.41535548421488,-0.0101435644117219,-0.0330309165928208,0.085863458673915,1.05617764511151,0.994930211857575,-0.782519701408828,1.40926312519131,-0.00786546482010431,0.242662761542397,83.936882019043,1.99783444824987,Yes,Yes,No,No,2,Promoter
cg27015931,-0.466528425,-0.764866217,0.0027,0.022,0.61,0.092,0.11,0.09,255762,36,16,21919905,36.1,21919929,-,MGC50721,,NM_173806.2,GI:31341127,go_function: protein binding,hypothetical protein LOC255762,negative,chr16:22012404,-0.740317798290888,-0.519416225962371,-0.528135673323977,-0.345011067256152,-0.516499408455421,0.392832512541078,-0.359468035989861,0.00308804714061017,-0.212817683635932,-0.420590153018502,69.9146071740814,2.5871132702311,Yes,No,No,No,16,Weak enhancer
cg27016307,-0.035326263,NA,0.014,0.00082,0.85,0.41,0.45,0.38,3270,36,19,54350725,36.1,54350493,-,HRC,,NM_002152.2,GI:75905816,histidine-rich calcium-binding protein; go_component: smooth endoplasmic reticulum; go_function: calcium ion binding; go_function: structural molecule activity; go_process: muscle contraction,histidine-rich calcium-binding protein precursor,negative,chr19:49658913,-0.575838473436717,-0.904591062269496,-0.238098935618797,0.16513601295256,-0.838771610492942,-0.792669414244354,0.372904755842079,-0.0600487916579456,-0.319702644643902,-0.439261680600165,80.244384765625,0.256221531132607,No,No,Yes,No,13,Active enhancer
cg27092035,-0.055768503,NA,0.00096,0,0.68,0.046,0.043,0.049,285598,36,5,175725486,36.1,175725111,+,ARL10,ARL10A; FLJ39249;,NM_173664.3,GI:46195790,ADP-ribosylation factor-like membrane-associated protein; ADP-ribosylation factor-like 10A; go_function: GTP binding; go_function: nucleotide binding; go_process: small GTPase mediated signal transduction,ADP-ribosylation factor-like 10,positive,chr5:175792880,0.200228047355484,1.26908180399944,-0.585926213701922,0.253303247785446,0.531764248588605,0.768361370948617,-0.604469625212025,-1.26351928940604,0.66922496142708,-0.291422888086207,73.903076171875,3.13197299167842,Yes,Yes,No,Yes,23,Bivalent promoter
cg27169020,0.087286864,NA,0.026,0.01,0.93,0.35,0.24,0.4,646,36,15,81745233,36.1,81744472,-,BNC1,BNC; BSN1; HsT19447;,NM_001717.2,GI:19743791,###############################################################################################################################################################################################################################################################,basonuclin 1,positive,chr15:83954229,-0.765873123335975,0.193420337907777,0.187342927476347,2.43259373640168,-0.864277775959799,-0.890149421255485,0.410493729760065,-0.86086335155847,0.939176146027246,-0.439261680600165,49.5554046630859,3.24713020150547,No,No,Yes,No,24,Repressed polycomb
cg27202708,-0.138635766,-0.104235908,0.014,0.0095,0.84,0.29,0.29,0.3,164127,36,1,221633332,36.1,221633391,+,C1orf65,FLJ35728; RP11-76K24.1;,NM_152610.1,GI:22749248,synonyms: FLJ35728; RP11-76K24.1,hypothetical protein LOC164127,negative,chr1:223566709,-0.733817858972492,-0.423901027812116,0.484534700841516,0.806124673961296,-0.606513985444051,-0.499466017450028,-0.289546665792959,-1.07236746357161,-0.515401031956114,-0.439261680600165,52.03369140625,2.17366722969324,No,Yes,Yes,No,24,Repressed polycomb
cg27319898,-0.211230721,-0.048598042,0.0017,0.0082,0.65,0.062,0.057,0.066,219578,36,7,88226939,36.1,88226689,+,FLJ32110,,NM_181646.2,GI:37202115,go_component: nucleus; go_function: zinc ion binding; go_function: nucleic acid binding,hypothetical protein LOC219578,positive,chr7:88389003,-0.756671369122333,-0.708012923541726,0.681956919338243,2.984126838057,-0.918996542460326,-0.171574173978045,1.50513391067565,0.335015496696325,0.854421857144259,-0.439261680600165,6.59927797317505,1.23461846890918,Yes,Yes,No,No,23,Bivalent promoter
cg27377450,0.092440884,0.362731851,0.0073,0.0055,0.99,0.88,0.88,0.88,23370,36,19,7352301,36.1,7351866,+,ARHGEF18,KIAA0521; MGC15913;,NM_015318.2,GI:41327768,P114-RHO-GEF; go_function: guanyl-nucleotide exchange factor activity,Rho-specific guanine nucleotide exchange factor p114,positive,chr19:7446301,-0.67293053863386,-0.731392582555307,9.54771670920524,-0.673045636712037,-0.928204736157703,-0.746321553240556,-0.0884417673901312,-0.242317397257865,-0.539247615043817,-0.3471497332797,60.0044121302274,2.59002965688705,Yes,No,No,No,8,Weakly transcribed
cg27413543,-0.261275244,NA,0.00029,0.022,0.56,0.066,0.064,0.067,22872,36,4,84031172,36.1,84031424,-,SEC31L1,ABP125; ABP130; SEC31A; HSPC275; HSPC334; KIAA0905; MGC90305; DKFZp686N07171;,NM_014933.2,GI:41349438,isoform 1 is encoded by transcript variant 1; yeast Sec31p homolog; protein-transport protein SEC31; go_component: COPII vesicle coat; go_function: molecular function unknown; go_process: ER to Golgi vesicle-mediated transport,SEC31-like 1 isoform 1,positive,chr4:83812148,2.48153257967294,1.85211334773918,0.26349897104849,-0.599451818447236,1.6511307893174,0.88887526303697,0.103639342260399,0.429123092848701,-0.710886434697735,0.985108165619913,72.5009231567383,3.32809223636272,Yes,Yes,No,No,3,Promoter
cg27494383,0.064596615,NA,0.0059,0,0.98,0.05,0.047,0.05,4058,36,15,39593160,36.1,39593369,-,LTK,TYK1;,NM_206961.1,GI:46249415,###############################################################################################################################################################################################################################################################,leukocyte tyrosine kinase isoform 2,positive,chr15:41805868,-0.637187440438026,-0.193714260465045,-0.298827380904753,1.25696477050543,-0.516433623126571,1.02270897384537,0.286374095980206,0.58617130853521,0.771066588418433,-0.330135684091782,83.7885513305664,1.30304049709882,Yes,No,Yes,No,2,Promoter
cg27544190,-0.869124446,-1.230694818,0.003,0.0088,0.6,0.088,0.1,0.086,59271,36,21,32707305,36.1,32706623,+,C21orf63,B18; SUE21; PRED34;,NM_058187.3,GI:38372914,go_component: integral to membrane; go_function: sugar binding,chromosome 21 open reading frame 63,negative,chr21:33785434,-0.0839313870925214,-0.208608287618701,0.159309843342594,0.237031648092727,-0.0358199096384356,0.279265907035402,0.379677437058035,-0.548593139103935,0.363365297557388,-0.259372011736683,59.9108998781428,2.05123694042115,Yes,Yes,No,No,3,Promoter
